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ABSTRACT
Compliance and angio-permissive, three-dimensional ingrowth spaces are important
determinants in the healing of vascular prostheses. Conventional ePTFE and Dacron prostheses,
as well as experimental polyurethane grafts, fail to provide satisfactory long-term outcomes in
small-diameter applications due to a lack of one or both of these criteria. Thus a compliant
polyurethane graft containing well-defined, interconnected pores is proposed. These structures
were successfully produced by a novel phase inversion/porogen extraction technique using
spherical porogens. The pore sizes and interconnectivity could be accurately controlled by
variation of the porogen size and the precipitation conditions. Thus pores of 66.1±0.3, 84.2±1.7
and 157.0±2.4flm containing interconnected windows of 30.1±0.8, 41.9±1.5 and 76.4±2.0flm
could be produced from 64.5±0.3, 87.5±0.7 and 129.0±0.9flm beads, respectively.
The healing response toward implanted devices often leads to excessive inflammation that, in
turn, leads to the formation of unwanted fibrotic scar tissue, and the need to eliminate or reduce
this response is obvious. Both pore size and surface characteristics have been shown to
influence this response. By increasing the pore size of porous scaffolds from 66 to 157flm, the
inflammatory response was reduced by 56% (p<0.05). A combination of increased pore size
with the pacification of the grafts surfaces with covalently immobilized collagen resulted in an
even further decrease in the foreign body response in the rat model (80% decrease; p<0.002).
A senescent chacma baboon model was developed for the evaluation of prosthetic vascular
grafts. The model consists of an isolated graft segment (between two isolating, low porosity
ePTFE segments) and allows for the evaluation of transmural healing in the test segment without
interference from trans anastomotic outgrowth.
In order to determine whether an increase pore in dimensions alone would result in the desired
healing response, very high porosity (150flm IND) ePTFE was compared to standard 30flm
material in the isolated primate model. Although the increase in pore size allowed for the
ingrowth of capillaries and arterioles, migration to the inner graft surface was inhibited by a
dense, impenetrable fibrin layer deposited on the lumenal surface. Elimination of the fibrin layer
by the application of a sealant resulted in slightly improved transmural healing, but the
node/fibril structure and non-compliant nature of ePTFE was not conducive to cellular re-
orientation.
Evaluation of high-porosity polyurethane grafts in the same model showed penetration of
capillaries and arterioles, as well as small smooth muscle cell bands throughout most of the
thickness of the wall. This response was, however, also limited by the hostile fibrin deposit.
The sealing of the lumenal surface in this case led to the desired outcome. Not only did
capillaries and arterioles migrate through and populate the entire thickness of the graft wall, but
also thick bands of helically oriented smooth muscle cells were observed directly on the outer
surface of the lumenal sealant. This is an important milestone in the development of synthetic
grafts that would mimic both the structure and function of natural arteries they are to replace.
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OPSOMMING
Meganiese uitsetting as gevolg van gepulseerde druk en 'n oop, drie-dimensionele, porieuse
struktuur is belangrike voorvereistes vir die herstel van vaskulêre prostese. As gevolg van 'n
gebrek aan een of beide van hierdie vereistes, bied konvensionele ePTFE - en Dacron prostese
nie bevredigende lang-termyn resultate in lae deursnit toepassings nie. Hierdie studie ondersoek
dus die gebruik van 'n elastomeriese poliuretaan (PU) prostese met goed-gedefineerde,
interkommunikerende porieë. 'n Nuut-voorgestelde tegniek, wat die fase-inversie en ekstraksie
van sferiese porogene behels, is gebruik om hierdie strukture te vervaardig. Die poriegrotes en
interkonnektiwiteit kon akkuraat beheer word deur die variasie van porogeengrote en
presipitasiekondisies. Porieë van 66.1±0.3, 84.2±1.7 en 157.0±2.4f1IIl, met interkonneksies van
30.1±0.8, 41.9±1.5 and 76.4±2.0Ilm kon gevolglik vervaardig word deur die gebruik van PU en
64.5±0.3, 87.5±0.7 and 129.0±0.9Ilm porogene.
Die reaksie tot prostetiese materiale in vivo, lei dikwels tot oormatige inflammasie wat weer tot
die ontwikkeling van fibrotiese letselweefsel lei. Daar word gewys dat beide poriegrote en
oppervlakeienskappe die inflammatoriese reaksie beinvloed. 'n Toename in poriegrote van 66
na 1571lm het bevoorbeeld gelei tot 'n 56% afname in inflammasie (p<0.05), terwyl 'n afname
van 80% behaal is (p<0.002) deur 'n kombinasie van vergrote porieë en pasifiseering van die
oppervakte met kovalent gebonde kollageen.
'n Volwasse femorale chacma bobbejaanmodel is ontwikkel vir die evaluasie van vaskulêre
prosteses. Die model behels die interposisionering van die toetsmateriaal tussen twee segmente
van 30llm interfiebrielafstand ePTFE. Dit laat die evaluasie van radiale ingroei van weefsel
(deur die wand) toe, sonder dat transanastomotiese uitgroei die resultate beinvloed.
Om te bepaal of 'n toename in poriegrote alleen tot die verlangde mate van herstel kan lei, is
ePTFE met baie groot porieë (150llm) met standaard 30llm materiaal in die geïsoleerde model
vergelyk. Alhoewel die toename in poriegrote die ingroei van kapillêre en arteriole toegelaat
het, is migrasie na die binneoppervlak verhinder deur 'n digte, ondeurdringbare fibrienlaag wat
deur die bloed gedeponeer is. Eliminasie van hierdie fibrienlaag deur die aanwending van 'n
seellaag het gelei tot 'n klein verbetering in radiale weefselingroei, maar die node/fiebriel
struktuur en nie-elastomeriese eienskappe van ePTFE het nie sellulêre orientasie toegelaat nie.
Hoë porositeit poliuretaan is ook in die bogenoemde model ge-evalueer. Afgesien van die
ingroei van kapillêre en arteriole deur die grootste gedeelte van die wand, is klein bundels gladde
spierweefselselle ook waargeneem. Hierdie herstel is egter weereens deur die fibrienlaag
beperk. Die aanwending van 'n seellaag op hierdie materiaal (1571lm PU) het egter die gewenste
uitwerking gehad. Buitenbehalwe die migrasie en besetting van die hele wand deur kapillêre en
arteriole, is die vorming van helies-georienteerde bundels gladde spierweefselselle op die
buiteoppervlak van die seellaag waargeneem. Dit is 'n belangrike deurbraak in die ontwikkeling
van sintetiese vaskulêre prostese wat beide die struktuur en funksie van natuurlike bloedvate
naboots.
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The surgical union organs, e.g. blood vessels, to ensure passageway
A fluid-filled sac in the wall of an artery that can weaken the wall and lead to excessive localized enlargement
A common arterial disease in which raised areas of degeneration and cholesterol deposits (plaques) form on the
inner surface of arteries
Derived from the patient's own body
Artery located under the armpit
A split or branch into two parts
Made of a substance that will degrade, in this case, in the body
Made of a substance that will be stable, in this case, in the body
A surgical operation to redirect the blood around the occlusion via a grafted blood vessel. Carried out when the
existing vessel has become blocked
A large artery on either side of the neck that supplies blood to the head
A fibrous protein found in skin, bone, cartilage, tendon and other connective tissue
The ability of a vessel to dilate and contract in sympathy with an internal pulsatile pressure
An artery supplying blood to the muscles of the heart.
Further away from the point of reference (e.g. the centre of the body or the heart)
A layer of cells that lines the inside of certain body cavities, for example, blood vessels
Originating outside an organism or system
Artery located in the thigh
An insoluble fibrous protein produced by the polymerisation of fibrinogen during the blood clotting process
A type of cell that secretes the proteins that form collagen and elastic fibres and the substance between the cells
of connective tissue
An abnormal thickening and scarring of connective tissue most often following injury, hypoxia, or surgery
The loss of blood from a ruptured blood vessel
A polysaccharide present in living tissue that functions naturally as an anticoagulant and is used medically to treat
thrombosis
Derived or taken from a different species
A graft of tissue from one organism to another of the same species
Corresponding in structure, position and origin etc.
Abnormal growth in a part of the body, caused by an excessive multiplication of cells
An inadequacy in the oxygen reaching the body's tissues
Artery located in the lower abdomen and pelvis
In an artificial environment such as a test tube rather than inside a living organism
Existing or carried out inside a living organism, as in a test or experiment
An inadequate supply of blood to a part of the body, caused by partial or total blockage of an artery
Anyone of the four pairs of veins in the neck that drain blood from the head
The tying of something with a surgical ligature
A cell present in the blood, lymph, and connective tissues, removing waste products, harmful organisms and
foreign material
Blocked
Used to describe an artery, duct or other tube in the body that is naturally open and unblocked
The percentage of grafts still patent after a gi ven time
Relating to , or arising from, disease
The scientific study of the nature, origin, progress, and cause of disease
A vessel that is used to bypass an occlusion in another vessel by resecting the distal end of the first but leaving its
proximal end attached in its original position
Artery in the part of the leg behind the knee
A substance (particle), the use of which is responsible for the creation of pores
Nearer to the point of reference (e.g. the centre of the body or the heart)
An artery that supplies blood to the kidneys
Vein that runs from the foot to the thigh near the surface of the skin
Approaching an advanced age
A type of muscle cell that functions involuntarily; found in blood vessels
The removal of a clot from a blood vessel
Surgical excision of the atheromatous tunica intima of an artery
The formation or presence of blood clots that may partially or completely block an artery or vein
The culture of living cells to form viable structures or organs
An event that occurs across the anastomosis (juncture between the natural vessel and the prosthesis)
An event that occurs through the wall of the prosthesis
Outer layer of a blood vessel (also adventitia)
Inner layer of a blood vessel (also intima)
Middle layer of a blood vessel (also media)
Vascular prosthesis
An artificial blood vessel
The arrangement of blood vessels in the body, an organ, or tissue
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Meaning
Stiffness parameter
Surface energy
Stress at break
Elongation at break
Polymer bulk density
Porogen bulk density
Critical surface tension
Dispersive component of solubility parameter
Dispersive component of surface energy
Hydrogen bonding component of solubility parameter
Polar component of solubility parameter
Polar component of surface energy
Polymer density
Porogen density
Solution density
Sol vent density
Total solubility parameter
Contact angle with water
Total concentration of unreacted monomers in the feed at any time.
Concentration of MI'
Concentration of polymeric species ending in an MI-type active center.
Concentration of M I in feed at zero conversion.
Concentration of M2.
Concentration of polymeric species ending in an Mrtype active center.
Concentration of M2 in feed at zero conversion.
Degrees Celsius
Micrometer
Compliance (based on diameter change)
Compliance (based on volume change)
Diameter at diastole
Diameter at systole
Modulus at 100% elongation
Young's Modulus
Mole fraction of un reacted MI in feed.
Instantaneous mole fraction of MI entering the copolymer.
Mole fraction of M, in feed at zero conversion.
Average mole fraction of MI in the total amount of copolymer formed up to that point.
Mole fraction of unreacted M2 in feed.
Instantaneous mole fraction of M2 entering the copolymer.
Mole fraction of M2 in feed at zero conversion.
Average mole fraction of M2 in the total amount of copolymer formed up to that point.
Gram per cubic centimeter
Rate constant for reaction of MI' with MI (radical first).
Rate constant for reaction of M I' with M2.
Rate constant for reaction of M2' with MI'
Rate constant for reaction of M2' with M2•
Molarity (mol/dm')
Total number of moles of unreacted monomers in the feed at any time.
Total number of moles of unreacted monomers in the feed at zero conversion.
Percentage by mass
Monomer I.
Polymeric species ending in an MI-type active center.
Total number of moles ofunreacted MI in the feed at zero conversion.
Monomer 2.
Polymeric species ending in an M2-type active center.
Total number of moles of unreacted M2 in the feed at zero conversion.
Number average molecular weight
Megapascal
Porogen mass
Polymer mass
Solvent mass
Solution mass
Weight average molecular weight
Number fraction of sequences of MI of length x.
Number fraction of sequences of M2 of length x.
Probability that growing radical ending in MI' adds to MI'
Probability that growing radical ending in MI' adds to M2•
Probability that growing radical ending in M2' adds to MI'
Probability that growing radical ending in M2' adds to M2.
Porosity by area (cross section)
Porosity by area (inner surface)
Porosity by area (outer surface)
Pressure at diastole
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Porosity of closed pores as determined by the gravimetric method
Porosity of open pores as determined by the gravimetric method
Total porosity of pores as determined by the gravimetric method
Pore size (inner surface)
Pore size (outer surface)
Pressure at systole
Porosity of macropores as determined by the theoretical method
Porosity of micropores as determined by the theoretical method
Total porosity as determined by the theoretical method
Porosity by volume
Porosity of closed pores as determined by the volumetric method
Porosity of open pores as determined by the volumetric method
Total porosity of pores as determined by the volumetric method
Pore size (cross section)
radius
Reactivity ratio of M!.
Reactivity ratio of M2.
Suture retention strength
Wall thickness
Glass transition temperature
Melting temperature
Volume at diastole
Volume of closed pores as determined by the gravimetric method
Volume of open pores as determined by the gravimetric method
Total volume of pores as determined by the gravimetric method
Porogen volume
Volume at systole
Solvent volume
Volume of closed pores as determined by the volumetric method
Volume of open pores as determined by the volumetric method
Volume of the polymeric scaffold containing open and closed pores (volumetric method)
Volume of the polymeric skeleton containing the micropores (volumetric method)
Total volume of pores as determined by the volumetric method
"Relative weight" of M! in the copolymer
"Relative weight" of M2 in the copolymer
Water permeability
Mole conversion of total monomer to polymer.
Average length of M, sequences.
Average length of M, sequences.
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CHAPTER I
Introduction
1.1 Background
The high demand for vascular grafts (prostheses) used to augment the insufficient functioning of
the vascular system may be inferred from the high number of clinical cases that require such
devices (estimated to be between 1 million [1] and 1.4 million [2] cases annualy).
The highest demand is for small-diameter vessels (xómm) used in coronary bypasses and the
alleviation of peripheral ischemia. Contemporary small-diameter vascular prostheses (expanded
polyterafluoroethylene (ePTFE) and knitted/woven polyethylene teraphthalate (PET, Dacron))
fail to deliver the desired long-term outcomes due to inadequate healing responses and resultant
thrombotic events [3]. Although research into the use of alternate porous scaffolds has been
underway for the past 30 years, a viable replacement for commercially available Dacron and
ePTFE prostheses has not yet been developed.
Tissue engineering, as related to vascular surgery, has been defined by Chaikof [4] as: "An
integration of the principles and methods from engineering, chemistry, medicine, and molecular
biology in defining biophysical and molecular mechanisms that control the function and
morphology of the vascular wall; establishes a framework for the development of improved
biologically functional vascular prostheses and enhanced therapeutic options for the treatment of
atherosclerosis." It is a field in which a variety of tissue types are cultured both in vitro and in
vivo, often using polymeric scaffolds as supports [2].
Although tissue engineering generally relies on the use of biodegradable scaffolds, this study
shows how porous, biostabie scaffolds may be used in an in vivo tissue engineering approach to
improve the fate of hybrid synthetic/biological vascular grafts.
1.2 Scope
This study forms part of a larger research project by a multidisciplinary group at the
Cardiovascular Research Unit at the University of Cape Town, aimed at the development of
tissue-engineered cardiovascular prostheses. The larger study is aimed at the combination of
porous scaffolds with engineered ingrowth matrices (within the porous structure) in order to
attain favourable long-term outcomes through suitable healing responses and transmural
endothelialisation.
This dissertation contributes to the knowledge pertaining to the preparation, characterization and
use of porous scaffolds for use as vascular prostheses. It describes how porous structures useful
in this application may be improved by the optimization of pore size, pore structure and surface
pacification. It additionally provides information on the use of in vivo methods suitable for the
evaluation of porous scaffolds, and healing responses obtained by the use of these methods.
Additional work closely related to this development, namely the computational mechanical
analysis by finite element methods and compliance measurements, forms the subjects of theses
by various students carried out under the guidance of the author [5-8].
Engineered biological and synthetic matrices, that would further encourage differential ingrowth
of the desired cellular and extracellular matrix materials into the porous structure, are being
developed in parallel with the scaffolds described in this dissertation.
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The scope of this dissertation includes:
~ An historical overview on the need for vascular grafts
~ The theoretical considerations influencing vascular graft properties and identification of
desirable and undesirable properties
Introduction
~ The development of a concept for novel vascular grafts
~ The development of porous scaffolds suitable for use in vascular prostheses
~ The development of novel synthetic vascular grafts consisting of:
• a porous scaffold
• a chemically modified surface, and
• a reinforcing structure
~ The in vivo evaluation of the healing response towards these grafts.
1.3 Objectives
The ultimate polymeric vascular graft is one that allows for the incorporation of the prosthetic
device in a polymer/tissue composite by the ingrowth of cellular material in order to produce a
living neo-artery. Such an ingrowth would involve not only the formation of an endothelium on
the lumen, but also population of the pores by active, helically-oriented smooth muscle cells (and
supporting blood vessels) with accompanying extracellular matrix materials. This research
contributes towards the ultimate goal by providing insight into the properties required of
structures for the transmural ingrowth and orientation of smooth muscle cells and blood vessels
required to support the viability of ingrown cells.
Thus, the objectives of this study were to:
~ Review the healing responses associated with experimental and commercially available
vascular prostheses and identify variables responsible for the poor performance of these
grafts in small-diameter applications
~ Provide a concept for a novel vascular graft that would provide improved healing responses
by eliminating some of the shortcomings of currently available grafts
~ Produce structures containing well-defined, interconnected pores (resembling pentagonal
dodecahedra) that would theoretically allow uninterrupted cellular ingrowth.
~ Decrease the in vivo inflammatory response normally associated with implanted porous
structures by the optimization of pore size.
~ Further decrease this inflammatory response by chemical surface-modification of these
structures.
~ Develop a circulating in vivo model, suitable for the evaluation of porous vascular grafts,
that would enable the differentiation between transanastomotic and transmural healing
effects.
~ Determine the effect of pore size on the healing response of expanded PTFE vascular grafts
in the circulating in vivo model, and determine whether large porosity on its own is sufficient
for full transmural healing.
~ Evaluate the healing response toward experimental polyurethane vascular grafts containing
well-defined, interconnected pores that should, theoretically, be conducive to full transmural
healing
~ Modify experimental polyurethane vascular grafts in order to achieve the population of the
porous structure by helically oriented smooth muscle cells and supporting blood vessels,
similar to those found in natural arteries.
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1.4 Layout
The document has been structured in the following manner:
~ The first four chapters provide an overall introduction and overview of historical and
theoretical aspects pertaining to the field of vascular grafts, and a concept for a new graft.
~ The subsequent chapters take the form of journal articles. Although some duplication is
inevitable, the information contained in these latter chapters is highly specific to each study.
This allows for a more detailed analysis of each topic in the relevant section.
~ A summary of the results obtained in the various studies, and an overall conclusion, is given.
~ An appendix that contains additional details pertaining to various subjects described in the
dissertaion isprovided.
1.5 References
1. Zdrahala, R., Small caliber vascular grafts. Part I: State of the art. J Biomater Appl, 1996. 10(4): p. 309-
29.
2. Niklason, L.E. and Langer, R.S., Advances in tissue engineering of blood vessels and other tissues. Transpl
Immunol, 1997.5(4): p. 303-6.
3. Bezuidenhout, D. and Zilla, P., Biomaterials in Vascular Surgery, in Encyclopedia of Materials: Science
and Technology, K. Boschow, Cahn, R., Flemmings, M., Ilscher, B., Kramer, E., and Mahakan, S., Editors.
2001, Elsevier.
4. Chaikof, E., Biomaterials that imitate cell microenviroments. Chemtech, 1996(August): p. 17-22.
5. Millam, R., Design of an adventitial type reinforcement of prosthetic vascular grafts through mechanically
affirmed material and structure modulation., in Faculty of Health Sciences. 2001, University of Cape
Town: Cape Town.
6. Yeoman, M., Design and optimisation of a fabric reinforced porous prosthetic graft using finite element
methods and genetic algorithms, in Mechanical Engineering, University of Cape Town: Cape Town.
7. Hughes, A., Mechanical design aspects of a small diameter vascular graft with structured porosity, in
Mechanical Engineering. 2000, University of Cape Town: Cape Town.
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3
Stellenbosch University http://scholar.sun.ac.za
Chapter 2 Overview
CHAPTER2
Overview on vascular grafting
2.1 The need for vascular intervention
The total length of blood vessels in the average adult human body has been estimated to be
100,000 miles. In addition to the classification of this complex network of vessels into arteries
and veins, the vascular tree may be further sub-classified into large elastic arteries, smaller
muscular arteries, arterioles, capillaries, venules, medium-bore veins, and large veins, Apart
from the obvious function performed by these vessels, namely that of providing a conduit for the
flow of blood from the heart to the organs and extremities, and the return of the blood to the
heart, each of these vessel types is highly specialised in form and function in order to perform
specific tasks to the best effect.
Clinical intervention may be indicated in the treatment of blood vessels affected by pathological
conditions and/or traumatic injury resulting in aneurismal dilation, arterial haemorrhage,
thrombotic or atherosclerotic occlusion. Although less severe and less critical injuries and
pathologies may be treated by alternative methods, all three cases may require surgical
intervention to avoid aneurismal failure, prevent excessive blood loss, or restore blood flow to
the distal vascalature. Surgical intervention, in tum, may take on many forms, including ligation,
suturing, reconstruction, anastomosis, thromboendarterectomy, arterialembolectomy, and
grafting (replacement and bypass).
This dissertation will focus on novel prosthetic devices used in replacement and bypass grafting,
and specifically on synthetic vascular grafts suitable for replacing or bypassing occluded small-
diameter arteries.
2.1.1 Vascular surgery
From antiquity to the eighteenth century, the management of arterial haemorrhage and
aneurysms mostly involved the use of manual compression, cauterisation and ligation. It was
only in the nineteenth century that laboratory designed techniques for suturing vascular wounds
and anastomosing blood vessels were introduced. Matas [1] was one of the first to describe these
methods for the management of aneurysms by using a technique in which a new vessel was
made out of the old one.
It could be said that the modem era of vascular surgery was ushered in by the work of Carrel [2]
in the first decade of the twentieth century. He carried out the basic investigations concerning
blood vessel surgery, including the study of functional and histological analysis of preserved
homografts. Carrel's innovations had such an impact that he received the Nobel Prize for
medicine in 1912 "in recognition of his work on vascular suture and transplantation of blood
vessels and organs." [3]
2.1.1.1 The replacement principle
Even though the pioneering efforts of Matas were of great importance during the early phase of
vascular surgery, the grafting of vessels was to have an even greater impact on its development.
Vascular replacement surgery involves, as the name indicates, the removal of a damaged arterial
section and the replacement thereof with a suitable conduit. At about the same time as Carrel
carried out his work, Goyanes described the use of a popliteal vein in situ to restore the
continuity of the popliteal artery after the excision of an aneurysm [4]. This was closely
followed by the use of a free vein graft by Lexer [5] in a similar operation, where an 8-cm defect
in an axillary artery was bridged with an autologous segment of saphenous vein. This method
was applied with equal success to the replacement of an iliac artery after removal of an aneurysm
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from such a vessel. Despite further successes with the use of free-vein transplantation for the
treatment of aneurysms before the first World War, and excellent results achieved in the
treatment of traumatic aneurysms by German surgeons during World War I, ligation remained
the treatment of choice for similar cases in the American Army, even during the Second World
War [6]. This practice remained in use also in the Korean war, when advances in civilian blood
vessel surgery were applied to traumatic vascular lesions. Autologous vein grafts are still used
today, not only for peripherál vascular reconstructions but also for coronary and cerebral bypass
surgery.
The application of the replacement principle to large-bore arteries (notably aorta and aorto-iliac
bifurcations) was made possible by two major developments in the 1940s and 1950s that
completely revolutionized surgery for cardiac and aortic lesions. The first was the use of
hypothermia to lower the body's oxygen consumption and the second the introduction of the
heart-lung machine for extra-corporeal circulation and oxygenation. Whereas autologous veins
suitable for the reconstruction of small-diameter arteries could be removed and transplanted to
the new position in the arterial vasculature, the replacement of large arteries presented surgeons
with the added impediment that no autologous veins of suitable size could be removed from the
patient without life-threatening implications. Gross et al. were the first to circumvent this
problem by using preserved homografts for arterial transplantation [7]. This led to the first
successful resection of the aortic bifurcation and replacement with a homograft by Oudot [8] in
1951, and the successful resection of an abdominal aortic aneurysm (AAA) with insertion of a
homograft by Dubost et al. [9]. Thereafter, many segments of the thoracic aorta, including the
arch, were treated by excision and replacement with homografts.
2.1.1.2 The bypass principle
The bypass principle, involving the bypassing of the diseased or injured vessel with a suitable
conduit while leaving the original vessel intact, was first advocated by Ernst Jaeger in 1913 for
the management of peripheral aneurysms [10]. Itwas not until 1948, however, that Kunlin [11]
reported this procedure for the treatment of femoro-popliteal occlusive arterial disease. This
approach was entirely novel and had significant advantages over the replacement procedure;
excessive operative trauma and damage to adjacent nerves and veins was avoided, permitting the
preservation of collateral vessels. It is interesting to note that this discovery, and historical
landmark in vascular surgery, was born out of necessity, when Kunlin's attempt to implant a
venous graft after the removal of an occluded femoral artery failed to relieve the ischemia (by
peripheral vasodilation). The end-to-end approach was impossible due to pronounced fibrotic
reaction in the previous operative area, and a decision was made to perform an end-to-side
implantation of the venous graft. Today, the bypass principle is applied to the management of all
sorts of arterial lesions and occlusions, especially those below the groin and, notably, in the
coronary artery position.
In conclusion it may be said that the replacement principle is utilised in the management of large
bore arteries, while the bypass principle is employed to treat pathologies associated with small-
bore blood vessels.
2.2 Types of grafts
Grafts used for the replacement and bypassing of blood vessels may be classified into two broad
groups: bioprosthetic and synthetic. Bioprosthetic grafts are composed of autologous,
homologous or xenogeneic tissue. These tissue grafts may, in some cases, be stabilised by
erosslinking with various fixation techniques or by reinforcement with synthetic materials. The
second group comprises prosthetic vascular prostheses fabricated entirely (or mostly) from
synthetic materials.
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2.2.1 Bioprosthetic grafts
2.2.1.1 Autologous grafts
Fresh, viable autologous veins have been demonstrated to be the preferred graft for use in
relieving lower extremity ischemia by, for example, femoropopliteal bypass grafting [12].
Depending on the exact nature and position of the graft vein relative to the position of the
bypass, the graft vein may either be excised and re-implanted in a reverse configuration, or left
in-situ with only the proximal and distal ends repositioned and anastomosed to the occluded
artery. The in-situ use of veins for arterial bypassing requires the removal of venous valves to
allow unrestricted blood flow. Autologous veins (saphenous and jugular veins, and veins of the
upper extremities) may further be used for carotid, renal, and other sites.
Although dispensable autologous arteries are usually not as readily available as autologous
grafts, their use is indicated as preferential grafts. In coronary artery bypass surgery, the pedicle,
left, internal-mammary (LIMA) has long been the superior conduit, but its application is
generally limited to the left anterior descending (LAD) coronary artery [13]. Depending on the
anatomical position of the graft, the age of the patient, and other factors, further stenoses may be
bypassed with either the pedicle or free right internal mammary artery (RIMA), radial arteries,
gastroepiploic arteries and saphenous vein grafts. Other specific examples of the use of
autologous arteries include the application of resected autologous iliac arteries (that are
subsequently replaced with a suitable synthetic prosthesis) to a more critical location, and the use
of radial arteries in coronary positions of young patients.
2.2.1.2 Homologous grafts
Prior to the development of good synthetic prostheses, homologous arterial tissue used to be the
standard clinical large-bore material. This tissue type has been used in various forms: fresh,
frozen, refrigerated in physiological solution, freeze-dried, glycerine preserved, alcohol
preserved, dried, and preserved in formalin [12]. The order of ascending reactivity elicited by
the host (and thus descending acceptability as a vascular graft) is equal to the order in which the
types have been listed above. Although arterial homografts are rarely used today, they still find
some application as aortic arch replacements.
Glutaraldehyde-fixed homologous umbilical veins have found some application as bypass grafts
for small-diameter arteries in the lower extremities. These grafts are typically externally
supported with a light Dacron mesh to enhance structural integrity, and may offer a reasonable
alternative to autologous veins when the latter are not available [14].
2.2.1.3 Heterologous grafts
Tissue fixation procedures similar to those used for the erosslinking of heterologous
bioprosthetic heart valves have also been used with some success to preserve heterologous
arterial tissue. Typically, bovine carotid arteries were fixed in dialdehydes to reduce the
antigenicity, reinforced with Dacron mesh to improve mechanical strength, and used as vascular
access grafts [12]. The use of heterologous vein grafts has not been reported to any great extent.
2.2.2 Synthetic grafts
The development of synthetic vascular grafts dates back to the beginnings of experimental
vascular surgery in 1912. Carrel [15] experimented with glass and aluminum tubes, while
parafin-coated silver tubes were used by Tufier in WW I [16]. More recently, many other
materials, including Vitaluminum tubes, polyethylene tubing, silicone rubber, steel mesh tubes
and Ivalon", have been used as experimental vascular conduits [17]. One of the first polymeric
conduits used for arterial substitution in humans was a solid, rigid poly(methyl methacrylate)
tube described by Hufnagel in 1947 [18]. These conduits all failed due to thrombosis.
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An observation made by Voorhees of an endothelial-like surface on a silk thread in the ventricle
of a dog led to the reasoning that textile fabrics might serve as suitable graft materials [19]. The
relative success with poly(acrylonitrile-co-vinyl chloride) (Vinyon-N") fabric tubes ushered in
the concept of the use of textile materials as vascular grafts. In addition to textile and expanded
structures, a variety of other fibrillar and foam-type porous structures have been used in the
design of experimental vascular grafts. Of the many materials and structures investigated, two
major types remain in regular use today. Poly(ethylene terephthalate) (PET) and expanded
poly(tetrafluoroethylene) (ePTFE) vascular prostheses are the synthetic conduits currently most
widely used for the clinical substitution of natural blood vessels.
2.2.2.1 Poly( ethylene terephthalate) (PET)
Poly(ethylene terephthalate) (PET) is a semi-crystalline polymer derived from the condensation
polymerisation of terephthalic acid and ethylene glycol. Although its ester bonds are potentially
susceptible to hydrolysis, its high crystalinity in the oriented fibre form renders it relatively
stable. Projections from in vivo experiments indicate a period of approximately 30 years for the
complete resorption of PET grafts [20]. It is a strong stiff material (tensile strength = 172MPa;
modulus = 14.1 GPa) with a high crystalline melting point [21]. Although the textile structure of
PET vascular prostheses imparts a small amount of compliance, the stiffness of the constitutive
fibres renders the structure much less compliant (C=1.9 %/lOOmmHg) than natural arteries
(C=5.9 %/lOOmmHg) [22].
PET is extruded and drawn according to well known spinning techniques into filaments of
various cross-sections (circular or trilobal) and linear densities (50 to 200 Decitex)
corresponding to diameters of approximately 11 to 18 11m. The multifilament yams used in
vascular grafts, typically consisting of 24 and 108 filaments, are readily woven and knitted into
various configurations. Most commercially available PET grafts are either plain weaves, single
jersey weft knits, 2-bar lockknits, or tricot warp knits, with the knits being either in the standard
or reverse configuration [23]. The simplest, namely the taffeta weave, produces the strongest
textile, the closest packing of yarns and hence the lowest porosity. The invention of specialized
knitting machines by Golaski, Edman and De Bakey afforded the opportunity of increasing the
porosity of the textiles. Weft-knit prostheses were often prone to dilation and unravelling, and
were often considered too permeable for some applications due to the excessive porosity. The
introduction of warp knitting techniques solved many of the problems associated with weft
knitting. The addition of the extra yarns decreased the porosity to a value (generally) between
that of woven and weft knit grafts, and the predominantly lengthwise threads eliminated the
fraying out of the ends. Warp knits have excellent dimensional stability as well as good
suturability and handling characteristics. Another method of improving the healing
characteristics of PET grafts through the improved anchoring and mechanical interlocking of
tissue was initiated by the introduction of velour designs. This roughening of the lumenal and/or
external surfaces is achieved by napping the surfaces with wire brushes or the addition of
textured yarns in the woven or knitted fabric.
After knitting, the excessively high permeability of knitted and velour prostheses is reduced to
within desired levels by chemical or thermal processes that effect compaction through the
longitudinal shrinkage of filaments. Concurrent or subsequent helical or circular crimping
increases the longitudinal elongation and decreases the tendency to collapse or kink. As dry or
moist heat may cause further deformation of PET vascular prostheses, ethylene oxide gas and
ionising radiation are the preferred methods of sterilization.
2.2.2.2 Expanded Poly( tetrafluoroethylene) (ePTFE)
Poly(tetrafluoroethylene) is a very inert material due to the large fluorine atoms protecting the
hydrocarbon backbone, its high molecular mass and high crystallinity. It has a low coefficient of
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friction, and one of the lowest critical surface tensions of any polymer. The hydrophobicity of
PTFE is evident from its high water contact angle and low water absorption «0.05%). It has a
moderate tensile strength of 21 MPa and tensile modulus of 413 MPa [24]. The compliance of
ePTFE grafts (C=1.6 %/lOOmmHg) is typically even lower than that of PET prostheses [22].
Although PTFE is generally classified as a thermoplastic, its melt viscosity is too high for
conventional melt processing, and it is too insoluble for conventional solution-processing
techniques. Initial PTFE prostheses made from fibres into textile configurations were prone to
unravelling and false aneurysm formation, and this type of prosthesis was discontinued by many
manufacturers. Expanded PTFE vascular prostheses are produced in an unique process in which
PTFE is ram extruded into the desired shape with an extrusion lubricant, typically a
hydrocarbon. Removal of the lubricant, stretching at high rates, and subsequent sintering of the
tube results in a porous product with a structure that contains PTFE nodules connected by highly
oriented thin fibrils. Grafts of this type are often characterized by an internodal distance (IND),
which is typically in the order of 30llm, although larger sizes have also been produced. The!ND
is often a misleading dimension, as the actual spaces available for tissue ingrowth, namely the
inter-fibrillar distance, is typically in the 4-51lm size range [25]. ePTFE grafts often contain an
additional reinforcing wrap for added strength, as well as spiral or circular reinforcing structures
for kink and crush resistance. PTFE is stable under steam, dry heat, and ethylene oxide
sterilization regimens, but it is not suited to sterilization by ionising radiation.
2.2.2.3 Other synthetic grafts
Various experimental grafts made from polyurethanes (PU) and other non-degradable materials,
as well as from materials that are designed to be resorbed by the host, were developed in an
effort to provide alternatives to these commercially available prostheses. A detailed account of
the structure and properties of polyurethane grafts is given in Chapter 5.
2.3 Shortcomings of contemporary grafts
2.3.1 Bioprosthetic grafts
Although autologous veins are currently the grafts of choice in small-diameter indications, their
use may be compromised by complications such as excessive intimal hyperplasia, late occlusion
and dilation. In up to 20-30% of cases these veins are unsuitable due to disease. This percentage
can be even higher in re-operative procedures when these veins are unavailable due to prior
harvesting [26]. Autologous arterial tissue may, in theory, be seen as the ideal arterial substitute,
but in arteriosclerotic patients sufficiently normal, dispensable arteries are at a premium.
The shortcomings of arterial homo grafts are evident from the changes that occur during the
healing response include slow wall lysis, compaction and loss of elastic tissue, ulceration, mural
thrombosis, and calcification. Such changes resemble atherosclerosis [27] and result in a poor
long-term outcome. Although few non-arterial homograft tissues have been used in the arterial
site, experiments evaluating homologous veins for aortic replacement show late fibrotic stenosis.
Glutaraldehyde-fixed, homologous umbilical veins have found some use in lower extremity
applications, but the general consensus is that they are not as reliable as autologous vein grafts.
Heterologous arterial tissues demonstrate a decidedly accelerated tissue response, due to
antigenicity, and are heavily subject to aneurysm formation and rupture. The antigenicity may
be reduced or abolished by certain chemical modifications, such as crosslinking, but these grafts
remain prone to aneurismal dilation. This shortcoming has been corrected by Dacron
reinforcement, and although studies have shown superior long-term fate to that of freeze-dried
homografts and some textile prostheses, the use of fixed heterologous arterial tissue is limited
mostly to arteriovenous shunts [28].
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2.3.2 Synthetic grafts
PET (Dacron®) is the material of choice for large-diameter, high-flow vascular graft
applications, such as aortic replacements. The manufacturing techniques used in the production
of PET grafts lend themselves to the inclusion of side branches and bifurcations, and PET grafts
are regularly used as aorto-femoral replacements. A secondary patency rate of 93% at 10 years
can be achieved with large-diameter grafts of this type [29]. Many large diameter PET grafts are
sealed with collagen, gelatin or albumin to render them initially impermeable to blood, thereby
obviating the need for the surgeon to pre-clot the device with blood or fibrin glue [30].
Expanded poly(tetrafluoroethylene) (ePTFE) is favoured in medium-bore (6-12mm) applications
when autologous veins are unavailable or unsuitable. Patency rates of 40-50% after 4 years of
implantation in femoro-popliteal reconstructions are lower that the rates achieved by using
reversed saphenous veins (70%-80%) [31].
These graft types fail to perform satisfactorily, however, in smaller-diameter applications
(xómm) due to occlusion caused by thrombosis and intimal hyperplasia. A more detailed
account of the shortcomings of commercial grafts in small-diameter applications, is given in
Chapter 3.
2.4 The need for alternative small-diameter grafts
The American Heart Association (AHA) estimates that 598,000 coronary artery bypass grafts
(CABG, requiring small-diameter grafts) were performed on 367,000 patients in 1996 in the
United States alone [32]. This makes CABG probably the most widely performed procedure in
which small diameter vascular substitutes are required (Table 2.1). It has been shown, however,
that numerous autologous arteries (and veins) may be, and are, successfully used to bypass
coronary stenoses. (See section 2.2.1.1)
Table 2.1: Scope, indications and worldwide market for vascular grafts [33J..
Graft size Large diameter Small diameter Coronary (CAB G)
Internal diameter ID=7-30+mm ID = 6 mm or less ID = 1-4mm
Utilization Thoracic cavity, Across, below the Coronary arteries
abdominal cavity, knee, peripheral graft
above the knee (PG), vascular access
graft(VAG)
World market -$150 million -$200 million $450 million
The second largest demand for small-diameter grafts is for peripheral grafts (PG) to relieve
lower extremity ischemia. The limitations associated with contemporary small-bore grafts of
biological or synthetic origin result in an inability of these grafts to provide satisfactory long-
term outcomes in the PG position. Although the ratio of coronary:peripheral graft usage has
been estimated at 6: 1 in the USA, the number of peripheral procedures performed in the United
States in 1991 (150,000) attests to the urgent need for a successful alternative conduit [34]. If
these figures are projected, then the current need in the USA is in excess of 200,000 peripheral
procedures.
In addition to the large peripheral market, there is also a need for small-diameter prostheses to be
used as vascular access grafts (VAG) for the treatment of end-stage renal failure.
2.5 Alternative approaches
2.5.1 In vitro tissue engineering
Recent advances in cell-culture techniques have created an opportunity for the in vitro
reconstitution of organs from living cells. Weinberg and Bell [35] were the first to apply such
9
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techniques to produce a completely biological tissue-engineered blood vessel (TEBV) from
collagen gels and cultured bovine endothelial cells (ECs) smooth muscle cells (SMC) and
fibroblasts. These grafts did not, however, display the required mechanical strength, even when
reinforced with Dacron mesh. Similar results were obtained by L'Heureux et al. who employed
the techniques with human collagen and vascular cells [36], and by Hirai and Matsuda [37] who
used a canine model.
A radically different approach by L'Heureux et al. involved the production of tissue-engineered
blood vessels from cultured human cells without the use of exogenous biological material, by
allowing the cells to create their own extracellular matrix in the presence of ascorbic acid [38].
Their method involved wrapping successive layers of acellular and cellular materials onto a
mandrel to produce a neo-artery. The first layer consisted of an acellular inner membrane
produced by the dehydration of a cultured fibroblast sheet. Onto this inner membrane,
successive layers consisting of smooth muscle cells and fibroblast (respectively) were wound
onto the inner membrane. After maturation of the composite layers in a bioreactor the lumen
was seeded with endothelial cells. The vessels were reported to have undergone histological
organisation and displayed burst strengths comparable to those of natural blood vessels.
Although the approach and results are very exciting, the procedure takes in excess of 4 months to
complete.
A slightly different approach was followed by Niklason and Langer [39]. They used temporary
synthetic scaffolds of polyglycolic acid (PGA) to produce tissue-engineered blood vessels by
seeding tubular non-woven meshes of PGA with high densities of smooth muscle cells.
Maturation of the cells in a bioreactor resulted in the proliferation of the cells and the
degradation of the PGA mesh. Pulsatile stretch was employed to facilitate proliferation and
enhance the contractile properties of the cells. Although the mechanical stretching did improve
the physical strength over that obtained during static culture, the vessels were not able to
withstand arterial pressure.
The tissue-engineering approaches detailed above offer valuable insight into the culturing
techniques required to produce neo-arteries. The in vitro generation of blood vessels holds the
distinct advantage that implanted devices consisting of living autologous tissue may be
incorporated and remodelled without foreign body response from the host. The problems
associated with the use this approach for the production of vascular grafts are, however, not
trivial. The techniques employed, namely for cell harvesting and culture, and the engineering of
such cells into viable vessels requires expertise generally found only in large centres and
academic hospitals. The time required to produce cells of sufficient numbers, together with the
time needed to engineer the cells into vascular structure by manipulation and maturation, may be
another factor limiting the use of the technique.
2.5.2 Endothelial cell transplantation
The failure of small-diameter, synthetic, vascular grafts may be attributed mostly to surface
thrombogenicity and anastomotic intimal hyperplasia. The surface thrombogenicity, in turn, can
be ascribed to a persistent lack of endothelial cell coverage, even after extended implant periods.
The basic concept behind endothelial cell transplantation is the lining of autologous endothelial
cells (EC' s) on contemporary synthetic grafts before implantation in order to mask the
thrombotic nature of the underlying synthetic material.
2.5.2.1 Single-stage venous EC seeding
This early method involved the single-staged seeding of endothelial cells harvested from
subcutaneous veins onto Dacron prostheses, and the subsequent clotting of the cells into the
wide-meshed porous structure of the synthetic graft [40]. The general trend at the time towards
the use of ePTFE grafts in peripheral reconstructions prompted researchers to attempt the
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application of this approach to an alternative material. The narrow interfibrillar spaces of the
ePTFE, however, resulted in the cells being clotted onto the lumenal surface of the graft instead
of into the graft structure. Seeding with cell numbers that were too low for the large surface area
of long grafts needed for human implantation, together with the high detachment rate of cells
after the restoration of blood flow, resulted in sub-optimal seeding densities. Although this
probably led to partial endothelialisation and moderate decrease in thrombogenicity [41], the
procedure did not result in an improved clinical patency rate [42]. Newer approaches to
circumvent the problem of low seeding densities due to low cell numbers include the mass
culture of venous endothelial cells [43] and the mass harvest of capillary endothelial cells from
fat tissue [44].
2.5.2.2 In vitro endothelialisation
In vitro endothelialisation was pioneered in the 1980s by a number of groups [45]. This is
essentially a two-stage method, the first of which is the mass-culture of endothelial cells isolated
from a suitable source, (e.g. a section of the jugular or cephalic vein). The large quantity of
endothelial cells cultivated in this first step is subsequently seeded at a high density onto the
lumenal surface of a suitable synthetic prosthesis, typically an ePTFE graft. Pre-coating of the
graft prior to seeding improves the adhesion of the seeded cells. Post-maturation allows for the
recovery from injury caused by the seeding procedure, the maturation of the cells' cytoskeleton
to better withstand the shear forces exerted upon it by the bloodstream [46], the formation of a
confluent layer of cells on the lumenal surface, and the reduction of the inflammatory activation
of the endothelium [47].
Clinical trials carried out with the use of in vitro endothelialised grafts as femoropopliteal bypass
grafts commenced in 1989 [48]. Since this date, a number of groups have reported their
experience with clinical trials with a follow up period of up to 9 years. The overall success of
the procedure is evident from the excellent improvement achieved in patency rates when
endothelialised grafts are compared to unendothelialised controls. Control groups typically have
a 5-year patency rate of 42% for above-knee ePTFE grafts, whereas patency rates in excess of
65% can be achieved when endothelialised grafts were used [45]. This compares favourably to
the 70% patency rate achieved by Veith with the use of reversed autologous saphenous veins in
the same position [31]. Multieentre clinical trials aimed at the verification of these results are
currently underway in Europe. Although in vitro endothelialisation may offer surgeons an
excellent and viable alternative to saphenous veins when the latter is unavailable, two factors
may stand in the way of its general acceptance as the graft of choice. The first is the relative
complexity of the cell-culture procedure that requires approximately 30 days from harvest to
implant date, as well as the infrastructure and expertise required to perform the necessary culture
and seeding techniques. These requirements limit the procedure to large centres where the
resources are available. The second factor revolves around regulatory issues. Although the
current preferred choice of protein matrix (fibrin glue) used in the coating of grafts prior to
seeding has clinical approval in Europe, approval of its use by the Food and Drug Administration
in the United States may prove problematic.
2.5.3 In vivo tissue engineering
In vitro tissue engineering potentially offers the possibility of vascular grafts that are "made to
order" [49]. The possible shortcomings of this approach, including infrastructural and time
constraints, have been elucidated. The inability of conventional synthetic grafts to offer good,
long-term outcomes in small-diameter applications has also been mentioned, and will be further
expounded upon in Chapter 3. In short, the failure of contemporary Dacron and ePTFE grafts to
perform optimally in small-diameter applications may be attributed to the poor healing response
exhibited by the body toward the implanted prostheses. This lack of healing, in tum, may be
attributed to a number of factors that prevent the graft from being incorporated into a viable
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composite of synthetic material and living tissue. Although cell transplantation onto (or into)
conventional synthetic prostheses has been successful in improving the patency rates of such
grafts, the negative aspects associated with both in vitro cell culture and conventional synthetic
grafts are maintained.
The concept proposed in this dissertation may be termed in vivo tissue engineering (TE).
Whereas in vitro TE involves the culturing and engineering of cells outside of the body, either
with or without exogenous biological or synthetic scaffolds, the present study is aimed at the
development of a porous, synthetic scaffold that will provide the complex and interrelated
chemical, physical and biological properties required to effect the engineering of tissue in vivo.
These properties should be tailored to ensure complete healing of prostheses through functional
integration of the synthetic material into a tissue/graft composite in order to produce a viable
neo-artery. In short, the ultimate aim is to provide a successful "ready to use" or "off the shelf'
vascular graft, as opposed to one that is "made to order" (See Chapter 4)
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CHAPTER3
Historical and theoretical considerations
3.1 Introduction
This chapter summarizes the theoretical considerations that need to be taken into account in the
design and development of vascular prostheses. It shows the structure and properties of native
vessels (that are to be replaced with the prostheses), and then highlights the demands placed on
prosthetic devices in order for them to mimic the natural vessels as closely as possible.
3.2 Natural arteries
In order to develop synthetic arterial substitutes intended to mimic natural arteries, an
understanding of the basic structure and function of arteries is essential.
3.2.1 Artery size and structure
Most blood vessels consist of three distinct layers, termed the tunica intima, tunica media and
tunica adventitia, that are arranged in concentric layers (Figure 3.1). Each of these layers
comprises a complex combination of cellular and extra-cellular materials that are specialized in
form and function in order to perform specialized tasks.
Vasa vasorum
.,,,,,"••r Collagen andI ~~ elastinn ~<D :::=Si..~ . ..::::::--.. .. ...;i/II- Media and mVmaF~ withelasticlamillae
Elastic artery
Nerve of blood vessel
'. .
:jl~P..~ii/~_:~-f~::';_1..:Nonstriated myocytes
in media
Muscular artery
Intemal elastic lamina o
\.4!Jnu1eArteriole
~M)(I$tn'atedmyocytes
in media
Figure 3.1 Structure of typtca: arteries [lj
Arteries show considerable variation in structure, size and function along the vascular tree. The
large arteries closer to the heart (e.g. the aorta) are termed elastic arteries, and contain a high
proportion of elastic material and a proportionally lower amount of contractile muscular tissue
(Table 3.1). This allows for the storage of energy by dilation under systolic pressure, and for the
release of that energy during diastole. This effect, which is similar to the Windkessel effect,
allows for the smoothing of the pressure pulse in distal vessels. Further from the heart, in typical
muscular arteries, the relative proportion of smooth muscle cells in the media increases, allowing
the vessels to actively constrict and dilate according to physiological stimuli. Capillaries, whose
main function of the exchanging of gases with the surrounding tissue prescribes minimum wall
thickness, consist of only an endothelium supported by a basal lamina.
Whereas arteries are required to withstand high pressures and to regulate and moderate the blood
pressure and flow profiles, the function of the venules and veins is perhaps less complex. Their
primary function is to provide a return path for the blood from the capillary bed to the heart. As
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this occurs at pressure that are much reduced from those encountered in the arterial tree, their
structures are adapted accordingly. The relative sizes of arteries, arterioles, capillaries, venules
and veins are summarized in Table 3.1. The decrease in artery size with increased distance from
the heart, and the subsequent increase in size on the venous return is self-evident. The
adaptation in the relative size and wall thickness of the different vessels closely follows their
function. Large arteries not only have large diameters to deal with the large volumes of blood,
but also contain walls that are approximately twice as thick as venous counterparts of similar
size.
Table 3.1. Relative dimensions and constitutive tissue of blood vessels. (Adaptedfrom [2J)
Aorta Artery Arteriole Sphincter Capillary Venule Vein Vena
Cava
0 0 0 0 0 0 0 0
Vessel
25mm 4-6mm 30jAm 35jAm 8jAm 20jAm 5mm 30mmDiameter
Wall
2mm 1mm 20jAm 30jAm 1jAm 2jAm 0.5mm 1.5mmthickness
Diameter!
12.5 4 1.5 1.2 8 10 10 20thickness
Endothe-
lium
Elastic
tissue
Smooth
muscle
Fibrous
tissue
As the development of a suitable substitute for typical muscular arteries is the main goal of this
dissertation, their structure will be described in more detail. The intima, consisting of the
endothelium attached to a basement membrane, provides a non-thrombogenic, blood-contacting
surface. The media contains smooth muscle cells (SMCs) as well as elastic and other
intercellular connective and matrix materials, and supplies two other important properties to the
blood vessel, namely compliance and contractility. In order to achieve these properties, the
tissues are oriented in a helical fashion in this medial layer. It is known that the orientation of
smooth muscle cells in the media is closely related to the stresses that these cells experience as a
result of pulsatile dilation. Liu [3] has shown that the orientation of these cells may actually be
changed by altering the applied stresses. SMCs in the rat aorta and jugular vein are oriented at
85° from the vessel axes (See Fig 3.2). Excision of the jugular vein and using it as an arterial
graft results in principle stress changes that result in the re-orientation of the SMCs in the vein
graft to 40° .
Another important property, namely structural integrity, is provided by the adventitia. The
configuration of elastin and crimped collagen fibres in this layer provides for the "stiffening" of
the vessel when subjected to high internal pressures, i.e. the decrease in compliance with
increased strain. A more detailed description of the structure and function of blood vessels may
be found in Gray's anatomy [1].
15
Stellenbosch University http://scholar.sun.ac.za
Chapter3
STRESS
30%
30%
Theoretical Considerations
SMC Direction STRESSSMC Direction
r:
10%
Rat Aorta Rat Jugular
SMC Direction SMC Direction
70%
Figure 3.2: Re-orientation of rat jugular vein smooth muscle cells as a result of a change ill appUed stress due to
relocation to an arterial position. [3]
3.2.2 Summary: Artery size and structure
Natural muscular arteries contain:
)0> An endothelium that provides a smooth surface for blood flow and the active non-
thrombogenic properties
)0> A medial layer that contains helically oriented smooth muscle cells and elastic elements
that provides for the contractile behaviour and compliance. The orientation of SMCs in
the media may be altered by applying the appropriate stresses.
)0> An adventitial layer that consists mainly of elastin and crimped collagen fibres that
provide structural integrity by progressively arresting expansion at high internal
pressures
)0> A typical peripheral muscular artery has a diameter of 4-6mm and a wall thickness of
Imm.
3.2.3 Mimicking of artery properties
The demands placed on a synthetic vascular prosthesis that would sufficiently mimic the
structure and properties of natural arteries to ensure successful long-term outcomes are described
in detail in the remainder of this chapter. It is useful to sub-classify these requirements under
three headings, namely: general, graft-related and host-related demands. The first relates to the
overall structure and function of the replacement vessel, the second to specific demands placed
on the physical and chemical properties of the graft, and the third to the response encountered
when the device is implanted into living tissue.
3.3 General demands
The desired outcome required from vascular grafting is known. The prosthesis should replace or
bypass the diseased or injured vessel, re-establish adequate levels of perfusion to the distal
vasculature and organs, and continue to do so for the lifetime of the recipient. Fifty years of
research into the use of synthetic biomaterials has highlighted a number of properties that should
be exhibited by a vascular graft in order to achieve this goal [4].
The manufacturing processes used for the production of grafts must be economically viable,
environmentally acceptable, and must allow for the production of devices of uniform and high
quality. Prostheses must then be sterilized and stored for extended periods in a sterile state. In
order to satisfy the requirements of vascular surgeons, prostheses should, during implantation,
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display good handling characteristics (drapability without forfeiting dimensional stability) and
good suturability. For correct size matching, the surgeon should have a range of diameters and
wall thicknesses to choose from, and must be able to trim the prosthesis to the desired length
without undue difficulty or adverse consequences to the integrity of the graft. Directly after
implantation, the graft should have adequate structural integrity to withstand the internal blood
pressure without excessive haemorrhage. Other requirements at this and later stages include
kink-resistance around bends and a resistance towards being flattened by surrounding anatomical
features.
In order to promote the healing and incorporation of the device into the body, the materials used
in its construction should not be toxic, inflammatory, carcinogenic or excessively thrombogenic.
Other important requirements, namely material properties, porosity, integrity, compliance
matching, biocompatibility and healing will be discussed in further detail below (Section 3.4 and
3.5).
3.4 Graft-related demands
In order to mimic the function of natural arteries, the demands placed on the graft properties are
numerous and complexly interrelated. The materials used to fabricate the prosthesis, as well as
the structure of the material that comprises the graft wall, determine not only the long-term
stability of the implant, but also the mechanical properties and thus function of the device.
3.4.1 Material requirements
Initial investigations into the use of polymeric materials for vascular grafts concentrated on
fibrillar materials that showed a high degree of in vivo stability. These studies led to the
acceptance of PET and PTFE (initially fibrillar, now expanded) as materials of adequate stability
to be used in current commercially available vascular grafts. In addition to the abovementioned
polymers, a wide range of other bios table materials have been evaluated for use in vascular graft
applications [5, 6]. These include polypropylene (PP), polyethylene (PE), polysiloxanes
(specifically polydimethylsiloxane; PDMS) and polyurethanes (PU). The biostabie approach is
based on the permanent incorporation of the synthetic material into a tissue/polymer composite
graft.
Another approach to vascular grafts involves the use of degradable materials in their
construction. Typical degradable materials routinely used include poly(glycolic acid),
poly(lactic acid) (PLA) and polydioxanone (PDS). Researchers in this field endeavor to effect
the generation of a new vessel by the degradation of porous scaffold after ingrowth of sufficient
cellular and extracellular materials (before degradation resulted in failure of the graft), followed
by complete (or partial) resorption of the polymeric material [7, 8]. The scope of this
dissertation is restricted to bios table materials, more specifically polyurethanes, and the demands
placed on these materials will be discussed.
3.4.1.1 Chemico-physical stability
It has been recognized that no material is completely inert in the hostile environment found in
the human body and even materials that are recognized as being extremely stable (gold,
platinum, titanium) are corroded in vivo [9]. Nonetheless, the demands placed on polymeric
materials used in durable vascular grafts require them to be chemically stable to the degree that
ensures structural integrity, and that prevents the generation of toxic or inflammatory breakdown
products. Even if the main component of the material is sufficiently biostable, the possibility
and extent of minor components (impurities and additives) leaching from the material must be
minimized or eliminated.
Whatever its location in the body, the biomaterial will encounter an aqueous environment
containing not only various cations and anions, but also a variety of proteins and cells. All
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polymeric (and other) materials respond continuously to changes in their environment, before
and after implantation [5]. All polymers are, to a more or lesser extent, permeable to gasses and
liquids. They adsorb, absorb, transmit and desorb components, resulting in changes in surface
and/or bulk properties [10]. Thus, degradation of a biomaterial leading to compromised
performance may be chemical, physical, or a combination of both.
Physical changes that may occur include swelling, crystallization, de-crystallization,
plasticization, fatigue fracture, creep and stress cracking. Chemical degradation is often
associated with the scission of covalent bonds, but may also involve ionic bond transformations
or even covalent erosslinking [11]. The major modes of chemical degradation in vivo result
from hydrolysis, oxidation and mineralization [5]. These modes will now be discussed in more
detail.
(A) Hydrolysis
Simple hydrolysis is the scission of susceptible functional groups by reaction with water, and
may be catalyzed by acids, bases, salts or enzymes. Polymers that are susceptible to hydrolysis
generally contain carbonyl groups bonded to heterochain atoms (0, S, N). The rate of hydrolysis
differs among the susceptible groups, and carbonyl group reactivity decreases in the order:
anhydride> ester> urethane> amide. Other polymers that are susceptible to hydrolysis under
certain conditions contain ether, acetal, nitrile, phosphonate or active methylene groups. The
rate of hydrolysis tends to increase with increasing hydrolysable group content, increased
hydrophilicity, decreased crystallinity, decreased crosslinking, increased surface-to-volume ratio
and increased mechanical stress [12].
The in vivo environment (37°C, pH 7.4) appears to be a rather mild reaction medium by in vitro
standards. Neutral water alone, although capable of hydrolyzing some readily hydrolyzable
polymers (e.g. poly glycolic acid etc.), is unlikely to be responsible for significant degradation of
more stable heterochain polymers. However, the complex interactions of components present in
extracellular fluid produce aggressive responses to foreign bodies. Zaikov has shown that
certain ions (e.g. POl), as well as localized pH changes due to inflammatory response, are
effective catalysts of polyester hydrolyzation, and may increase reaction rates by several orders
of magnitude [13]. Quite remarkably, certain enzymes are not only able to increase hydrolysis
rates of certain polymers, but are able to do so selectively [14, 15].
Polymers that are hydrolytic ally stable include hydrocarbons, silicones, sulphones, halocarbons
and polymers containing isolated carbonyl groups (ketones) [5].
(B) Oxidation
Oxidative degradation of biopolymers results in the modification or destruction of molecular
structure by electron-transfer reactions [16]. Polymers that are prone to oxidative attack are
generally those that contain groups capable of resonance stabilization of resultant free radicals.
They include branched aliphatic hydrocarbons (alkyl, aryl or allyl branch), allylic hydrocarbons,
and those that contain aromatic side groups, ether linkages, alcohols (and phenols), aldehydes
and secondary arnines.
Prior to implant, processes that may induce oxidation include melt processing, y-sterilization and
exposure to light (ultraviolet radiation). Although molecular oxygen may be directly responsible
(auto-oxidation) [17], other effective oxidants include metal ions, hypochlorite and hyperoxides
[18].
In vivo, biomaterials are susceptible to oxidative attack by powerful oxidizing agents (hydroxyl
radicals, peroxynitriles and hypochlorites) resulting from phagocytic activation that occurs
during inflammation and foreign-body reaction [16, 18]. In addition, there is some evidence of
the limited effect of direct enzymatic catalysis of oxidation [15, 19]. Although the exact
mechanisms of in vivo oxidation are not known, it is generally accepted that both
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polymorphnuclear leucocytes (PMNs) and macrophages metabolize oxygen to form the
superoxide anion (ot). The superoxide may oxidize the polymer directly, or it may be
transformed into even more powerful oxidants. Superoxide dismutase (an ubiquitous peroxidase
enzyme) can catalyze the conversion of superoxide to hydrogen peroxide, which in turn may be
converted to hypochlorous acid (itself a strong oxidant) [20]. Hypochlorite is able to oxidize not
only free-amine functionalities (in proteins), but also substituted functional amine groups such as
amides, ureas and urethanes [12].
The in vivo oxidation of polyurethanes has been extensively studied. [15-18]. The effect of
oxidation usually manifests itself in surface fissuring, deep-crack formation, fragmentation and
wear, often in areas of elevated stresses [5].
The mitigation of these structural changes may be achieved by limiting the concentration of
stresses, minimising exposure to radiation, the use of antioxidants, isolation of the susceptible
polymers from direct phagocytic attack or soluble oxidants, and by the use of polymers that are
resistant to oxidation [16-18, 21]. Polymers that are stable to oxidation include straight-chain
hydrocarbons (e.g. polyethylene), halocarbons (e.g. PTFE), and those containing fully oxidized
groups (e.g. ketones, sulphones, esters, urethanes), although some evidence exists of the
susceptibility of carbon atoms next to hetero-atoms in some carbonyl-containing materials [22].
(C) Mineralization
Although mineralization (calcification) mayor may not be responsible for significant scission of
covalent bonds, it does involve chemical transformation that can cause structural damage to
biopolymers. It involves the deposition of insoluble calcium phosphate salt on or in the polymer
(extrinsic and intrinsic calcification respectively). The levels of calcification have been shown to
be more a function of soluble calcium levels and device function, rather than the chemical
composition of the polymer [23, 24]. Although high levels of calcification are associated with
devices that undergo high levels of cyclic deformation (such as prosthetic heart valves and heart
assist devices), it has been reported to occur in synthetic vascular grafts where deformation
levels are more moderate [23].
3.4.1.2 Mechanical Properties
The requirement of compliance (discussed in more detail below, see 3.4.5) further demands that
the vascular graft dilates and contracts in sympathy with the internal pressure pulse. This
requires that either the polymer from which the device is constructed be of an elastic nature, or
that the graft be constructed in such a way that it allows for elastic behaviour (or both). All
currently available prosthetic grafts are constructed from highly crystalline materials (PET and
PTFE), and they are all undercompliant. In order to overcome this disadvantage, both
thermoplastic (e.g. polyurethanes) and thermoset elastomers (e.g. polysiloxanes) have been used
to produce a wide range of experimental prostheses that match the compliance of natural blood
vessels.
3.4.2 Suitability of polyurethanes for use in medical devices
Due to the almost endless number of formulations that may be used to prepare polyurethanes,
they offer the greatest variety of chemical and physical properties of any family of polymers.
Their physical properties range from hard, rigid thermosetting materials to those of softer
thermoplastic elastomers, while their chemical properties may be tailored to control durability
and chemical stability. It is not surprising, therefore, that polyurethanes have been extensively
studied over the past four decades for use in medical applications [20,25].
The total use of plastics in medical and pharmaceutical applications has been estimated at
830,000 metric tons in 1989 [25]. Although thermoplastic polyurethanes (TPU) account for only
4,500 tons of that total (in comparison to that of the most commonly used plastic, PVC: 220,000
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tons), this figure does not reflect the versatility of the materials and their relative success as
biomateriais.
A number of TPUs in particular exhibit a unique combination of biocompatibility, toughness,
biostability and surface functionality [26] that has led to widespread use in implantable medical
device such as pacemaker leads, blood bags, catheters, bladders and artificial hearts [25]. The
elastomeric properties of certain PUs also make them good potential candidates for applications
where interaction with and mimicking of soft tissue is required. This is particularly true for
vascular grafts [26], where the matching of compliance has been highlighted as an important
factor governing the fate of prostheses [27].
3.4.3 Polyurethane classification
Depending on the combination of raw materials used in their synthesis, it is possible to sub-
classify polyurethanes into a variety of subgroups. Firstly, these polymers may be divided into
two groups, namely aromatic or aliphatic. This distinction is based on the nature of the
diisocyanate employed in the synthesis as the polyols and chain extenders are generally aliphatic.
A second distinction is based on the nature of the polymeric diol, i.e. whether it contains
polyester, polyether, polycarbonate, siloxane or hydrocarbon linkages. Thirdly, it is useful to
distinguish between polyurethanes and polyurethane ureas, based on whether diols or diamines
(respectively) were employed as the chain extender. Thus aliphatic polyether urethane ureas
would be polymers derived from aliphatic diisocyanates, polyether diols, and diamine chain-
extenders.
3.4.3.1 PU synthesis: Reaction conditions
In order to discuss the material properties and the effect of polymer structure on such properties,
a brief introduction to segmented polyurethane synthesis is required. Although polyurethanes
may be produced by a simple one-step process, segmented polyurethane elastomers intended for
use in medical applications are generally synthesised in a two-step process to gain more control
over stoichiometry. Briefly, (see Fig. 3.3) a macromolecular diol is reacted with an excess of
diisocyanate to form an isocyanate end-capped prepolymer (Mn up to 15000-120000). The
prepolymer (and the remaining unreacted diisocyanate form the first step) is then further reacted
with a chain extender to produce the desired segmented multiblock copolymer of type (AB)n,
where A denotes the soft segment and B represents the hard segment.
~ ~
n OH-RcOH + 1.2n O=C=N-R-N=C=O ___. OCNLR-N-C-Q-R -O-C-N'LR-NCO
"\ H 1 HJ:
Macromolecular glycol Oiisocyanate Isocyanate terminated prepolymer
.... +R-N-~-O-R-O-~-NVR-N-~-O-R-O-~-NliH 1 j.i(\ H 2 Hx y z
Polyurethane
~ial chain extender
-ft ~ ~~ ~ ~1iR-N-C-Q-R-Q-C-N R-N-C-N-R-N-C-NH 1 H H 3H Hx y z
Polyurethaneurea
Figure 3.3: Two-step process for the synthesis of segmented polyurethanes and polyurethane ureas
...
Diamine chain extender
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Great care must be taken in the choice of reaction conditions, as the reactive diisocyanates group
may further react with:
• urethane groups to form allophanate linkages (that may result in covalent crosslinking)
• urea groups to form biuret linkages (that may result in covalent crosslinking)
• water to form carbamic acid (that may dissociate into amines and carbon dioxide)
• amines from carbamic acids degradation to form ureas
• with another diisocyanate to form uretidiones
• with another diisocyanate to form carbodiimides
• with two more diisocyanates to form isocyanurates
Apart from accurate stoichiometry, the reaction temperature, catalyst choice and reaction
medium may influence the reaction products. Generally, low temperatures «50°C) favour chain
extension, while higher temperatures (50-150°C) promote erosslinking and branching reactions.
Higher temperatures (> 150°C) lead to dissociation of biuret and allophanate linkages and
degradation of aromatic polyurethanes, while temperatures in excess of 220°C will result in the
decomposition of aliphatic urethanes. Catalysts that promote the reaction of isocyanates include
sodium hydroxide, tertiary amimes and organo-metallic (especially tin) compounds. Careful
choice of catalysts must be employed to promote the preferential reaction of isocyanates with the
preferred species (such as diols) and minimise the reaction with others (e.g. urethanes and ureas)
or vice versa. Although bulk polymerisation is often used, solution polymerisation in N,N-
dimethylacetamide (DMAC), dimethylformamide (DMF), tetrahydrofuran (THF) and
dimethylsolphoxide(DMSO) may also be employed [25]. Some polymer grades are sold as
concentrated solutions «25%) in these solvents.
3.4.3.2 Raw materials
The chemical and physical properties of polyurethanes are also determined by the nature of the
raw materials (diisocyanates, polymeric diols, and diamine/diol extenders) used in the
production. Polymeric diols used in the synthesis of elastomeric polyurethanes include
polyesters, polyethers, hydrocarbons, and polydimethylsiloxanes. Both aromatic and aliphatic
diisocyanates and chain extenders (diols or diamines) can be used. A list of commonly used raw
materials is given in Table 3.2. This is followed by a comprehensive list of medical-grade
polyurethanes (Table 3.3).
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Table 3.2: Chain extenders, diisocyanates and polymeric diols used in the production of medical-grade
polyurethanes
methylene bis (toluene isocyanate)
O=C=N-R2-I\I=C=O
R2 =alip,atic
generic aliphatic diisocyanate AID!
IPD!
methylene bis(4,4-cyclohexyl isocyanate) HMDI
1,4-cyclohexane diisocyanate CHD!
3-isocyanatomethyl-3,5,5-trimethylcyclohexyl
isocyanate (isophorone di isocyanate)
PesDgeneric polyester diol
polyethylene adipate glycol PEA
polycaprolactone PCL
PED
PEO
POPG
PTMEG
hydroxy terminated polyisobutylene
PBO
Hotr3 CH)OHCH3 1.
PIB
hydrogenated polybutadiene
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Table 3.3: Listing and properties of medical grade polyurethanes.
Theoretical Considerations
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4 Surelhane Cardial Con Sys MDI
5 SRI series Stanford Res MDI
6 Mod,PUU Mercor ArDl
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9 Biospan PTG MDI
70A
10 TM5 Toyoho MDI PDA
PTMEG I EDA 1~ 1 1 1
PTMEG I DA d
PED I DA I, 1 1(' L iL '
PED I DNSur!, I I '
PTMEG
PTMEG I DA I I I I:, 1
'I
E,.. (Mi'a) ; I,,,f (glcm') Ref
[30,36,37]
---rzoJ
PTMEG I DA I, 41 5,9
~(%)
[20,38]
:[20]
[20]
20
POPG I EDA I i 'I;;, ." h' ,;>4;1\ 1
PHECD
Jil " d
20]
[20]
[30,33)
850 ,I _
Bionate (Corethane)
80A
90A
55D
75D
MDI BD
Cardiotech Inc,
(Polymedica)
Chronollex C
80A
55D
75D
Ref
[30,31,,34,37]
[28, 30, 31,33]
[34)
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PCDO
EDAIDAC
.Extender
HMOI BOCarbothane
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PC-3575A
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3.4.3.3 Structure of polyurethanes
The properties of segmented polyurethanes depend not only on their chemical nature and
constitutive elements, but also on the manner in which these hard and soft segments are arranged
in the bulk of the material, and on the nature of the interaction between these phases. It is now
generally agreed that the hard segments form glassy or semicrystalline domains dispersed in an
amorphous or semicrystalline soft segment matrix, and that the hard domains act as reversible
physical erosslinking sites and reinforcing fillers. It is for this reason that segmented PUs exhibit
high moduli and elastic behaviour normally associated with covalently crosslinked polymers.
In general, hard segments are responsible for tensile strength, hardness, permanent elongation
and compression set associated with the polymer, while soft segments determine the elastic
expansion and glass transition temperature (Tg).
3.4.3.4 Effect of diisocyanate on properties
Polyurethanes that contain aromatic diisocyanates in their hard segments generally have superior
mechanical properties to PUs derived from their aliphatic counterparts. MDI, an example of an
aromatic diisocyanate, has a rigid planar structure that provides stiffness, strength and hard-
segment character to polyurethanes. HMDI (the fully hydrogenated version of MDI), on the
other hand, provides for weaker hard-segment aggregation and yield weaker polyurethanes with
poorer dynamic performance such as shorter flex life, larger stress hysteresis, and lower impact
and abrasion resistance [21]. Polyurethanes based on aliphatic isocyanates also tend to possess
poorer high-temperature properties and lower solvent resistance. The symmetry of the
diisocyanate is also an important determinant of physical properties. Increased symmetry'
favours the crystallisation and degree of phase segregation, which in turn results in increased
modulus, hardness, and abrasion resistance [25].
The major advantage of the use of aliphatic diisocyanates is the increase in chemical stability
imparted to the polymer. Aromatic isocyanate-based PUs tend to turn yellow with even mild
exposure to UV radiation (e.g. due to diquinone-imide formation), while aliphatic polyurethanes
are non-yellowing. Aliphatic urethanes are more stable when subjected to alkaline hydrolysis
[40] and have shown to have greater thermal stability than aromatic analogues [41]. Certain
harsh treatments, such as steam sterilisation can also liberate amines by hydrolysis of urethane
and urea groups [42]. The aromatic amines originating from MDI are suspected carcinogens,
while those of its aliphatic analogues (HMDI) have not been implicated in a carcinogenic
response.
3.4.3.5 Effect of polymeric diol on properties
The polymeric diol, which constitutes the soft segment, is responsible for the flex life and the
ultimate elongation of the material. As the molecular weight of the macroglycol increases (with
equivalent proportions of other reagents) the elongation and resilience increases, while the
hardness, modulus and tensile strength will be lower [21]. Increased macroglycol length also
decreases the Tg of the polyurethane. Increased phase separation leads to increased backbone
rotation and a decrease in the Tg to levels closer to those of the macroglycol itself. When the
polymers are formulated with equal hard-segment weight ratios, however, increased hard-
segment length will improve phase separation and thus increase the modulus.
The chemical stability of polyurethanes is closely linked to the chemical nature of the
macroglycol that constitutes its soft segment. Early polyurethane implants failed due to
degradation of the hydrolytically unstable polyester macroglycols used in their synthesis.
Replacement of the polyester-based soft segments with those based on poly ethers provided the
required in vivo hydrolytic stability while retaining most of the desired mechanical properties
[18]. Subsequent studies have shown, however, that, although hydrolytic ally stable, certain
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polyether urethanes are susceptible to oxidative degradation in the presence of metal ions and
other strong oxidants [20]. This realisation has spurred extensive research into alternative
formulations, that continues to this day. Although polyether urethanes are still available and
useful in certain applications, the trend toward the full or partial replacement of the polyether
functionalities with those consisting of polymeric carbonates [30-32, 34, 37], siloxanes [29, 33,
35, 39], hydrocarbons [36], and fluorinated ethers [43,44] continues. The use of polycarbonate
soft segments has been reported to increase chemical stability (especially ESCR) when compared
to PUs containing polyethers [28, 45, 46], but possibly at the risk of decreased hydrolytic
stability. Siloxane soft segments increase the oxidative stability of urethanes without an
accompanying decrease in hydrolytic stability [39]. These polymers do tend, however, to have
lower tear strengths than their polyether soft-segment counterparts. Medtronic Inc. eliminated
the use of polyester, polyether and polycarbonates by basing an experimental urethane of
hydrocarbon soft segments. Takahara et al. [36] compared the in vitro oxidative resistance of
this polymer ("Biostable PUR" = M48) to a number of urethanes containing PEO, PTMEG,
PBT, HPBT and PDMS soft segments (all with the same MDI-BDO based hard segment).
Their findings include:
~ "Biostable PUR" and PUs containing PBT and HPBT showed minimal oxidative
degradation
~ PDMS-based PUs also showed high oxidative resistance, but degraded rapidly under
oxidative conditions in the presence of an organic carboxylic acid salt
~ PEO and PTMEG-based PUs showed degradation in oxidative environments, and that it
was the ether linkages that were oxidized.
The mechanism of oxidative degradation of polyetherurethanes was further elucidated by
Schubert et al. [47] and Stokes et al. [17]
3.4.3.6 Effect of extender on properties
Both the chemical nature and proportion of chain extender used in the formulation of a
segmented polyurethane influences its chemical and physical properties. Generally, the use of
aliphatic extenders leads to polymers that are softer than those obtained with aromatic extenders.
The use of diamines instead of diols yields polymers with more polar urea functionalities that
increases phase separation and hydrogen bonding between hard segments, thus resulting in
improved physical properties. The nucleophilic character of diamines also provide for a more
rapid reaction with the diisocyanate, and catalysts are not needed for this reaction. The strong
hydrogen bonding associated with urea linkages, however, decreases solubility and melt-
process ability , and a very high urea content may render the polymer unsuitable for melt
processing in its dry form without the risk of thermal decomposition [21].
3.4.3.7 Summary: Graft-related demands
In order for a vascular graft to withstand the chemical and physical requirements placed on it
when implanted into the hostile environment encountered in the body, and in order to achieve the
compliant properties believed to be essential in vascular graft design, the following required
material properties are proposed: .
A) Manufacturability: The material(s) should be
~ readily processed into uniform, high quality devices of the desired size and structure in
an economically feasible manner without excessive negative environmental impact.
~ readily sterilizabie by conventional means without negative impact on its integrity and
other properties
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B) Biostability: The material(s) should not be excessively
~ toxic, inflammatory, or thrombogenic, either in itself, or by the release of toxic,
inflammatory or thrombogenic additives or degradation products
Theoretical Considerations
~ succeptable toward oxidative and hydrolytic attack, and not prone to environmental
stress cracking or excessive calcification
C) Mechanical properties: The material(s) should:
~ display good handling characteristics and suturability
~ be amenable to trimming without adversely affecting mechanical properties
~ be elastomeric
In order for these requirements to be filled by polyurethanes, the PU should preferably contain:
~ aromatic hard segments for good mierophase separation and thus improved dynamic
performance
~ hydrocarbon or siloxane-based soft segments for oxidative and stress cracking
resistance.
3.4.4 Porosity
3.4.4.1 The need for porosity
Porosity has long been known to be a determining factor in the fate of prosthetic vascular grafts.
Initial attempts to replace arteries with solid tubes of synthetic material were unsuccessful due to
thrombotic occlusion [48-52]. Wesolowski affirmed the importance of porosity when he
screened a variety of materials and showed that synthetic polymers - successful as porous
prostheses - were not successful as solid-wall prostheses [6]. Subsequent efforts by prosthetic
vascular graft pioneers to achieve complete graft healing through porosity were unsuccessful
[53-55].
The complete surface healing of arterial prostheses became possible with the advent of highly
porous ePTFE grafts, and then only in a juvenile animal model. Clowes et al. showed that higher
porosities may allow for surface endothelialization [56, 57]. However, if the intent of tissue
engineering of prosthetic vascular grafts is to emulate functional arteries, the narrow focus on
endothelial cells will need to be broadened to a more comprehensive concept in which the other
constitutive elements of natural arteries are also encouraged to populate the pores.
Researchers were long puzzled why interstitial graft spaces of particular prostheses were
sufficient to allow macrophages and other inflammatory cells to migrate in, whereas connective
tissue cells of similar dimensions were often conspicuously absent [58-61]. Today it is
understood that certain of these connective tissue cells like smooth muscle cells, mainly follow
the ingrowing endothelial cells [62, 63]. Therefore, one important determining dimension for
complete graft healing is that which mechanically allows capillaries to sprout into the meshwork
of a synthetic graft and still leave some space for accompanying cells. Thus, although the
average diameter of a capillary is 8-10jlm, the diameter of a functional arteriole, i.e. an
endothelium, and at least one layer of smooth muscle cells is approximately 30llm [2,64-66].
3.4.4.2 Porosity measurement
The attempt to determine porosity requirements for graft healing is complicated by material-
specific characteristics and structural uniqueness. The complex three-dimensional structure of
contemporary grafts results in a wide range of voids between the synthetic surfaces, which
makes precise definition of ingrowth spaces difficult (See Figure 3.4). Dacron manufacturers
28
Stellenbosch University http://scholar.sun.ac.za
Chapter 3 Theoretical Considerations
circumvented this problem by defining water permeability in lieu of porosity. Grafts were then
distinguished not only on the basis of being knitted and woven, but further characterised as being
of high porosity (1500 to 4000 ml.cm'ê.min') or low porosity (200-1000 ml.cmi.min') [67].
i
(a) Weft knit textile (b) Expanded P1FE (Bare l Oum) (c) Foam type PU (Bar=100Ilm)
Figure 3.4: Typical pore structures of three commonly encountered vascular prostheses. (a) a schematic
representation of a weft knit textile, (b) scanning electron micrograph of a typical low porosity ePTF E prosthesis,
and (c) scanning electron micrograph of a foam-type PU prosthesis
The porosity of ePTFE grafts is generally characterized by average distances between the centres
of adjacent nodes of the expanded material, the so-called internodular distance (IND). For most
commercially available ePTFE grafts this value is typically in the order of 30Jlm, although larger
sizes have been produced. The IND distance is often a misleading dimension, as the actual
spaces available for tissue ingrowth, namely the inter-fibrillar distance, is typically in the 4-5Jlm
size range [68]. The morphology of foam-type porous scaffolds used in experimental
polyurethane grafts is potentially more definable in terms of actual pore size. This would be true
for foams in which the pores and inter-pore windows are clearly discernable. However, the use
of salts and other irregularly shaped porogens, together with the premixing methods used during
graft production, generally result in irregularly shaped pores and limited pore interconnectivity
[69]. Thus the porosities of these graft type are also generally expressed either in terms of water
permeability or, indirectly by stating the average size of the porogens used in their production.
Although these values serve as useful parameters in characterising the materials, they are not
helpful with regards to healing. The poorly defined space dimensions made it impossible to
come to a conclusive answer concerning the role porosity plays in the mitigation of tissue
ingrowth into prosthetic vascular grafts. If one attempts to gain a better understanding of the
relationship between porosity and healing one needs to make a clear distinction between porosity
and permeability in order to avoid a confusion of terminology. It is important to understand that
these terms are not synonymous, because a highly porous material may have a low permeability
and vice versa.
The water permeability of a graft is defined as the volumetric flow-rate of water through a unit
area of graft wall in a unit time at a predefined pressure; it is usually measured at 120mmHg and
expressed in ml.cmê.min' [70]. Porosity, on the other hand, is traditionally described as the void
volume of the structure as a percentage of the total graft volume. It is generally expressed as a
percentage, and may be determined by planimetric, gravimetric or volumetric methods [70].
A third, and arguably best, way of describing the porous nature of a vascular prosthesis involves
the actual measurement of openings available for tissue ingrowth. Unfortunately, hardly any
information is available regarding the dimensions of porous structures in commercial vascular
grafts. In order to get a better insight into this critical parameter for tissue incorporation, the
interstitial space dimensions in a few typical contemporary grafts have been evaluated, both
before and after implantation [68].
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3.4.4.3 Further requirements
Although the voids within a material will allow water to flow through them, numerous pores
may well be dead-ends that fail to provide an open corridor from the ablumenal to the lumenal
surface. Moreover, vascular prostheses are not designed to be rigid structures. They are
compressible for ease of handling and can be readily deformed by radial and longitudinal
tensions as well as by internal pressures, even in the relatively non-compliant contemporary
grafts. Such stresses not only change the dimensions of the prostheses, but also lead to a
redistribution of the yarns and fibres within the material. Naturally, the change in textile
structure by both circulatory stress and compression by ingrowing tissue itself affects the
distribution, size and tortuosity of the channels that run from one side of the graft to the other.
Since the limiting factor for tissue ingrowth is the bottle-neck of the narrowest part of a
transmural space, it is further important to look at interstitial spaces throughout their three -
dimensional course. Thus it is not only the pore dimensions that are important, but also the
arrangement of the pores in the three-dimensional structure. This is especially true when not
only radial ingrowth of capillaries and accompanying tissue is required, but also the
circumferential arrangement of connective tissue is thought to be of importance (for the
mimicking of a natural vessel structure).
3.4.4.4 Summary: Porosity
Although porosity is generally agreed to be a crucial factor in the design of vascular prostheses,
the exact nature and dimensions of the porosity required for proper healing is neither clearly
understood nor have they been clearly defined or measured.
It may be deduced, however, that the minimum porosity requirements for a tissue-engineered
graft that would heal in a way that mimics the natural artery are:
)0> Continuous ingrowth spaces from the ablumenal to the lumenal surface.
)0> Pore "channels" that are at least as large as the size of an arteriole, and possibly
appreciably larger, to accommodate for the narrowing effect of the three-dimensional
structure.
)0> A porosity that allows for not only the radial ingrowth of capillaries, but also for the
ingrowth and circumferential orientation of smooth muscle cells and connective
tissue.
3.4.5 Compliance
3.4.5.1 Definitions
Both the complex function and the structure of blood vessels require unique mechanical
properties. One parameter used to describe the mechanical properties, namely the compliance, is
a measure of the expansion and contraction a vascular graft undergoes as a result of the pressure
and flow changes occurring between diastole and systole. The diameter compliance (CD) is
defined in eq. (3.1), where D and P are the internal diameter and pressure, and subscripts sand d
denote systole and diastole, respectively [27]. It is usually expressed as %/lOOrnrnHg.
CD = (Ds-Dd)
(ps-Pd)xDd
(3.1)
The compliance of a tube is indirectly proportional to the modulus of the material constituting
the tube wall, and is related to it by eq. (3.2), where r is the inner radius of the tube, t is the wall
thickness, and E, is the circumferential tensile modulus of the wall.
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For isotropic solid-walled tubes, the wall tensile modulus (Ew)equals the tensile modulus of the
material (Em). In porous walls, the constitutive elements defining the wall (e.g. fibres) fill only a
fraction of the wall volume. Additionally, these elements are not completely aligned in the
circumferential direction, and the deformation is not purely tensile. In such cases the modulus of
the vessel also depends on the frictional forces involved in the relative movement between
individual elements, as well as the flexural and shear moduli of the elements themselves. It is for
this reason that prostheses constructed from very stiff materials such as PET fibres may exhibit
only some, but not adequate, compliance. A mismatch in the compliance of the synthetic graft
and the host vessel has been implicated in the inability of conventional grafts to have long-term
patencies, especially in small-diameter prostheses. This phenomenon is illustrated by a
significant correlation between compliance and patency [27, 71, 72]. Increased impedance and
decreased capacitance, causing disturbed flow patterns, have been cited as causes for intimal
hyperplasia that results in the failure of under-compliant grafts.
Compliance measurement has also been based on the change in volume of a test specimen
instead of its internal diameter. Thus, the volumetric compliance is defined as Cv, with Vs and
Vd the systolic and diastolic internal volumes of the vessel, respectively (See Appendix 1):
C - (v,. - Vd ) - 2C
v - (Ps - P
d
) X V
d
- D
(3.3)
Since blood vessels have non-linear elastic properties (they stiffen with increasing pressure), the
compliance decreases with increasing pressure. Most compliance values quoted in the literature
have been determined in the physiological pressure range of Ps=120 mrnHg and P, = 80 mmHg.
Blood vessels are also viscoelastic, and compliance values depend on the strain rate applied
during compliance testing. It is therefore also important to distinguish between static and
dynamic testing. During static testing, the pressure is incrementally increased and the
corresponding diameter (or volume, as the case may be) measured while the pressure remains
constant. Dynamic testing involves the real-time acquisition of diameter (or volumetric) data
under pulsatile internal pressure. Due to the viscoelastic nature of the vascular tissue, there is a
phase shift between the pressure and diameter (volume) change, and dynamic compliance values
are generally lower than those obtained by the static method. In this dissertation, the subscripts
dyn and stat will be used to infer dynamic and static compliance, respectively, while the pressure
range at which the compliance was determined will be indicated by a superscript p[ps. Thus, a
dynamic volumetric compliance determined between 80 and 120mrnHg may be indicated with
the symbol CSO-I20Vdyn •
The distensibility of a vessel under internal pressure may also be described by a stiffness
parameter, ~, defined in [73-76]:
JJ = Dd In(Ps - Pd)
Ds-Dd
(3.4)
The stiffness parameter is an attempt to linearise the non-linear response observed with natural
arteries (and elastomeric vascular prostheses), and is thus independent of pressure.
3.4.5.2 Compliance measurement
The foregoing definitions of the various parameters used to describe the pulsatile behaviour of
arteries have in common that they are all based on the accurate measurement of vessel size
(diameter or volume) and the internal pressure at both diastolic and systolic pressure without
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undue influence on these parameters due to the measuring technique. Both in vivo and in vitro
techniques have been developed.
(i) In vivo assessment
Standard pressure transducers, available in surgical theatres, are commonly used for measuring
pressure profiles. As catheterisation may influence the pressure profile, these probes are
typically inserted proximal or distal to the test section (where diameter measurement is
performed), and it may be argued that the difference in pressure between the test section and
measuring point may introduce errors. In order to minimise the error, an average of proximal
and distal reading may be used. Alternatively, more specialised microtransducers, inserted to the
exact point of diameter measurement, are advocated. Diameter measurements may be obtained
by invasive techniques involving the use of strain gauges but, ideally, non-invasive techniques
(Doppler, ultrasound) are preferred [77].
(ii) In vitro assessment
Whereas the pressure pulse in the in vivo assessment of compliance is provided by the host, the
in vitro measurement of compliance provides the additional challenge of mimicking the pressure
and flow patterns (as encountered in vivo) by artificial means. The demands and limitations on
pressure measurement are similar to those encountered in the in vivo case, whereas the
measurement of diameter (or volume) lends itself to more varied approaches due to the
accessibility of the test section. Cantilevered strain gauges, video monitoring, and non-contact
laser micrometry are examples of methods that may be employed [77].
3.4.5.3 Compliance of human arteries
As the structure and function of blood vessels change along the vascular tree, so do their
mechanical properties. Table 3.4 shows compliance and stiffness parameter data for human
blood vessels.
It is also important to note that, in addition to variation of compliance between healthy
individuals within the same age group, the compliance is also a function of age, and may be
further influenced by disease (notably atherosclerosis, hypertension, diabetes). The effect of the
age of the patient is clearly demonstrated by Kawasaki et al. [73], who showed significant
stiffening of arteries with increased age. They were able to derive a linear function to predict the
stiffness parameter, p, as a function of age. Thus, for the human femoral artery: f3 = 106x + 7.6,
where x is the age of the patient (fit: r=0.58). The extent and significance of an age-related
increase in arterial stiffness can further be seen from the actual average stiffness values listed in
Table 3.5.
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Table 3.4: Compliance and stiffness parameters for typical blood vessels in humans.
(CD in %/lOOmmHg; IJ: dimensionless)
CCA 3.2
CFA 10.6
CFA 10.5
AA 4.3 - 9.8
BA 8.6-13.7
CCA 19.84
CFA 5.25
CCA -5
FA -20
CoA -39
CCA
SFA
FA
SV
MA
SV
CFA
DSFA
MPA
CCA
FA
in vivo, ultrasound 28 [78]
in vivo, ultrasound 29 [73]
in vivo, ultrasound
in vivo, ultrasound 28 [79]
[73]
in vivo, ultrasound
<19 - >60 yrs
<19->60yrs [73]
[80]
[80]
[81]
[81]
[81]
6.6 ultrasound
1.8 ultrasound
5.9
4.4
8.0 in vitro, ultrasound
5.0 in vitro, ultrasound
14.1 in vivo, ultrasound
2.2 in vivo, ultrasound
4.7 in vivo, ultrasound
5.18 in vitro, TV camera
19.8
DSFA: Distal Superficial Femoral Artery CoA:
MPA: Midgenicular Poplitial Artery BA:
MA: Muscular Artery AA:
SV:
[82]
[82]
[77]
[77]
[74]
[74]
[83]
[83]
[83]
[76]
[76]
CCA:
CFA:
SFA:
FA:
Common Carotid Artery
Common Femoral Artery
Superficial femoral Artery
Femoral Artery
Carotid Artery
Brachial Artery
Abdominal Aorta
Saphenous Vein
Table 3.5: Influence of age on the stiffness of human femoral arteries [73J
Age (years) Stiffness parameter (P) Significance (P) *Compliance
1-19 9.41±2.71 ('!l; (b) 14.4
20-39 10.6±3.32 11.6
40-59 12.63±3.77 (a) 9.2
>60 15.31±4.52 (b) 7.3
* Calculated from average data (a)p<0.01 (b) p<O.OOI
The effect of disease and drugs on the compliance has also been investigated. Smilde et al.
showed a significant improvement in CFA compliance with a lowering of cholesterol levels in
hypercholesterolemic patients with statins [84]. Similarly, the compliance of arteries could be
increased by administration of converting enzyme inhibitors and calcium entry blockers [85].
Estrogen and anti androgens significantly reduced both FA and BA compliance in men.
Testosterone had no observed effect on the compliance of these arteries in women, but an inverse
correlation between fasting insulin levels and compliance was observed in this test group [86].
Surprisingly, Giltay et al. also found a positive correlation between arterial compliance and fat
mass variables [87]. Other factors that negatively affect arterial compliance include smoking,
hyperhomocysteinemia and hypertension [88].
3.4.5.4 Sub Summary: Compliance
The following factors are important in compliance measurement and matching:
~ Compliance matching of graft with host vessel is an important determinant in the
patency of the prosthesis
~ Various parameters have been defined to describe the compliant characteristics of grafts
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);0- The dynamic compliance or stiffness parameter is the most accurate measure as its
definition accounts for the dynamic pulsatile pressure encountered in vivo
);0- Artery compliance is affected by age, disease and drugs, and these factors should be
taken into account when matching is undertaken
);0- In order to match the compliance of peripheral arteries (e.g. femoral arteries), a
dynamic diameter-compliance of the prosthesis should be approximately
lO%/lOOmmHg (the average values for femoral arteries are shown in Table 3.5)
3.5 Host-related demands
3.5.1 Biocompatibility
3.5.1.1 Introduction
Complete inertness, a property that has been shown to be unattainable with current materials,
may actually be an undesirable property as it may cause incomplete functional incorporation and
healing of the device due to limited interaction with the living tissue. It is for this reason that
biomaterials are now being rendered "bioactive" by a variety of surface and bulk modification
techniques in order to promote constructive interaction between the implant and the host tissue.
3.5.1.2 Tissue/Polymer interaction
The nature of the reaction elicited by the implantation of a vascular graft determines not only the
short-term fate of the implant, but also its long term stability and function. The sequence of
events that follow implantation is summarized in Fig. 3.5, and briefly described below [89,90]:
<--- Acute ---- Chronic ---- Granulation tissue ----------->
Reaction
Intensity .
'" - - - - - - - - - - - - .Macronhazes,,
I
I
I
I
I
----------- Neovascularization
" - - - - - - - - - - - - - - - - FBGCs,
/ Fibroblasts,,,
, / Fibrosis
............ .,~............... "
, ;..~ Mononuclear
/ leucocytes
Time
Figure 3.5: Chronology of events after implantation (Adaptedfrom [90])
);0- Injury, causing the release of fluid, proteins and blood cells into the injured area. Blood
proteins adsorb to the lumenal, peri-adventitial and interstitial spaces of the implanted
device, and facilitate the adhesion of infiltrating cells.
~ Acute inflammation, a relatively short phenomenon (minutes to days), characterized by
the exudation of fluids and proteins, and the immigration and adhesion of leucocytes
(predominantly neutrophils).
~ Chronic inflammation, characterized by the presence of monocytes, macrophages and
lymphocytes with the proliferation of blood vessels and connective tissue. The chronic
inflammatory response may be influenced by the physical and chemical properties of the
implant, and also by motion in the implant site.
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~ The formation of granulation tissue, characterized by the proliferation of fibroblasts and
vascular endothelial cells. Fibroblasts also synthesise collagen and proteoglycans in the
developing granulation tissue.
~ Foreign body reaction, characterized by the formation of foreign body giant cells
(FBGC). FBGCs are multinucleated cells derived from the coalescence of activated
macrophages.
~ Fibrosis and fibrous encapsulation. Repair of implant sites can involve two distinct
processes:
o regeneration, the replacement of injured tissue by cells of the same type, or
o replacement by connective tissue that constitutes the fibrous capsule. This is
generally the end-stage healing response towards implanted biomaterials.
3.5.1.3 Surface modification
Surface modification is a useful tool that allows for the alteration or masking of the chemical
nature of the implant that is exposed to the surrounding tissue, as it may be used to alter this
property without undue influence on physical properties that may have been optimised for the
intended application. The wide variety of surface modification techniques employed includes
overcoating, deposition of surface gradients, self-assembly, addition of surface-active bulk
additives, surface roughening and chemical reaction [91]. Chemical modification with synthetic
reagents (monomeric or polymeric) rely on the alteration of functional surface-groups and hence
physico-chemical properties such as hydrophilicity, charge etc.) to alter the in vivo response.
Modification agents also include materials of biological origin that may render the material
bioactive, i.e. actively interact with the host tissue by mimicking naturally occurring materials.
Other approaches rely on the immobilization of oligopeptide sequences (identified as being the
active binding sites in proteins) to obtain the desired effect.
The surfaces of biomaterials may be modified for a number of reasons, all intended to improve
the biocompatibility of the material. The reasons include: to decrease the adhesion of proteins
and/or inflammatory cells, to decrease the thrombogenicity of the material, and to increase the
adhesion, proliferation or migration of desired cell types on or in the material.
Leucocyte and macrophage adhesion (and differentiation of macrophages into FBGCs) playa
pivotal role in the inflammatory response. The adhesion of these cell types has been shown to
depend on several factors that include surface chemistry, hydrophilicity and protein adsorption
[92]. Smetna et al. [93] demonstrated how the incorporation of -S03H and -COOH groups
could inhibit both the spreading of macrophages and the formation of FBGCs, while Bruil
showed an increase in leukocyte adhesion to PU surfaces modified with amino and carboxyl
groups [94]. Yun et al. modified FEP surfaces by grafting neutral (polyacrylamide, PAam),
partially anionic (acrylic acid/acrylamide copolymer, PAam-co-PAac), anionic (acrylic acid,
PAac) and cationic (polyetheleneimine, PEl) hydrogels. They found optimal (minimum)
adhesion of human macrophages on neutral or partially anionic surfaces [92].
Polyethylene glycols are shown to be a very versatile polymer in surface modification
applications. Not only have they been shown to decrease protein and macrophage adhesion [95-
97] and bacterial adhesion [98], but also to be effective antithrombotic agents [99-101]. This
anti thrombotic effect was attributed to a thermodynamic restriction effect and high mobility of
the immobilized PEG chains (effectivity increased with chain length).
Thrombotic events have also been decreased by the immobilization of a number of active anti-
thrombogenic agents. These include acetyl salicylic acid (ASA or aspirin) [102], hirudin [103,
104], dipyridamole [l05-107], lumbrokinase [108, 109] and heparin [110-118]. The
immobilization of heparin will be discussed in more detail in Chapter 8.
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The improved incorporation of synthetic devices may be facilitated by the immobilization of
extracellular matrix materials such as collagen [119-124]. Collagen and other extracellular
matrix materials contain distinct peptide sequences that have been identified as the adhesion sites
for certain cells. These include the well-known RGD sequence, as well as the YIGSR and
IKVAV sequences. These oligopeptides (with flanking sequences) have all been covalently
immobilized on biomaterials with the aim of improving tissue interaction [125-131]
3.5.1.4 Summary: Biocompatibility and surface modification
The following are important factors relating to the biocompatibility of materials:
~ The minimization of the inflammatory response, by:
o decreasing the leukocyte adhesion,
o decreasing the macrophage adhesion and proliferation, and
o decreasing the differentiation of macrophages into FBGCs
~ Mimicking the extracellular conditions by presenting a naturally occurring
macromolecule (or active part thereof) to the host.
These objectives may be met to some extent by surface modification techniques, by keeping the
following principles in mind:
~ polymeric hydrogels are effective in that they not only change the surface chemistry, but
also provide a hydrophilic barrier
~ protein, leukocyte and macrophage adhesion may be decreased by the use of neutral to
anionic surfaces.
~ tissue incorporation may be improved by the immobilization of collagen or specific
oligopeptide sequences responsible for adhesion.
3.5.2 Healing
In order to understand the in vivo response to vascular grafts, it is important to distinguish
between the different modes of healing. Tissue originating from the native vessel may grow
across the anastomosis, either on the graft surface or into the porous structure. This mode of
healing is termed transanastomotic healing. The tissue surrounding the graft is a second source
of tissue. In order for this tissue to form part of the implant, a second mode of healing, namely
transmural healing, is required. In the past, very little distinction was made between these
modes of healing, and healing patterns were described without specific reference to the source of
the tissue. Due to the differences in healing responses observed in different animal models, it
will be shown that knowledge of the tissue source is of critical importance. A graft that may
show complete surface healing (and even complete surface endothelialization) in one model due
to transanastomotic effects, will not necessarily show the same favourable response in the
clinical applications.
3.5.2.1 Transanastomotic healing
Shortly after implantation of a vascular graft, smooth muscle (and other) cells in the media of the
native artery start to proliferate and migrate through the damaged internal elastic lamina into the
intima [132]. This hyperplastic tissue subsequently migrates and proliferates onto the graft
(from each anastomosis), toward the midgraft area, forming a "tongue" of tissue generally
referred to as the pannus. (See Figure 3.6) Even before the proliferation of the pannus, smooth
muscle cells (SMC) start migrating onto the graft [133-135]. Thus the leading endothelium (EC)
grows on the exposed (or fibrin covered) graft even before the layer of smooth muscle cells grow
in underneath it [136-139]. This layer, consisting of smooth muscle cells, fibroblasts, collagen
and macrophages [56, 140-142], gradually thickens with time. The subendothelial layer lacks,
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however, the features of a native artery (e.g. elastic fibres between the SMCs and an internal
elastic lamina [143, 144].
SMC
Pannus EC
Vessel
Figure 3.6: Transanastomotic healing showing the migration of endothelial cells and the pannus tissue onto the
graft surface.
A number of factors influence the thickness on synthetic grafts. These include the anatomical
position [145, 146], variations in flow conditions [147, 148], shear stress [148] and also whether
the anastomosis in question is the proximal or distal anastomosis [146, 149, 150].
Three major factors influence the extent of pannus growth. The first two, namely the porosity of
the graft and the presence of tissue under the inner fibrinous capsule, may be closely interrelated.
Although the fibrin layer on woven and knitted Dacron grafts are of equal thickness [51, 53, 60,
140, 141, 151-153], the presence of an almost continuous layer of tissue under the fibrin layer in
knitted grafts results in faster outgrowth [53, 60, 142, 145, 154, 155] than is that observed with
woven prostheses [1.56] (that contain minimal tissue in this location). Faster outgrowth also
occurs with high porosity ePTFE grafts that have been externally wrapped with tissue. This may
be due to the facilitated transmural ingrowth that provides the sub-fibrin tissue layer that in tum
allows for increased transanastomotic outgrowth [134].
The third factor affecting transanastomotic outgrowth is the animal model. Although the
proliferative capacity of human endothelial cells does not differ significantly between
experimental animals [157], there is a marked difference in the extent of endothelialization
observed in vivo between the human and experimental animal models. For reasons unknown,
trans anastomotic endothelialization stops after only a short distance from the anastomosis in
humans [53, 158, 159].
In the dog (the most commonly used model), the transanastomotic endothelialization proceeds
for approximately 2cm on ePTFE grafts [60, 160-165] and more than 3cm on Dacron grafts [53,
60, 145, 166-168]. Due to the limited length of grafts used in many studies, it is not possible to
gauge the further progress of the endothelium on these grafts, as most of them were completely
endothelialized after this time-point. Similar 3-month distances are observed with the second
most common model, the yellow baboon (papio cynocephalus). [57, 135, 151, 169-171].
On standard porosity ePTFE (30pm), the coverage achieved in humans in .56 weeks occurs in
dogs, the yellow baboon, and the chacma baboon in 3.5,5.6 and 7.6 weeks respectively [60, 161,
162, 164, 165]. The difference between the baboon models may well be related to the fact that
the yellow baboon is a juvenile model (lOkg), while the chacma baboon with a body weight of
up to 40kg is a senescent model.
Thus, the chacma baboon, in which transanastomotic outgrowth is 2.1 times slower than in the
most commonly used model (the dog), seems to be the best choice for the evaluation of
transanastomotic endothelialization of grafts intended for man.
3.5.2.2 Transmural healing
Peripheral vascular grafts used to alleviate lower extremity ischemia (femero-popliteal) may be
up to 60 cm in length. This fact, combined with the very short distance the endothelium is able
to migrate (in humans) onto the surfaces of such grafts by transanastomotic surface healing,
indicates that future grafts intended for clinical use should rely more on transmural healing. If
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full transmural healing could be achieved, it would not only lead to the formation of a viable
endothelium, but would also result in the formation of viable tissue in the graft wall, and thus to
the improved incorporation of the prosthetic material in the host. The mural tissue should
consist, as previously indicated, not only of smooth muscle cells and accompanying extracellular
matrix, but also of a fully developed vasa vasarum capable of sustaining the viability of the cells.
The ability of tissue to migrate through the graft wall is, again dependent on both the structure of
the graft and the proliferative and migratory capacity of the cells of the host. The need for
sufficient porosity to accommodate cellular ingrowth has been introduced in Section 3.4.4. The
healing patterns observed with standard (30J.lm) and large (60J.lm) porosity ePTFE prostheses
will be described in detail in Chapter 10; these historical results will be compared to results
obtained by the author on very large porosity materials (150J.lm). It is useful, however, at this
stage to give a few general observations on the effect of graft type and animal model on the
transmural healing.
The full endothelialization of vascular grafts in the dog model due to trans anastomotic healing
has been shown, and although the researchers typically discussed the transmural ingrowth into
the graft walls, this mode of lumenal surface healing has generally precluded investigation into
the contribution of transmural ingrowth. Standard porosity ePTFE, due to its restricted ingrowth
spaces, does not allow for significant transmural ingrowth, irrespective of the animal model
used. It is interesting to note, however, that the differences regarding this type of healing
between the two baboon models is even more pronounced than that observed with
transanastomotic healing. In 60J.lmePTFE, transmural ingrowth of capillary vessels leads to the
surface endothelial in as little as two weeks in the yellow baboon, whereas the peri graft tissue
does not even penetrate the outer two-thirds of these grafts in the chacma baboon [68].
The healing of Dacron grafts is also greatly affected by porosity. Low-porosity Dacron
prostheses (woven) show perigraft incorporation similar to the standard (30J.lm) ePTFE during
the initial period after implantation. Subsequently, some fibroblast and capillary infiltration into
the narrow spaces between the Dacron yams is observed [156, 172]. In dogs, this can occur after
2-3 weeks of implantation [156], whereas in humans this may be observed after 5 months [159]
or absent even after 18 years [152, 158, 173]. Even if the tissue does manage to grow through
the tight interfibrillar spaces, however, it is unable to penetrate the compact inner fibrin layer
deposited on the graft surface [174]. In high-porosity Dacron (knitted), transmural tissue reaches
the compact lumenal fibrin layer within 3-4 weeks in the calf [53], the yellow baboon [171] and
the dog [60, 166] and 3-6 months in humans [53, 175]. The complete endothelialization of long
prostheses, comparable to that one in highly porous ePTFE grafts, is occasionally seen in knitted
prostheses. [154, 176]. In the yellow baboon, for instance, knitted Dacron grafts may form
complete endothelial linings although not as readily and consistently as in 60J.lmePTFE [57, 171,
177, 178]. However, in contrast to high-porosity ePTFE grafts it remains unclear whether this
endothelium is derived from transmural tissue ingrowth, facilitated transanastomotic outgrowth
or fall-out healing [179, 180]. The latter is a phenomenon predominantly observed in Dacron
grafts where - apparently independent from transmural tissue ingrowth and with some delay -
endothelial islands emerge on the surface of the compacted fibrin.
3.5.2.3 Summary: Healing
The following factors are important in the design of spontaneously healing synthetic grafts;
).> Conventional Dacron and ePTFE vascular grafts do not generally permit
uninterrupted transmural ingrowth of endothelial smooth muscle cells.
).> Even when transmural ingrowth is achieved, ingrowing cells are blocked by an
impenetrable fibrin matrix deposited on the lumenal surface.
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~ Transanastomotic healing in the human stops near to the anastomosis, and may not be
relied upon to achieve endothelialization of the full length of the prosthesis.
~ The dog and yellow baboon model is not representative of what could be expected in
humans, as they allow for complete trans anastomotic and a greater degree of transmural
healing.
~ The adult chacma baboon should be the model of choice for vascular graft evaluation.
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CHAPTER4
Vascular graft concept
The proposed design concept for a vascular graft may conveniently be discussed by the use of
illustrations below. First, an overview of the overall concept will be presented, after which more
details on the individual concepts will be given. Although the overall concept includes
components that fall outside the scope of this dissertation, they are included in the interest of
completeness, and to highlight where the current research fits into the ultimate goal of producing
a fully functional vascular graft by in vivo tissue engineering.
4.1 Overall concept
The overall concept of the vascular graft proposed in this dissertation involves the fabrication
and evaluation of a tubular structure comprising (See Fig 4.1):
)i;> An internal diameter of 4-6mm and a wall thickness of O.5-1mm,
)i;> An openly-porous wall that will be permissive to cellular infiltration and re-orientation.
)i;> An external reinforcing structure consisting of helically wound fibres (optimization of
alternative adventitial reinforcing structures is part of the overall concept, but falls
outside the scope of this dissertation),
)i;> A surface pacification layer lining the exposed graft material,
)i;> A temporary lumenal sealant to prevent the ingress of blood products into the structure
and prevent the deposition of fibrin on the lumenal surface (permanent sealants will be
used in this dissertation to prove this concept), and
)i;> An ingrowth matrix optimised for preferential ingrowth of preferred cell types (the
development of these matrixes is the subject of parallel research in our laboratories, and
does not fall within the scope of this dissertation).
(a) (b) (c)
Figure 4.1: Overali vascular graft design concept showing (a) complete structure; (b) wau cross-section
highlighting the surface pacification (SP), lumenal surface layer (SL) and ingrowth matrix (M); and (c) the
proposed ingrowth of endothelial ceUs (EC) and smooth muscle cells (SMC).
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4.2 Porosity
4.2.1 Dodecahedral unit-cell foams
The units defining foamed structures are often idealized by open-faced pentagonal dodecahedra.
Figure 4.2 (a) shows a side view of such a pore. Figure 4.2 (d) relates the diameter of the
pentagonal interconnecting window (W) with the height of the pore for the two routes indicated
by the coloured lines in Figure 4.2 (a). The green and red dashed lines indicate the approximate
size of capillaries and arterioles respectively. A three-dimensional view of a dodecahedral pore
is depicted in (b). In reality, the struts defining the pores as well as the interconnecting windows
between pores are often rounded, as shown in (c). This structure offers the least restriction to
infiltration in three dimensions. Cells growing into a foam of this structure are equally free to
migrate or orient themselves in all directions (e).
(a) (b)
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(c)
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i 0.04 +---------------:7""'--------___j
'ii 0.03 +------------o;,..-éL----~......,::::=-----_lI0.02
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(d) (e)
Figure 4.2: Pores resembling open-faced pentagonal dodecahedra.
Low-porosity ePfFE (Fig 4.3 (a» does not allow for considerable cellular ingrowth due to
limited ingrowth spaces. High porosity ePfFE (Fig 4.3 (b) and loosely knitted Dacron grafts
(Fig 4.3 (c) may allow for the radial ingrowth of cells, but the re-orientation of cells into the
circumferential direction is clearly not feasible due to their structures. In order to differentiate
between the effect of increased ingrowth spaces alone and the effect obtainable with
dodecahedral structures (that allow for improved ingrowth and circumferential orientation),
ePfFE grafts with very large internodal distances will also be evaluated.
!IIr. !IIr.
f9f'·
(a) (b) (c)
Figure 4.3: Possible ingrowth directions obtainable with ePTFE and Dacron vascular grafts.
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4.2.2 Circumferential orientation
It is well known that smooth muscle cells exist in natural arteries in helically-wound bundles or
sheets. The reorientation of these cells in sympathy with applied stresses has also been shown.
It is thus proposed that helical orientation of ingrowing (ingrown) smooth muscles cells should
occur when the graft is subjected to pulsatile dilation (resulting in circumferential stresses). As
the proposed foam structure is equally amenable to growth in all directions, the structure should
not impede orientation (Fig. 4.4).
Pulsitile
pressure
...
(a) Radial ingrowth (b) circumferential orientation
Figure 4.4: Circumferential orientation of smooth muscle cells as a result of pulsatile pressure.
4.2.3 Helical ingrowth channels
In the event that smooth muscle cells are not able to orient themselves circumferentially despite
open porosity provided by the foams described above, an alternative is proposed. The alternative
configuration comprises interconnecting helical channels in the graft wall. Consider the model
in Figure 4.5 (a) (the channel spacing in this model is larger than proposed for ease of
visualization). If the helical channels have openings where the successive layers cross, radial
cellular ingrowth could occur if the cells were to follow the interconnections from the ablumenal
to the lumenal surface. This concept is further illustrated in Fig 4.5 (b), which shows a cross-
sectional view of the proposed graft wall (again the number of channels and helical angle are
exaggerated). The arrows clearly indicate the route cells may follow to migrate from the
ablumenal to the lumenal surface, and further indicate how cells may also be "forced" to orient
themselves in the circumferential direction.
(a) (b)
Figure 4.5: Schematic representation of interconnected helical channels in the wau of a conceptual vascular
graft.
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4.3 Production materials and methods
Polyurethanes have been selected as materials of choice due to their processability,
biocompatibility and elastomeric properties. The majority of the work will be done with a
proprietary PU developed by Medtronic Inc (Code M48), although other PUs will also be
considered during the development process (notably Elast-Eon 2). The choice of these two
materials was based on their superior biostability (See Chapter 3).
Phase inversion with extractable porogens is proposed as the primary method by which the
porous structures are to be fabricated. Although many variations on this method have been
previously employed to produce porous polyurethane grafts, the use of irregular porogens and
premixing techniques have resulted in ill-defined structures, often with limited interconnectivity.
As the idealised dodecahedral pore structure may be considered as consisting of spherical pores,
the use of spherical pores will be evaluated. In order to improve the interconnectivity between
pores, the porogen will be pre-packed into an annular mould prior to infiltration of the interstices
with the polymer solution. This concept is illustrated (in 2 dimensions) in Figure 4.6 below. It
is evident that the combination of spherical porogens and the pre-packing technique should yield
pores of a more regular shape and increased interconnectivity.
Precipitate
lit
Extract
Polymer solution Salt crystals Paste Porous scaffold
r ....................................
l A A A A ,J
" " " " "Precipitate A A A ... ...
+ lit r y y y y
,
~ A ... ... ... ,
Extract " y ... y y... ... A ... ...
r y y y y ,
~ ........................ ~
Polymer solution Pre-packed beads Paste Porous scaffold
Figure 4.6: Proposed use of pre-packed spherical porogens for the creation of interconnected pores (lower
seematiet vs. a conventional technique of pre-mixing salt crystals (upper schematic).
Alternate methods will include melt processing techniques whereby pores are created either by
extraction of porogens, or by the use of chemical blowing agents.
Two methods for the formation of interconnected helical channels are proposed:
~ the winding of polyurethane-coated extractable fibres on a rotating mandrel, followed by
precipitation of the polymer and extraction of the fibres.
~ the combination of particulate and fibrillar porogens to render a graft containing both
foam-type pores and helical channels.
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4.4 Surface modification
Surface modification techniques will involve the covalent attachment of collagen (a protein
known to improve tissue/device integration), and heparin (a polysaccharide known for its
thromboresistant and growth factor binding capabilities). Attachment will be performed via a
poly(acrylic acid-co-acrylamide) hydrogel layer covalently attached to the polyurethane by graft
copolymerisation (Fig 4.7).
CH2---CH-CONH2
CH2---CH-COOH
+ Diamine
+ Heparin
~
CO-NH-CH2-C~-NH-Heparin
~ + Collagen
+ Heparin___.
CO-NH-Collagen- NH -Heparin
Figure 4.7: Schematic representation of techniques usedfor the surface modification of polyurethanes.
4.5 Lumenal surface sealant
The lack of healing throughout the walls of large-porosity ePTFE and PU grafts may be
attributed to the formation of impenetrable fibrin layers deposited on the lumenal surface and in
the inner portion of the graft wall. A proposed method of testing this hypothesis involves the
application of a lumenal sealant (Fig 4.8). This sealant would prevent the deposition of the
impenetrable layer, and thus allow cells to penetrate the full thickness of the graft wall (from the
tissue surrounding the graft). If the sealant was engineered to degrade at a time point after full
transmural ingrowth has been accomplished, the cells would be able to also populate the lumen
of the graft.
· : . : . : . : . : . : . : . : . : . : . : . : . : . : iinjle:nëtrirlil-éFjhriil' :
::Blood: ::::::::::::::::::::::::::::::::::::::· .. . . . . . . . . . . . . . . . . . . . . . . . .· .
·: . : . : . : . : . : . : . : . : . : . : . : . : . :L-~~e~·$~<).nt· : . : .· m' id. .. ' :00 .. . . . . . . . . . . . . . . . . . . . . . . .· .. .
Healing through 50-70% of graft thickness Healing through whole graft thickness
Figure 4.8: Schematic representation of the lumenal sealant concept
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CHAPTERS
Effect of porogen structure and incorporation technique on the
structure and properties of porous vascular prostheses
5.1 Introduction
The importance of porosity in the long term healing response toward vascular grafts has been
elucidated (See Chapter 3). Commercially available vascular grafts are mostly limited to
expanded structures and textile structures (woven, knitted, velour etc). Over the past 30 years, a
large variety of alternative techniques have been used to create porous structures from
polyurethanes in efforts to overcome the inherent drawbacks associated with the structures and
properties of the commercial products.
One class of techniques used in graft development of the polymer comprised the processing of
fibres into wound or woven tubes, resulting in the formation of fibrillar structures containing a
porosity defined by the interfibrillar spaces. Another method, of which a number of variants,
have been evaluated, is termed phase inversion/porogen extraction. It involves the shaping of a
polymeric solution containing porogen particles, precipitating the polymer in a non-solvent, and
subsequently extracting the porogen to yield a structure in which a macroporosity, roughly the
size and shape of the porogen, is superimposed on the rnicroporous structure resulting from the
phase-inversion process. These micro and macropores were mostly ill-defined and lacking in
the degree of interconnectivity needed for full transmural ingrowth of tissue upon implantation
into the host.
In an attempt to improve on the structures obtained by the phase-inversion/porogen extraction
technique, the different methods of porogen incorporation were reinvestigated, and a novel
method of incorporating spherical porogens for the creation of well-defined, interconnected
macropores is proposed.
The use of crystalline porogens and historical techniques of porogen incorporation resulted in
structures that will be shown to be similar to those obtained by previous researchers. The first
adaptation of these techniques involved the pre-packing of the porogen into annular moulds
before impregnation with the polymer solution. This resulted in an improvement in the
interconnectivity of the macropores, but the pore structures remained ill-defined. The second
adaptation consisted of the use of spherical porogens in place of angular salt crystals. By using
the spherical porogens in the column impregnation technique, well-defined, spherical pores
(approximating pentagonal dodecahedral pores observed in idealized foams) could be produced.
In addition, a novel method of producing vascular grafts containing interconnected, helically-
oriented channels by the extraction of extractable fibres is introduced.
5.2 Introduction
In describing the structure and porosity of polyurethane vascular prostheses, it is useful to
distinguish between two major categories, namely those that have a fibrillar composition and
those that resemble cellular or foamed structures.
5.2.1 Fibrillar PU grafts
Fibrillar structures have been produced by the electrostatic spinning [1] (Fig 5.Ia,b) or winding
processes [2, 3] (Fig5.Ic-f) by which PU filaments (molten or dissolved) are deposited onto
rotating mandrels. Cooling or solvent evaporation lead to a coherent structure containing voids
defined by the interstices between adjacent fibres. Accurate control over fibre orientation, fibre
thickness, density, and wall thickness allowed for the tailoring of the porosity and optimization
of mechanical properties. The use of the winding method led to the development of the
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Vascugraft" vascular graft (Fig 5.1g,h), a product of B Braun Melsungen AG (Germany) that
made it to clinical trials in below-knee indications. The graft was, however, withdrawn by the
manufacturers [4]. Another method of producing fibrillar grafts involved the use of conventional
knitting and weaving techniques generally applied to Dacron vascular grafts. Gupta et al. [5]
used this method to produce PU/PET textile grafts by weaving a combination of PU and PET
fibres into textile structures (Fig. 5.li,j).
5.2.2 Foam type grafts
5.2.2.1 Phase precipitated PU grafts
Phase precipitation of polyurethane solutions by the addition of a non-solvent, the evaporation of
the solvent, or by the lowering of the temperature, is a versatile technique that has been used
extensively in the production of porous grafts. These processes generally lead to the formation
of small (1-1 Oum) pores, although larger pores and pore gradients have been reported.
Figure 5.2 shows various structures obtained by this method. Dip-coating, followed by phase
inversion led to the creation of 10-20f..lmmicropores [6] (Fig 5.2a,b) or the formation of the
laminar structures seen in Fig 5.2c and d [7, 8]. An alternative method, termed the flotation
method, involves the deposition of a PU solution onto the surface of a non-solvent, and
subsequent winding of the precipitating polymer onto a mandrel. This procedure leads to
laminar structures [9] (Fig 5.2e,f) similar to those obtained by the use of Lommen's dip-coating
method (Fig 5.2c). A third method of fashioning a tubular structure before phase precipitation is
the extrusion of the polymer solution into the non-solvent [10-12]. Figure 5.2g-j shows the
variety of porosities obtained by this method.
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(a) Electrostatically spun graft (A) Annis [1] (b) Electrostatically spun graft (X) Annis [I]
(c) Wound graft (A) Wilson[2] (d) Wound graft (X) Wilson [2]
(e) Wound graft (L) Leidner [3] (f) Wound graft (A) Leidner [3]
(g) Vascugraft (L) Zhang [4] (h) Vascugraft (X) Lamba [12]
(i) Woven PUIPET graft (A) Gupta [5] G) Woven PUIPET graft (L) Gupta [5]
Figure 5.1: Fibrillar polyurethane grafts.
L=lumenal surface; A=ablumenal surface; X=cross-section; 3D=three-dimensional reconstruction
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(i) Extruded graft (X) Ota [11] (j)Mitrathane graft [12]
Figure 5.2: Polyurethane grafts produced by phase precipitation without the addition of porogens.
L=lumenal surface; Aeablumenal surface; X=cross-section
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5.2.2.2 Reticulated foam grafts
A number of processes have been evaluated for suitability in the production of grafts containing
larger pores (than those obtainable by phase precipitation alone). The first vascular grafts of this
nature were produced in the early 1970s by fashioning existing porous polyurethanes into tubular
structures. Examples of these grafts include grafts produced from BF Goodrich VC sponge [13]
and grafts prepared by rolling a reticulated sheet (Scottfoam") into a tubular structure [14].
Figure 5.3 shows the structures of Scottfoam before and after reticulation (heat treatment to
transform a closed-celled foam into an open-celled structure).
(a) Unreticulated Scottfoam (b) Reticulated Scottfoam
Figure 5.3: Structure of Scottfoam in its unreticulated and reticulated forms. [14J.
5.2.2.3 Replamineform grafts
"Replamineform", an ingenious process by which the microstructure of sea urchin spines is
replicated, was used to yield PU grafts with interconnected (open-cell) structures. A wide
variety of pore sizes could be achieved by using the spines of different sea urchins, and although
fault-lines present in the calcite structures could be eliminated to a certain degree, laborious
machining processes were involved in this process. Figure 5.4 shows examples of machined
spines (a), a cuboid section showing the pore structure (b), and a close-up view of the porosity
(c).
(a) (b) (c)
Figure 5.4: Examples of sea-urchin spines used in the manufacturing of PU grafts [12, 15, 16J
5.2.2.4 Phase-precipitated grafts with extracted porogens
Large pores (typically 25-150llm) can also be introduced by the inclusion of extractable
porogens to the PU solution prior to precipitation. The porogens (typically salt crystals) are
added to the polymer solution and extracted concurrent with, or subsequent to, the precipitation
of the polymer. A macroporosity of roughly the dimensions of the porogen is thereby
superimposed on the microporosity achieved by the phase-inversion process. Depending on the
conditions used during processing, the macropores may be either open or closed. The
Chronof'lex" vascular access graft (VAG) graft depicted in Figure 5.5 is an example of the
structure obtainable by this method. Itwas produced by the extrusion of a polyurethane solution
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containing suspended salt particles onto a mandrel and subsequently precipitating the polymer
and extracting the salt.
Similar structures were obtained by Kambic [17], Murabayashi [18] and Uchida [19], who used a
dip-coating method to apply the paste to the mandrel.
(a) Cross section (b) Unreinforced graft (c) Reinforced graft
Figure 5.5: Scanning electron micrographs of the ChronoFlex vascular graft made by phase
inversion of polyurethane solutions containing extractable porogens. [12, 20, 21J
The dip-coating process was also employed by der Lei [22] and Hinrichs [23] to fabricate the
experimental grafts from PU/PLA blends (Figure 5.6). Porosity gradients may be achieved by
altering the porogen size and/or loading in successive coatings.
(a) van der Lei [22] (b) Hinrichs [23]
Figure 5.6: Polyurethane grafts produced by phase inversion of Pu/PLA solutions containing
extractable porogens.
5.3.2.5 Other PU grafts
Two more methods of creating macropores in polyurethane structures merit further discussion.
Doi et al. [24] used laser ablation techniques to create transmural, cylindrical pores in solid
polyurethane tubes produced by dip-coating followed by air drying (Fig 5.7a). The final method,
employed by Kowligi et al. [25], involves the deposition of a polyurethane solution with
pressurized nitrogen gas, followed by drying at elevated temperatures. A vascular graft
containing large, closed pores is thus produced (Fig 5.7b).
(a) Laser perforation [24] (b) Nitrogen blowing [25]
Figure 5.7: Polyurethane grafts produced by (a) laser perforation of dip-coated polyurethane tubes
and (b) spraying with nitrogen.
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5.2.3 Contemporary polyurethane grafts
The Corvita" graft (Corvita Corp., Miami FL) is a helically-wound graft (Chronoflex AR wound
at 45°) [26] that contains a sealed external PET mesh (Fig. 5.8a,b). The process is thought to be
based on the methods of Leidner [3].
Two companies have used phase inversion to produce vascular grafts. The Thoratec® graft
(Thoratec Lab Corp., Berkeley, CA) was produced by a multilayer casting technique, whereby
material was sequentially added to a rotating/transversing mandrel. The graft contained an
impermeable layer (sandwiched between two porous layers of varying porosity) and helical,
reinforcing monofilaments within the wall (Fig 5.8 c,d). The Pulse- Tec® (Newtec vascular
products Ltd., Clwyd, UK; now Polymedica Industries Inc., Woburn, Mass) has a higher and
more irregular porosity than the Thoratec" graft. It contains a skin on both the lumenal and
ablumenal surfaces, with porosities much lower than in the bulk (Fig 5.8e,f). The exact
conditions used in the production of these two proprietary grafts (i.e. whether porogens were
used) are not known to the author.
(a) Corvita" (3D) (b) Corvita" (A)
Figure 5.8: Contemporary polyurethane grafts produced by Corvita Corporation, Thoratee Laboratries and
Newtee vascular products. [26J A=ablumenal surface; 3D ethree-dtmensional reconstruction
5.2.4 PU graft porosity
The size of voids or pores in vascular grafts, i.e. the spaces between adjacent fibres (fibrillar
grafts), the microvoids resulting from the phase-inversion process, or the macrovoids resulting
from extracted fillers or other porosifying agents, are not always readily quantified. This can be
attributed to the irregular and ill-defined shape of these spaces. It is, however, possible to give a
semi-quantitative account of these pore sizes (as measured by researchers).
For fibrillar grafts, the pore size depends on the fibre thickness, the winding angle used during
fabrication, the regularity of the deposition and extent of coagulation of fibres in the melt or
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solution. Although these parameters may be readily varied, the fibre size is usually limited by
other considerations (if the fibres are too thick, the graft will be stiff and drapability will be
compromised). Thus, fibres ranging from 1-30llm were reported [1, 27], with resultant pore
sizes the pore sizes in the 10-60llm range [1, 26-28]. Leidner [27] gave a detailed theoretical
analysis of the effect of wind angle on pore size, and further reported a volumetric porosity of
60% (the percentage of volume occupied by pores).
Phase precipitation (without the inclusion of extractable porogens) has been shown to lead to a
variety of structures, and may thus lead to the formation of pores with various shapes and sizes.
Apart from the ±lOOllm closed pores produced in the outer layer of the Mitrathane graft [29],
mieropore sizes are generally smaller than 151lm [6, 10,26,29].
The addition of extractable porogens offers the opportunity of increasing the porosity of grafts
prepared by the phase-inversion technique. Pores of 30-751lm [23], 40llm [17, 18] and up to
200Jlm [30] have been obtained by the use of suitable porogens. A pore-size gradient (10-
100Jlffi) has also been achieved by changing the size of the porogen in successive layers used to
build up a graft [22].
The ability to produce foam-type structures of various pore sizes by the use of the replamineform
process was discussed in section 5.2.2.3. Although the vascular graft produced by Hiratzka [15]
contained pores ranging from 18 to 251lm, this process has been applied to the fabrication of
square samples containing distinctly different pore sizes (18-28, 30-45, 75-95, 60-120 and 120-
180Jlm).
The closed-cell foams produced by Kowligi [25] by solution spraying and nitrogen expansion
contained the largest reported pore (up to 475Ilm). These pores were, however, not
intercommunicating. The pore sizes obtainable by the use of pre-existing reticulated foams
naturally depend on the processing conditions used. Besides the observation that pore sizes of
the Scottfoam used by Berkowitz et al. had a pore size of 190-250llm [14]), these foams will not
be discussed further.
5.2.5 Mechanical properties
One of the main driving forces behind the control of porosity was the effect that pore shape and
size have on the mechanical properties of grafts. Graft compliance is, however, also dependent
on a number of other factors such as material properties, wall thickness, the presence of solid
layers or skins and reinforcing structures. The methods used to measure the compliance of
vascular grafts are also not standardised [31]. For these reasons, a direct comparison between
the compliances of grafts made by different techniques is not always meaningful.
Itmay be said, however, that a wide range of compliances, ranging from levels lower than that of
the intended host artery to levels far exceeding that value, may be produced by all of the methods
discussed thus far. Diameter-compliance values, for example, range from 5% [32] to
49.5%/100rnmHg [18] for grafts produced by phase inversion and porogen extraction, whereas
phase inversion alone (without porogen incorporation/extraction) yielded grafts, in two cases,
with compliances of 1.4-2.4% [29] and 4.2-9.5%/100rnmHg [10].
A more meaningful comparison may be drawn between grafts evaluated in the same study.
Eberhart et al. [26] compared the Corvita", Thoratec" and Pulse- Tec® grafts in a recent review
on the properties of these three commercially available PU grafts, and found their static
diameter-compliances to be 1.2-1.9,2.1-3.1 and 2.5-3.5 %/lOOrnmHg respectively. A full
chronological summary of vascular grafts produced over the past 30 years, including production
methods, porosities, mechanical properties and in vivo evaluations is presented in Table 5.1.
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Table 5.1: Chronological listing of polyurethane grafts, showing manufacturing methods, properties and in vivo assessment.
Preformed foam
Marinescu I PU I Graft fabricated from BF Goodrich
6.8-12 ; VC sponge
(14) I Scottfoam I Preformed foam
Berkowitz Reticulated foam glued to Dacron
tlfelt) and fashioned into tube
Rep/amineform
polyurethane I Impregnation of PU into porous tubes
(BEP) fashioned from sea-urchin spines
(33) I Bioelectric PU I Rep/amineform
White (BEP); Impregnation of PU into porous tubes
4; I Biomer fashioned from sea-urchin spines
(34) I PEUU I Dip coating sans porogen
Lyman MDIIPPOIEDA 7-10% PU in DMF; phase inversion,
PET reinforcing sock
[I) I PEU I Electrostatic spinningAnnis, MDIIPTMEG/ 12.5% PU (DMFlButanone) ejected
10; 0.65 BDO near charged rotating mandrel.
(35) I Biomer I Dip coating sans porogen
Lyman,I978 7-10% PU in DMF; phase inversion;
PET reinforcing sock
PU/PLA blend I Dip-coating sans porogen
PU/PLA solution coated onto
mandrel; phase inversion
Pellethane 75D Fibre winding
Wilson PU fibres spun from DMF solution;
10; 0.5 wound on rotating mandrel;
evaporation
(3) Pellethane
Leidner
4-10 ; 0.82-0.86
I PU(36)
Hess
1.6
Open cell foam
P, = 190-250~
N/A
Open cell foam
P,=18-25~
Pv=32%
N/A
WP=67
Fibrous mesh (I-1.6~ fibres)
P,=IO~
p=280
WP=25
IIl-defined foam
P,=40-50J.lm
Fibrous mesh
Fibrous mesh (I3-30J.lm fibre)
Detailed pore size calc
P,=21-120J.lm
week dog infrarenal aorta implants
100% patency rate
Full endothelialization after 8wks (3cm grafts)
Minimal
N/A 3-15 day dog carotid and femoral implants (n= lO) 3cm
90% patency rate
Well-formed neo-intima
lO-III day dog femoral. 33% patency rate (n=9) 5cm No
loss of compliance after implant (patent grafts).
DMA results given
O.=4.9MPa
£.=400 %
SR=4N
=I.1MPa
dog aortic and femoral implants (5+5)
6/9 compliant grafts patent vs. on for non-compliant
controls.
N/A 3/6/12 week rat aorta interposition (n=
Complete EC lining, elastogenesis
100% patency
Ecrrc=12.1-14.5MPa
EIo"g=O.309-0.507MPa
aorta interposition (n=8+6)
Detailed information on wind-
angle vs. properties
3 month dog aorta and carotid artery (n= I+ I ) 5cm
Outer encapsulation
Smooth glistening neo-intima formed
N/A 1-25 month rat aorta interposition (n=47) lcm
Time course description of healing
Full endothelial covering by 12 weeks.
Neo-media with circulariv arranged SMC
Historical
1972
1972
1976
1977
1978
1978
1983
1983
1983
1983
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GA crosslinked gelatin impregnated
3d-6m dog carotid implants (n=30) Scm
Psuedo-neointima formed after 6 months.
Microporous foam Dog femoral and iliac implants (n= 14) I 1984
All femoral occluded after 4 weeks
Biomer Dip coating with porogen III-defined open porosity Co=49.5 Biolized grafts: Gelatin impregnation I 1985
Murabayashi I 10% PU in DMAC containing 1:2 to P,<40J.1m Co=3-4 (biolized) 3day-13month dog carotid (n=30) Scm
77% patency (Imonth)
Unhealed psuedo-intima formed.
[II) I Mitrathane I Solution extrusion I Lumenally skinned foam Pb>SOOmmHg 1-12 week dog carotid interposition (n=IO) I 1987
Ota clone Tube drawn from PU solution; phase WP=O membranous surface covering; anastomotic hyperplasia.
inversion IC = IS-26% (200 - 300mrnHg) Limited clinical VAG trial for puncture resistance: bleeding
stops cámin
[22) PUIPLA blend Dip coating with porogen III-defined foam 1h-12 week rat abdominal aorta interposition (n=28) Icm I 1987
van der Lei PU/PLA solution in DMAC Pv = 1O-IOOJ.1mgradient Transanastomotic neo-intima formation Circularly
I.S ; 0.3 containing NaCI; evaporation; arranged SMC after 12 wks (growth from media of aorta)
extraction
[29) PEUU Mitrathane" graft (type 1) 31ayer foam Cv=2.8-4.8 N/A I 1987
Martz Phase inversion (sans porogen) P,(outer): 100J.1mclosed cell ab =9.3MPa
3-8 ;
[9) Surethane Foam flotation IIII--defined foam I ab=0.OS-2.3MPa I N/A I 1988
Kowligi 2-S% PU solution in DMAC sprayed WP=0-6.6S Eb =ISO-600 %
3-S ; O.SS-I onto water surface with N,; rolled
onto mandrel
[2S) Tecoflex 80A Solution spraying I Closed cell foam I SR=8N (4/0, Imm) I N/A I 1988
Kowligi PU solution sprayed onto rotating P, = I3-47SJ.1m C=4.9
3-6 ; 0.S-1.2 mandrel with
[38) PU/Siloxane N/A I Microporous foam I ab =4.9MPa Pre-lined with EC I 1988
Muller-Glauser copolymer Co=13.2 24 hour dog arteriovenous shunts.
4: PB>S bar No thrombus.
[39) N/A N/A N/A N/A 3-7 month sheep carotid (n=21) 6cm 1988
[Underwood 100% patency (0-3 months)
; 1 78% atene (3-7 months)
[6) PU Dip Coating sans porogen Open cell foam ElOo=0.6-0.8 kPa N/A 1989
Hayashi MDIIPTMEG PU solution coated on mandrel; phase P,=7-9J.1m; ab=3.9-4.6 kPa
3; 0.8 Siloxane/EDO inversion; PET felt outer PA><=3S-40% ~=22.9
reinforcement WP=34-S8
[40) I PU I Vascugraft'" (B. Braun Melsungen) Fibrous mesh N/A Iweek-12month dog vena cava implants (ne l l ) 6cm
Kogel Fibres spun from PU solution spun 43% patency at 12 months
with air pressure onto rotating
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6-12 week dog infrarenal vena cava implants (n=12)
Neo-intimal pannus (2-3cm)
No transmural EC ingrowth
Historical
1989Biomer Dip coating with porogen Macroporous foam Co=13.5
PU solution with salt crystals salt
coated onto mandrel; phase inversion;
extraction
PEUU Mitrathane" graft (2) Fibrous mesh N/A
Electrostatic spinning
Estane 5714 Dip coating with porogen Macroporous foam 230% dilation (6months)
PU solution with salt crystals coated Pv=70%
onto mandrel; phase inversion; WP=30
extraction
[28] Corethane Fibre winding Fibrous composite
Wilson PU fibres spun from DMAC solution P, = 30-60~ (inner)
onto rating mandrel; warp knit PET
outer reinforcing
[8] PU blend with Solution spraying
Soldani PAAc, PAArn, Spraying of PU solution onto
1.5; 0.3 PVAL, mandrel; phase inversion
etc
Dip coating with porogen Ill-defined foam I Fl(M)=0.5-1.9(long)
PU solution with citrate crystals Px=30-75~ cr. ande , after implant
coated onto mandrel; evaporation; p=0.1l-0.31
extraction Pv=70-90%
. - , , vascugraft" (B. Braun Me/sungen) Fibrous mesh I N/A
Huang,
3; 0.7
[46] PU Fibrous mesh N/A
Hess
3
mandrel; eva oration
[47] PU Yascugraft" (B. Braun Me/sungen) Fibrous mesh N/A
Hess Fibres spun from PU solution spun lurn fibres
3mm; with air pressure onto rotating
mandrel; eva oration
[30] I Terathane 2000 I Dip coating with porogen 31ayer foam €.=930%
Williams +MDIlEDA PU solution with salt crystals extruded outer:
4; into water; phase inversion; extraction mid: ±100-200~m
inner: 0.5~m
WP=50
N/A
(2) 24hour-6month dog infrarenal aortic implants
Thin inner capsule
of blood elements
6 month dog end-to side infrarenal aorta and external iliac. I 1990
Aneurismal dilation detected. 75% patency (n=8). Higher
thrombogenicity that ePTFE (59% vs. 22%)
Gelatin ± heparin filled I 1991
1-12 m dog femoral interposition (n=20) 5cm
100% patency (n= I0) vs. 60% for non gelatinlheparin filled
controls (n_
A I I~I
1-12 week peritoneal cavity in rats (n=24) I 1992
FBGC surrounding prostheses. Cellular penetration
(fibroblasts) limited to outer portion.
1.5week-53month dog carotid 1 femoral implants (n=72) I 1992
Complete transanastomotic endothelialization after 6
months (3cm)
Fibronectin coating 1 gelatin coating I 1992
Grafts pre-seeded with EC in vitro
No implants
Grafts pre-seeded with EC in vitro (n=9) 6cm I 1992
5 week dog carotid interposition. 67% patency (6/9)
Multicellular lining on lumen formed (detached after 5
weeks)
6 week rat abdominal aorta interposition Icm
12 types of prosthesis implanted (n=3)
100% patency
1992
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Gershon
coating with Pellethane matrix
[49] Lycra + Fibre winding Px= 0 (initial) PB>IOOOmmHg 90 day dog carotid implants (n=13) 6cm I 1992
Cohn Pellethane + Lycra fibres wound onto mandrel after Px= 50J.llTI(I week) SR = 6.5-18.6N 12/13 patent (same as ePTFE controls)
-; 0.44 PELA coating with Pellethane/PELA matrix C=2,5% initial Smooth glistening neo-intima formed
[50] PU Yascueraft'" (8. Braun Melsunzen) Fibrous mesh N/A
Guidoin (Mitrathane I;
Mitrathane 2)
mandrel; evaporation I
[19] Biomer Dip coating with porogen Macroporous foam CD= 10.3 Gelatin sealed grafts (n=14) Scm I 1993
Uchida 15% PU solution with salt crystals Decrease with implant time 6 wk dog carotid implants
4; 0.5 (6:1) coated onto mandrel; phase 64% patency (vs. 50% for non-compliant controls)
N/A
Open cell foam CD=±6 No implant. 1994
EC lining in vitro
[12,32] Chronoflex Extrusion with porogen Macroporous foam, skinned CJ.=2.14 kPa 6 week dog carotid interposition 1995
Edwards PU solution with salt crystals extruded Pv=70% Cv=5-10% 24wk patency = 50% (n=4)
5-6; 0.9 into water; phase inversion; extraction Wp<5 SR> 2.5N Neo-intimal
[24] Cardiomat 610 Laser ablation Translumenal cvlindrical holes 6=37.7-80.5 N/A
Doi Dip coating of solution on mandrel;
2;0.1 evaporation
ILaser holes
[53] Polycarbonate- Fibre winding (Vascugraft~) Fibrous structure N/A Grafts pre lined with EC. I 1996
Poole-Warren urethane Fibres spun from PU solution spun 1-6 week ovine carotid implants. 4cm
4: with air oressure onto rotatinz Slightly higher patency of seeded vs. control grafts.
Decrease in EC coverage before recovery to 80% at 3wks.
I 1996[54] I Thoralon I Thoratec" VAG graft (Thoratec Lab) I I I Multieentre VAG clinical trial (n=145)Allen 44.9% primary patency (lyr)
64.5% secondary patency (Iyr)
Graft loss: thrombosis (17%) and infection
I 1996[55] I PU I Yascugraft" (B. Braun Melsungen) I Fibrous mesh I I 4-6 month dog abdominal aortic bypassMarois Fibres soun from PU solution spun Low thrombogenicity towards platelet and fibrin deposits
Breaks in micro fibrous structure observed
11997[5] PU and PET Fibre weaving Open woven Ep=61-88 kPa 1-12 month dog carotid interposition
Gupta Fibres PU and PET fibres woven into textile WP=0.18-2.06 1}=4.8-7.8 thin internal layer, no thrombus
4-6 ; 0.42-1.23 8-9 tex graft Cv=O.31-0.43 ECcoverage
[56] Chronoflex Corvita" graft (Corvita Corp) 3-6 month dog abdominal aorta I 1996
Akiyama Filament wound 100% patency (6 months) vs. 50% for ePTFE controls
Sealed external PET mesh Intimal thickening less than ePTFE controls
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[lO]
Chen
4.9-5.2; 0.16-
0.39
Segmented
polyether
urethane
CDst .. =4.2-9.5
C""yn=4.4-9.7
[26]
Eberhart
Co.,.,=1.2-1.9 @40mmHg
COsta,=2.4-2.5 @ 200mmHg
Chronoflex
[26]
Eberhart Co.,., =1.8-2.2 @ 200mmHg
ThoraIon Micoporous foam
P,=I 5J.lm
solid middle layer (70J.lm)
helical reinforcement
Eberhart
Co.", =2.5-3.5
[57]
Farrar
2.5-3mm
Micoporous foam
Inner: 28-140J.lffi pores
Outer: 28J.lm pores
Surfaces skinned
ThoraIon CABG graft
Historical
21-358 day human femoral-popliteal interposition (n=4) 3-
5cm
All failed due to thrombosis
Withdrawn
N/A
N/A
N/A
N/A
Clinical CABG trials (27 patients)
Data incomplete:
So far no device related serious .
[21]
Tai
Micoporous foamgraft
Low temperature coagulation of PU
solution
Co=8.1
13=20
N/A
free
1999
1999
1999
1999
2000PU
MDUPCDO
EDA
ElOo = 100% modulus
Ed'" = Circumferential modulus
E'ong= Longitudinal modulus
crb = Stress at break
Eb = Extension at break
13= Stiffness parameter
CD= Diameter compliance
Cv = Volumetric compliance
Cdyn= Dynamic compliance
C." = Static compliance
SR = Suture retention force (N)
PB = Burst pressure
Pv= Porosity by volume (%)
P,. = Pore size (cross-section)
P,,= Pore size (inner surface)
Po = Pore size (outer surface)
PAu PAhPAO= pore area
WP = Water Permeability (ml/min/cm.)
EC = Endothilial cell
CABG = Coronary artery bypass graft
VAG = Vascular access graft
PET = Polyethylene teraphthalate
DMF = Dimethyl formamide
DMAC = Dimethyl acetamide
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5.2.6 Scope
In this study some of the historical methods used for foam-type scaffold production (including
both solution and melt techniques) are described and alternate approaches evaluated. This was
done in an effort to produce vascular grafts and porous scaffolds containing well-defined
interconnected porosities (approximating pentagonal dodecahedra). These approaches may be
sub-classified according to:
• The technique used to process the polymer, i.e. solution or melt processing,
• The porosifying agents used, i.e. particulate porogens, fibrous porogens or blowing
agents,
• The technique by which the porosifying agents and polymers were combined, i.e.
premixing of polymer solution (or polymer melt), infiltration of polymer solution into a
packed column of porogen,
• The shape and size of the porogen, and
• The various parameters that influence the phase-inversion process or melt extrusion
process
The following organizational chart is useful to distinguish the different techniques evaluated in
this study:
Porous Scaffold Production
Solution Processing
Pre-mixing Infiltration Combination
Figure 5.9: Organizational chart illustrating the techniques used to evaluate the effect of processing conditions
on the structure of porous scaffolds.
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5.3 Materials and methods
Two techniques were used to incorporate particulate porogens in polymer solutions, with the
goal of producing foam-type structures:
• Pre-mixing: This method consisted of premixing the porogen and polymer solution to
form a paste that is subsequently formed into the desired shape. This method of porogen
incorporation was used in the production of dip-cast grafts and roll-cast grafts.
• Infiltration casting: In this method the porogen is pre-packed into a mould of the desired
shape and the polymer solution infiltrates the interstices between the individual particles.
vacuum/pressure-cast rods and vacuum/pressure-cast grafts were produced by this
method.
Two methods for the incorporation of fibrous porogens, with the goal of creating synthetic grafts
with interconnected helical channel porosities, were also evaluated:
• Combination casting: This is achieved by incorporating of soluble fibre into roll cast
grafts to produce a structure containing both open pores and helical channels
(combination grafts).
• Helically Winding: This method involved the coating of water-soluble fibres with a
polyurethane solution and winding the coated fibre onto a mandrel to produce helically-
wound grafts.
Two further methods, based on the melt extrusion techniques, were also evaluated:
• Melt extrusionlporogen extraction: Particulate fillers were compounded with polymer
melts, extruded into tubes, and subsequently extracted to form melt-extracted grafts.
• Melt extrusionlblowing agents: Chemical blowing agents were used in this method to
create pores in melt-extruded tubes (melt-blown-grafts).
5.3.1 Porogen properties
5.3.1.1 Porogen types
The three types of particulate porogens evaluated in this study were: sodium bicarbonate crystals
(Saarchem Holpro, RSA), hydroxyapatite beads (Biorad) and custom-made gelatin microspheres
(Thies Technologies, St Louis, USA). All porogen types were dried in vacuo (-700mmHg, RT,
48h) before use, to remove traces of water that could initiate the precipitation of the polymer
solution during scaffold manufacture. The bicarbonate salt and gelatin beads were sieved to
obtain fractions of the desired size range while the hydroxyapatite beads, due to high cost and
limited original size fraction available, were used without further size classification. In addition
to the particular porogens described above, water-soluble fibrous porogens were obtained for use
in the production of vascular grafts containing oriented helical channels as opposed to the foam-
type structures prepared with particular porogens. Soluble poly(vinyl alcohol) (PVAL) fibres
(Sanyo ML45, 45 denier), nominal diameter 85J..l1Il,were used in the winding process.
5.3.1.2 Particulate porogen size fractionation
Fractionation of the porogens to the desired size fractions was achieved by passing them through
graded sieves of known mesh sizes. The relationship between mesh size and sieve opening is
illustrated in Figure 5.10.
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Figure 5.10: Mesh sizes and corresponding sieve openings for a series of standard sieves
5.3.1.3 Porogen size determination
The porogen size distributions were also determined by standard image analysis techniques (by
scanning electron micrography after size classification), and are quoted as mean±standard error
of the means (Fig 5.11). Particulate porogen sizes are quoted as being either nominal sizes
(according to the sizes of the two sieves between which they were collected), or as actual
(determined by image analysis). The diameters of fibrous porogens were determined by image
analysis of SEM micrographs.
(b) Automatic Detection (c) Size determination
Figure 5.11: Determination of porogen size by automatic feature detection and size analysis using NIH Image
software (Gelatin Microbeads, 150-180pmfraction, Mag=350x)
5.3.1.4 Porogen density determination
The absolute density of a particulate porogen fraction (Ppor) was determined by a volume
displacement method. A volumetric flask was about half-filled with a known mass of porogen,
m por' and the remainder of the flask filled with a liquid that does not swell or dissolve the
porogen. The density of the porogen was determined from the mass of porogen, mass of liquid
added, and the volume of the flask. Thus:
mpor
Ppor = V
por
(5.1)
mpor
Ppor = V V
f - solv
mpor
(5.2)
where Vr is the volume of the flask, Vpor the volume of the porogen, and ID.olv and Psolv the mass
and density of the solvent, respectively. The bulk density (PBpor) was determined by filling a
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measuring cylinder with porogen particles (with agitation to ensure close packing), noting the
mass of porogen needed to fill the cylinder to known volume (Vey')' and calculation by:
-~
PBpor - V
cyl
(5.3)
5.3.2 Material properties
5.3.2.1 Materials used
Seven medical-grade polyurethanes were originally evaluated in this study (Table 5.2). As
different polyurethanes were used in different applications, depending on availability and
suitability, evaluation of the different properties was selectively performed. The Medtronic M48
turned out to be the polyurethane used to produce most of the grafts shown in this study, and
should be assumed as the graft material unless otherwise indicated.
Table 5.2: Medical grade polyurethanes used ill the production of porous scaffolds.
Number Material Supplier
1 M48 Medtronic
2 Pellethane 80A Dow
3 Chronoflex AL 55D Cardiotech
4 Chronoflex AL 75D Cardiotech
5 Hydrothane CT Biomaterials
6 Elast-Eon 2 85A Aortech
7 Texin Bayer
5.3.2.2 Solubility determination
The solubility parameters of polyurethanes were determined by the solvent spectrum method
described by Hansen [58]. Ampoules containing l.()() ml of solvent and 0.10 g of dried
polyurethane were shaken for 7 days at room temperature. The liquids were then classified, by
visual assessment, as good solvents, good swelling agents, poor swelling agents or non-solvents.
Hansen divided the total solubility parameter (Ot) into polar (bp), dispersion (()d) and hydrogen
bonding (~) forces:
(5.4)
These solubility parameters can be represented in three-dimensional vector space and may be
depicted by the point (()p, ()d, ()h) in the center of a solubility sphere. The solubility parameters of
the polyurethanes were calculated by using the mean value of the liquids that acted as good
solvents.
5.3.2.3 Surface tension determination
Three methods, namely the Zisman plot method, the Geometric multi-liquid method and the
Harmonic/Geometric two-liquid method, were used to study the surface characteristics of
polyurethanes. The Zisman plot method involves plotting the cosine of advancing contact angles
at liquid /surfaee interfaces against the surface tension of that liquid for a series of liquids [59].
The linear relationship between these values is then extrapolated to cosê = 1 (or e = 0°), at which
point the critical surface tension (yC> is defined. Liquids with a surface tension greater than Ye
will not spread on the subject solid and liquids with surface tensions less than the Ye will exhibit a
0° contact angle or, more likely, spread spontaneously. The geometric multi-liquid method used
is an adaptation of a method developed by Kaelble [60]. The essential assumption is the
additivity of the different molecular interactions that determine the surface tension and surface
energies of liquids or solids, i.e., dispersion forces, dipole and induced dipole interactions and
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hydrogen bonding. By making a further few assumptions the following relation for surface
tension can be derived:
(5.5)
where Sd and sP represent dispersion and polar interactions. The harmonic mean two-liquid
method is an adaptation of the method used by Wu [61].
Rat sheets of Chronoflex AL 55D, Pellethane and Medtronic were cast from 20 % solutions of
these polymers in N-methyl-2-pyrrolidone. The sheets were air dried for two days followed by 5
days drying at 60 °C in vacuo. Blocks of 22 x 30 mm were cut and the contact angles
determined by the Wilhelmy plate method on a Cahn Dynamic Contact Angle Analyser 322.
Water, glycerol and di-iodomethane were used as wetting liquids.
5.3.2.4 Density determination
The density and bulk density of polymers were determined by methods similar to those used for
porogens. (See 5.3.1.4)
5.3.3 Graft production
5.3.3.1 Solution processing
(A) Dip-cast grafts
Dip cast grafts were produced by methods adapted from those employed by various researchers
[17, 18, 22, 23, 42]. Briefly, cleaned glass mandrels (6mm) were dipped into a paste
(salt:polymer ratio = 10: 1) consisting of porogen particles (90-106Jlm NaHC03) suspended in a
polyurethane solution (10% M48 in NMP). After removal of the coated mandrel from the
suspension, the polymer was solidified by solvent evaporation, after which the
dipping/solidification process was repeated until the desired wall thickness had been achieved
(measured by image analysis of scanning electron micrographs). Final solidification was
followed by the extraction of the porogen to yield the vascular graft (Fig 5.12)
A DB c E F
Figure 5.12: Schematic representation of the dip-casting met/wd used in the production of porous polyurethane
grafts.
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(B) Roll-cast grafts
For the production of roll-cast grafts, a paste was first prepared by premixing a polymer solution
(20% M48 in NMP) with various quantities of NaHC03 crystals of desired size fraction. The
porogen loading was expressed as the porogen:polymer ratio (or porogen: solution ratio). The
paste was subsequently extruded by means of a SOml syringe onto a polished stainless steel
mandrel (of desired diameter) containing, at both ends, an annular PTFE spacer of a thickness
equivalent to the wall thickness of the graft to be produced (Fig 5.13). The rolling of the
extruded paste around the mandrel on a glass plate, followed by precipitation of the polymer
(and subsequent or simultaneous extraction of the porogen) resulted in the prototype vascular
graft.
Extrude paste onto mandrel
).
G~~ss Plate ,,! .' _
Roll to predefined thickness
Precipitate polymer and extract porogen Porous vascular graft
Figure 5.13: Schematic representation of the method used in preparing RoU Cast Grafts
(C) Vacuum/pressure-cast grafts
Porogen particles were packed into the annular space between cylindrical glass tubes
(ID=5.4mm, length =l80mm) and central stainless steel mandrels vertically mounted in a
custom-made manifold containing upper and lower reservoirs. The upper reservoirs were filled
with a polyurethane solution, after which a pressure of 7SOkPa and a vacuum of 100kPa were
applied to the upper and lower manifolds, respectively.
After complete infiltration of the entire length of the packed bead column, the resultant
polymer/solventJporogen grafts were demoulded and the polymer precipitated by phase
inversion. Subsequent or simultaneous extraction of the porogen beads, extensive washing to
remove traces of porogen and solvent, and drying resulted in the porous scaffold. Initially, the
centering mechanism depicted on the left hand side of Fig. 5.14 was employed. This mechanism
relied on centering the mandrel in the upper reservoir and lower manifold. An improved
centering mechanism (Fig 5.14b) using laser cut spacers (see insert) to align the mandrel inside
the glass tube was later employed. The complete rig, capable of producing 6 grafts, is shown in
Fig.5.15.
During the adaptation of the vacuum/pressure casting technique to the use of gelatin
microspheres, several alternative techniques were evaluated. These techniques may be
differentiated according to the technique used to demould the graft. The first demoulding
method consisted of removing the central mandrel, whereafter the polymer was precipitated (in
water) while residing in the glass tube. In the second method, a custom-made device was used to
remove both the central mandrel and the graft from the glass tube, after which the polymer was
precipitated on the mandrel (in ethanol).
Figure 5.16 shows sequential steps of vacuum-cast graft production (second method) after
removal of (A) a single mould from the rig, (B) the upper reservoir, (C) the graft (on the
mandrel) from the mould and subsequent phase inversion, (D) the porogen by extraction in a
suitable solvent, and (E) the graft from the mandrel and drying.
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t -E------ Compressed air (7-8 bar)---------'''O> t
-E--- Sealing cap
'JIZ:IlII!;U---- Centralising spacer
Reservoir for
polymer
solution
Mandrel
Glass tube
Figure 5.14: Schematic representation of the device used in the production of vacuum cast grafts, highlighting
the two centring mechanisms.
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Figure 5.15: Photograph of the custom-built device
used in the production of vacuum/pressure cast grafts
c
D
E
Figure 5.16: Sequential photographs of
vacuum/pressure cast graft production
(D) Combination Grafts
Prototype grafts containing a combination of foam-type pores and helical channels were
manufactured by a multi-layering technique involving the successive winding of soluble PVAL
fibres and impregnating the interstices with a polymer/solvent/porogen paste (Fig 5.17).
Subsequent precipitation of the polymer and extraction of both the particulate and fibrous
porogens resulted in the desired graft.
Etc. ..
Extract
Figure 5.17: Schematic representation of the method used in the production of composite grafts.
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(E) Helically-wound grafts
Grafts containing helical channels were prepared on a custom-built winding device. A soluble
poly(vinyl alcohol) fibre from a spool was passed through a syringe containing a 20% M48
polyurethane solution and wound onto a stainless steel mandrel (Fig 5.18 and 5.19). The
winding device consisted of two stepper motors fitted in a frame in such a manner that the first
provided for rotation of the mandrel containing the graft, while the other was mounted to a screw
that could provide for translational movement of a carriage containing the fibre spool and
syringe. Application of multiple layers by the to-and-fro winding (multiple traverses) the
vascular graft was built up on the mandrel. Specialised software provided for accurate control of
the two motors through the computer interface, thereby allowing for the accurate and
reproducible winding at the desired pitch. Precipitation of the polymer, extraction of the PVAL
fibre and subsequent drying resulted in a graft that contained the helical channels.
Soluble Fibre
Stepper motor
(Translation)
Figure 5.18: Schematic representation of winding technique used in the winding of helically wound grafts
Figure 5.19: Photograph of the production of porous polyurethane grafts containing helical porosities with
the use of computer-controlled winding apparatus using soluble PVA fibres.
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5.3.3.2 Melt processing
(A) Melt-extracted grafts
Polyurethane (M48) was compounded with various loadings of dried inorganic filler (NaCl, 90-
106}tm) on a twin roll mill (Brabender attachment) at 180°C for 1Ornin. The sheet of filled
material was then cooled, pelletised, and extruded (Brabender single screw; 160/170/1801140°C)
through a tubular die (6x8mm). The NaCI was subsequently extracted by extensive washing in
hot water to produce a porous graft.
(B) Melt-blown grafts
Polyurethanes were premixed with chemical blowing agents (Genitron VKA 9164 and Genitron
DP 35/22) with the use of a small quantity of mineral oil (to facilitate homogeneous dispersion)
and subsequently extruded through a 6x8mm tubular die. Various blowing agent loadings and
temperature profiles were used to produce porous structures.
5.3.3.3 Graft reinforcement
A Brabender extruder was fitted with a 2mm circular die and M48 was extruded from the die and
drawn to the desired dimensions by winding on a spool. The temperature profile, from the feed
zone to the die, was 160/170/180/140°C. Fibres of different diameters could be produced by
varying the relative speed of winding to the extrusion rate.
Helical reinforcement was performed on the custom-built winding device shown in Fig 5.20.
When the device was used for reinforcement, fibres that are non-soluble in the polymer
precipitant were used. Precipitation in water (RT, 24hr), washing in water to remove traces of
solvent introduced during the winding process, and subsequent drying resulted in a helical
reinforcement that was firmly attached to the outer surface of the graft. A helical pitch of 2.5mm
was used unless otherwise indicated.
Figure 5.20: Custom-built winding apparatus used in the winding of reinforcing fibres onto the
outer surface of porous polyurethane grafts.
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5.3.4 Porosity determination
5.3.4.1 Pore size measurement
Pore (Dp) and interconnecting window (Dw) sizes were determined from scanning electron
micrographs by image analysis using NIH Imaging software for the Macintosh. Depending on
the orientation of the windows relative to the cut plane of the section, circular features may
appear to be elliptical. Thus the long axes of the ellipses were quantified, and the features were
assumed to be of a circular shape with a radius equalling the long axis.
5.3.5 Residual porogen determination
Residual porogen determination was performed on scaffolds prepared by using gelatin
microbead porogens. Gelatin content was evaluated by an adaptation of a method of Sarin et al.
[62] for quantitative monitoring of solid-phase peptide synthesis reactions. Briefly, to 2-5mg
porous sample in an Epindorf tube, 100#1 of solution A (a mixture of: 40g phenol, lOml EtOH,
stirred with 4g Amberlite resin and filtered; and 65mg of KCN in lOOml water, 2rnl of which is
diluted to looml in pyridine and stirred with 4g Amberlite resin and filtered) and 25#1 of
solution B (2.5g ninhydrin in SOml absolute EtOH; kept in dark under N2) was added.
The samples were mixed and heated to 95°C in a heating block for 10min, cooled by immersion
in cold water, and lrnl of 60% EtOH was added. The suspensions were subsequently filtered
through a Pasteur pipette containing a glass-wool plug, rinsed twice with O.2ml of O.5M Et4NCI
in CH2CI2, and made up to 2ml with 60% EtOH. Absorbance was measured at 570nm against a
reagent blank. The standard curve depicted in Fig 5.21 was produced by using known quantities
of gelatin.
1.8r;======:::;------------~
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Figure 5.21: Standard curve for the determination of residual gelatin content
in porous structures by the ninhydrin method.
The porogen content of grafts based on dry mass before porogen extraction was calculated from
eq 5.6 below (See Appendix 4)
Por= PB
PBpor + xp so In(1- (PBPor / P por ))
(5.6)
where Por is the mass fraction of porogen present in the dried, precipitated structure (before
porogen extraction), PBpor and Ppor the bulk and absolute densities of the porogen, respectively, x
the concentration of the polymer (mass%) and Ppor the density of the polymer solution.
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5.4 Results and discussion
5.4.1 Porogen properties
5.4.1.1 Porogen types
Figure 5.22 shows the shapes of the three particulate porogens used in the fabrication of foam-
type scaffolds, as well as the water-soluble poly(vinyl alcohol) (PVAL) fibre used in the
production of vascular grafts containing oriented helical channels. The sodium bicarbonate
crystals depicted in Fig. 5.22 (a) are from the 90-106 urn size-fraction. The irregularity of the
crystals and their large aspect ratios (length: width) make the sieving of narrow size distribution
difficult, as elongated crystals may pass through the sieve opening in certain directions
(orientations) only. The hydroxyapatite beads approximated rough spheres, and are more
conducive to narrow fractionation by sieving techniques. It was found however, that a large
percentage of the beads were smaller than 80flm, and the beads were used in their unfractionated
state due to limited availability. The gelatin microbe ads (Figure 5.22c) were smooth and
spherical, and although a small percentage of the particles were ellipsoid or thoroid in shape,
they were readily fractionated into the desired size ranges. The fibrous porogen was a poly(vinyl
alcohol) (PVAL) fibre, shown in Fig. 5.22 (d).
(c) Gelatin microbeads (Mag=350X) (d) PVAL fibre (Mag=500KX)
Figure 5.22: Scanning electron micrographs of three types of particulate and fibrous porogens used in the
production of porous scaffolds.
5.4.1.2 Porogen size
The dimensions of the NaHC03 crystals, hydroxyapatite beads and gelatin microspheres are
given in Table 5.3. The irregularity of the bicarbonate crystals is confirmed by the large aspect
ratio of this porogen type. The hydroxyapatite beads had a much lower aspect ratio, while the
sherical shape of the gelatin beads is confirmed by an aspect ratio close to unity.
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Table 5.3: Dimensions (Mean±SEM; JIm) and aspect ratios of the three particulate porogens.
Porogen Sieve Fraction Count Long axis Short axis Diameter Aspect ratio
NaHC03 63-75 50 79.0±2.5 46.8±1.8 6O.1±1.7 1.80±0.1
NaHCO~ 90-106 60 148.5±.5.5 82.0±2.6 109.1±3.1 1.89±O.09
NaHC03 150-180 50 246 ..5±8.1 139.1±6.4 182.6±6.2 2.00±0.1
HA all 85 87.4±1.8 71.0±1.9 74.1±2.5 1.27±O.03
Gelatin 63-75 241 66.3±O.4 62.8±O.3 64.5±0.3 1.06±0.01
Gelatin 90-106 208 9O.3±O.5 84.7±O.5 87.4±O.4 l.07±O.O1
Gelatin 150-180 207 134.0±1.0 124.5±O.9 129.0±0.9 1.08±O.01
The actual porogen size distributions of gelatin microspheres (for the three sieve fractions
indicated) are shown in Fig. 5.23. From the shape of the histogram (and the standard errors of
the means) it is evident that narrower size distributions were obtained with the smaller beads. A
possible explanation of this phenomenon pertains to the production process. It was originally
optimised for 9O-106}lm beads and thus conducive to the production of small beads of narrow
size distribution. The larger beads are less stable during the manufacturing process, hence larger
size distributions are obtained (personal correspondence with Curt Thies, Thies Technologies).
Thus, although beads were re-sieved in our laboratories, problems encountered with the manual
re-sieving (high blocking rates), the distributions could not be narrowed further than those shown
below. The bead sizes will be referred to by the sieve fractions in most cases; actual sizes are
given only when specifically determined.
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Figure 5.23: Histogram of gelatin microbead size distributions after sieving and
collection of the 63-75, 90-106 and 150-180Jlm sieve fractions.
5.4.1.3 Particulate porogen densities
The bulk and absolute densities of the particulate porogens, as determined by methods described
in 5.3.1.4, are listed in Table 5.4. These values were used to determine the theoretical porosities.
Table 5.4: Bulk and absolute densities of particulate porogens.
'orogen Type Sieve Fraction BuIk Density _...Absolute Density
(g/cm3) (g/cm3)
NaHC03 63-75 1.15 2.16 *
90-106 1.18 2.16
150-lSO 1.20 2.16
Hydroxyapatite <80 0.58
Gelatin 63-75 0.83 1.32
90-106 0.82 1.33
150-lSO 0.81 1.31
* [63]
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5.4.2 Polymer properties
5.4.2.1 Solubility parameters
The values for the Hansen three-dimensional solubility parameters, as calculated from the
averages of good solvents (Tables 5.5; data Appendix 2). Chloroform, N,N-dimethyl acetamide
(DMAC), N-methyl pyrrolidone (NMP) and pyridine proved to be good solvents for all four of
the polyurethanes evaluated. Although the dispersive component of the solubility parameter was
slightly higher for M48 than for the other three polymers, both the polar and hydrogen-bonding
components were lower, resulting in a lower total solubility parameter. These lower values may
be explained by the nature of the soft-segments of the polyurethanes. The soft segment of M48
contains hydroxymethyl octadecanol that can be expected to be less polar and less capable of
hydrogen bond formation than the polycarbonate diols used in Chronoflex. The author does not
know the soft-segment chemistry of Hydrothane.
Table 5.5: The three-dimensional solubility parameters of polyurethanes.
5.4.2.2 Surface tension
The critical surface tensions of Medtronic and Chronoflex are very close to one another with the
value for Pellethane nearly double the latter. This implies that water (surface tension 72.8
dynes/cm) spreads better on Pellethane than on the other two polyurethanes (Table. 5.6).
Table 5.6: Critical surface tension (rJ, and dispersive (~) and polar (~) components of the surface energy of
polyurethanes (units: dynes/em).
5.4.2.3 Density determination
The densities of various polyurethanes under investigation at the time are given in Table 5.7.
The density of a 20% M48 solution (the solution used in a majority of cases) is 1.04 g/cm", while
the density of NMP is 1.03g/cm3•
Table 5.7: Densities of polyurethanes (g/cm'].
76
Stellenbosch University http://scholar.sun.ac.za
Chapter 5 Porogen Incorporation
5.4.3 Reinforcing fibres
An example of an extruded fibre with an average diameter of 2201lffiis given in Figure 5.24.
Figure 5.24: Scanning electron micrograph of an extruded polyurethane
fibre used in graft reinforcement (Mag=lSOX; bar=SOpm)
5.4.4 Solution processing
5.4.4.1 Dip-cast grafts
Figure 5.25 illustrates grafts produced by the dip-casting method. The structures resulting from
this casting method were similar to those obtained by Murabayashi [18]. Grafts consisted of
randomly distributed, ill-defined pores, with limited interconnectivity.
(a) Mag=75X; bare l Oêum (b) Mag=500X; bar=50Ilffi
Figure 5.25: Structure of porous polyurethane grafts produced by the dip-casting method (90-
106pm NaHCOJPorogen).
5.4.4.2 Roll-cast grafts
Premixing of the porogen and polymer solution resulted in the porous structures shown in Fig
5.26. When NaRC03 was used as porogen, the structure contained macrovoids resembling the
size and shape of the bicarbonate crystals. A high degree of microporosity was observed, but the
interconnectivity between macropores was low (Fig 5.26 a).
Since the optimal shape of a porogen for the creation of a well-defined pore is spherical,
hydroxyapatite (HA) porogens were employed. Although the structure depicted in Fig 5.26 (b)
contained some irregular, large voids (possibly the result of RA bead clusters), it gave the first
indication that well-defined, spherical pores may be produced by the use of spherical porogens.
Gelatin microspheres failed to produce the desired spherical porosity (Fig 5.26 c) when the roll-
cast method was used.
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(a) Mag=75X; bar= l Oêum (b) Mag=849X; bar=30J1ffi (c) Mag=160X; bar=lOOJilll
Figure 5.26: Micrographs of porous vascular grafts produced from 20% M48 in NMP by roll
casting. Porogens: (a) 90-106pm NaHC03, (b) HA and (c) 90-106pm gelatin microspheres.
5.4.4.3 VacuumlPressure-cast grafts
(A) NaHC03 crystals and HA beads as porogens
Attempts at using the vacuum/pressure-cast method with NaHC03 particles as porogens were
successful in that an openly porous structure, that would allow for the uninterrupted passage of
material through the graft wall, could be produced (Fig 5.27 a,b), The pore structure was,
however, quite random, as the material surrounding the pores did not define clear "cells", but
was randomly constructed and "finger-like".
Figure 5.27c shows a porous structure obtained by the use of HA beads in combination with the
vacuum/pressure casting technique. The beads were only partially extracted to show how the
pore formed around the porogen. Complete extraction of the beads yielded the structure depicted
in Fig 5.27d.
(b) Mag=200X; bar=IOêum (d) Mag=500X
Figure 5.27: Micrographs of porous vascular grafts produced from 20% M48 in NMP by
vacuum/pressure-casting. Porogens: (a,b) 90-106pm NaHC03, (c,d) hydroxyapatite beads.
(B) Gelatin Microspheres as Porogens
(i) Water Precipitation
Initial attempts to use gelatin microspheres as porogens in the vacuum/pressure casting method
used water as both the precipitation and porogen-extraction solvent. Grafts produced in this
manner contained interconnected pores approximating the size of the spherical porogen used, but
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the pores were not as well-defined as those obtained with the HA porogen. Precipitation in water
had a number of other disadvantages. The swelling of the grafts (while constrained on the
ablumenal surface by the mould) caused thickening of the graft wall (Figure 5.28a) and the
undulation of the lumenal surface (Figure 5.28b). Figure 5.8 (c and d) show cross-sectional
views of the same graft.
(c) Mag=292X; bar= 1OOj.lll1 (d) Mag=317X; bar= 1OOflm
Figure 5.28: Micrographs of porous vascular grafts produced from 20% M48 in NMP by vacuum/pressure-
casting followed by water precipitation. Porogen: 90-106pm gelatin microspheres.
(ii) Ethanol Precipitation
The swelling of precipitating grafts seen during precipitation in water (due, in part to the
swelling of the gelatin microbeads) was eliminated by the use of an alternative precipitant, i.e.
one that would not swell the porogen before the solidification of the polymer was complete.
Thus the precipitation of the graft in ethanol resulted in the desired structure. The well-defined
spherical pores, interconnected by multiple windows, are evident in Figure 5.29. Examples of
grafts produced by this method, using gelatin microbe ads of distinctly different pore sizes, are
shown in Figure 5.30. The effect of the increase in porogen size on the size of the pores and
interconnecting windows is evident, and will be quantified in a later section. (See 5.4.4.4)
(a) Mag=3500X; bar=Iêum (b) Mag=350X; bar=l Oêum
Figure 5.29: Micrographs of porous vascular grafts produced from 20% M48 in NMP by the
vacuum/pressure-casting followed by ethanol precipitation. Porogen: 150-180pm gelatin
microspheres
79
Stellenbosch University http://scholar.sun.ac.za
Chapter 5 Porogen Incorporation
(g) Mag=38X; bar=300pm (h) Mag=300X; bar=l00pm (i) Mag=l87X; bar=l00pm
Figure5.30: Micrographs of porous vascular grafts producedfrom20%M48 inNMP by
vacuum/pressure-casting followed by ethanol precipitation. Porogens: (a-c) 63-75pm, (d-f} 90-106pm
and (g-i) 150-180pm gelatin microspheres.
5.4.4.4 Porosity determination
The porogen sizes of the 63-75, 90-106 and 150-180 sieve fractions were 55.8±O.5, 84.8±0.6 and
137.9±1.1]lm respectively. On average, the pores created were 1.21±O.07 times the diameter of
the porogens from which they were formed, and the interconnecting windows were
approximately half the size of the pores (window:pore = 0.52±0.04). The intrafeature porogen,
pore and window sizes obtained from the three sieve fractions were distinctly different (p<0.15).
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Figure 5.31: Pore and interconnecting window sizes of porous polyurethane grafts produced by
vacuum/pressure casting with gelatin microspheres and subsequent phase inversion and porogen extraction
(Average±SEM; um)
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5.4.4.5 Residual porogen determination
The calculated percentage of porogen present in the precipitated graft (before porogen
extraction) was 94%. Washing of the grafts for a period of 172hrs at 55°C in water was able to
remove the gelatin (used as porogen) to the extent that the porogen percentage decreased to
0.52%. The blue diamonds in Fig. 5.32 represent the gelatin content of five grafts produced
subsequent to the establishment of the 172hr minimum extraction procedure (all less than 1%).
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Figure 5.32: Elution curve (red) showing the residual gelatin content of porous polyurethane grafts after
extraction in water at 55°C over a period of 172 hours. Blue diamonds represent the gelatin content of five
subsequently produced grafts washed for 172 hrs.
5.4.4.6 Graft reinforcement
The winding of polyurethane fibres onto the ablumenal graft surface resulted an evenly-spaced
reinforcement. The pre-coating of the fibres prior to application resulted in the bonding and
slight penetration of the fibres into the lumenal surface, as seen in Fig. 5.33.
(c) Mag=200X; bar=100}lffi (d) Mag=75X; bar=l00}lffi
Figure 5.33: Macro and microphotographs showing porous grafts containing helical reinforcement
consisting of bound polyurethane fibres.
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5.4.4.7 Elast-Eon grafts
As Medtronic had ceased production of the M48 polyurethane, an alternative source of biostabie
material was sought. Elast-Eon 2 (Elastomedics, Australia), a polyurethane containing a
siloxane based soft segment, was selected due to its excellent biostability. This section describes
the efforts to replicate the structures obtained with M48 with the new material.
(A) Ethanol Precipitation
Standard ethanol precipitation of Elast-Eon 2 grafts resulted in the formation of well-defined
spherical pores in the graft wall, but the interconnectivity between the pores, as well as that to
the lumenal and ablumenal surfaces, was poor (See Fig. 5.34). The poor interconnectivity was
ascribed to the relative instability of the Elast-Eon 2 solution. Due to the high siloxane content
of this polymer, precipitation occurred before the interconnecting windows could be formed by
the minimization of surface area. The measures taken to increase the inter-pore connectivity,
and the results obtained by these methods, are given in subsequent sections.
(c) Lumenal surface (Mag=200X; bare l Oêum) (d) Ablumenal surface (Mag=200X; bare l Oêum)
Figure 5.34: Micrographs of porous vascular grafts produced from 20% Blast-Eon in DMAC by the
vacuum/pressure-casting followed by ethanol precipitation. Porogen: 125-150pm gelatin
microspheres.
(B) Reticulation
The first method used to increase interconnectivity is based on the reticulation of standard
ethanol precipitated structures. Representative structures of samples subjected to heat treatment
(160 to 190°C, 10 minutes) are shown in Figure 5.35. The unreticulated control (Fig 5.35 a)
shows the typical, poorly connected porous structure. After heating at 160°C, the melting of the
interpore windows is clearly evident. The increase in temperature to 170°C had no visible
additional effect on the porous structure. At 180°C, the deformation of the spherical pores is
evident, and a further increase in temperature to 190°C resulted in the complete collapse of the
porous structure. Thus an increase in interpore connectivity could be achieved by reticulation.
Some evidence of polymer degradation (yellowing of the samples) was observed at temperatures
above 170°C. As a difference in structure between samples treated at 160 and 170·C was not
observed, the temperature of 160°C was concluded to be the optimum temperature for
reticulation.
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(ct) 180·C
(e) 190·C
Figure 5.35: Micrographs of porous vascular grafts produced from 20% Elast-Eon in DMAC by the
vacuum/pressure-casting followed by ethanol precipitation and reticulation at the indicated
temperature. Porogen: 125-150pm gelatin microspheres. (original Mag: 100X)
(C) Alternative alcohols as precipitants
The use of alternative alcohols (Cl to CI2), both at ambient and low temperature (4°C), and the
addition of a surfactant to the polymer solution, failed to have the desired effect. The reasoning
behind the use of these conditions was that the mobility of the precipitant, and thus the speed at
which the precipitant enters the precipitating solution, would decrease due to increased chain
length and decreased temperature. The polymer solution would then have more time to decrease
its surface area (due to surface tension), and thereby increase the interconnecting window size.
Figure 5.36 shows selected structures obtained by the use of the conditions indicated in the
figure. The use of methanol, cold ethanol and propanediol as precipitants had no beneficial
effect on the interconnectivity. Similar structures to these (Fig. 5.36 a-c) were obtained with
alcohols with increased chain length (C12). An interesting honeycomb structure was obtained
when the casting solution contained 5% sodium lauryl sulphate (SDS), but although an increase
in the microporosity could be observed, the maeropore interconnectivity remained poor (Fig.
5.36 d).
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(c) Propanediol (d) 5%SDS in dope; methanol
Figure 5.36: Micrographs of porous vascular grafts produced from 20% Efast-Eon in DMAC by the
vacuum/pressure-casting followed by precipitation in various solvents. Porogen: 125-150pm gelatin
microspheres. (Orig Mag=100Xj bar=100pm)
(D) Dual precipitation
The addition of solvents to the non-solvent used for the precipitation is known to decrease the
rate at which the polymer precipitates form solution. The failure to obtain the desired
interconnected structures with the addition of various amounts of DMAC (the solvent used for
Elast-Eon) to the ethanol precipitation bath (results not shown), prompted investigation into the
use of other non-solvent combinations. The best results were obtained by the use of a dual-
precipitation regimen, in which the polymer is partly precipitated in DMSO, and thereafter fully
precipitated in ethanol (Figure 5.37). Structures containing well-defined pores of high
interconnectivity could be produced by using this method.
(a) Mag=l00X; bar=l00j.1IIl
(c) Mag=750X; bare l Opm (d) Mag=l00X; bar=lOOj.1IIl
Figure 5.37: Micrographs of porous vascular grafts produced from 20% Blast-Eon in DMAC by the
vacuum/pressure-casting followed by dual precipitation (2hr DMSO followed by 18hr EtOH).
Porogen: 125-150pm gelatin microspheres.
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5.4.4.8 Grafts containinghelical channels
Grafts containing helical channels and interconnected pores could be produced by using a
combination of particulate and fibrous porogens (see 5.3.3.1 D). Figure 5.38 shows an example
of such a graft containing concentric layers of helical channels. The interconnectivity between
the channels and the pores are evident from Figure 5.38 b. Figure 5.38 c-f shows a prototype
grafts containing helical channels (without additional macropores) produced by the winding
process described in 5.3.3.1 (E).
(e) Mag=58X; bar-=200j.tm (f) Mag=41X; bar-=300j.tm
Figure 5.38: Scanning electron micrographs of prototype grafts containing (a,b) a combination of
helical channels and pores, and (c-f) helical channels without additional macropores
5.4.5 Melt Processing
5.4.5.1 Melt-extracted grafts
The melt processing of polyurethanes with salt crystals (and subsequent extraction of the
crystals) resulted in structures not unlike those obtained by solution techniques in which the
porogen and particulate porogen were premixed. The pores were ill-defined (See Figure 5.39)
and the interpore connectivity was low.
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(a) Before extraction (Mag=200X; bar= lOêum)
Porogen Incorporation
(b) After extraction (Mag=100X; bar=lOOllm)
Figure 5.39: Micrographs of structures obtained by extruding M48 after compounding with 50%
Nael (90-106pm)
5.4.5.2 Melt -blown grafts
Melt extrusion of polyurethanes with chemical blowing agents resulted in the formation of non-
connected pores similar to those obtained by Soldani [8]. Although the porosity could be
influenced by changing the type and quantity of blowing agent, open-cell foams could not be
produced by this method. Two representative samples of the structures obtained with two
polyurethanes using two different blowing agents are shown in Figure 5.40. Further attempts to
increase the porosity were accompanied by the collapse of the foam structures.
Texin + 1phr Genitron VKA 9164 (175/1901205/125°C)
(Mag=75X; bar= l Oêum)
M48 + 3phr Genitron DP 35122 (145/160/170/125 °C)
(Mag=75X; bar=l00J.lffi)
Figure 5.40: Micrographs of the pore structures obtained by the melt extrusion of polyurethanes with
chemical blowing agents.
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5.5 Summary
The different techniques that have been used to produce porous vascular grafts resulted in the
formation of a wide variety of structures that may be classified as being either
• fibrillar (polyurethane fibres constructed into a tube by winding or weaving techniques),
• rnicroporous (structures containing pores in the 5-15Jlm, range resulting from the phase
inversion techniques), or
• macroporous (larger pores produced by the addition of porogens prior to phase inversion,
or by reticulation, replarnineform, or gas spraying methods).
Reinvestigation of the porogen leaching techniques involving the pre-mixing of particulate
porogens (salt crystals) resulted in foam-type structures similar to those obtained by previous
researchers. The pores in these structures were ill-defined and contained poor interconnectivity.
Although the interconnectivity of these structures was improved by a technique whereby the
porogens were pre-packed into annular moulds prior to impregnation with the polymer solution,
the structures remained ill-defined due to the shape of the porogens used. Spherical porogens
were subsequently used to obtain structures containing both well-defined dodecahedral pores and
a high degree of interconnectivity. The size of the pores could be controlled by the use of
porogens of well-defined, narrow size distributions.
A rigorous porogen extraction procedure ensured the removal of the porogen. This was
confirmed by a ninhydrin protein determination assay. Graft reinforcement was achieved by the
helical winding and bonding of a polyurethane fibre to the ablumenal surface.
The application of the technique to an alternative polyurethane was not without problems, but the
desired structures could be obtained by reticulation or optimization of the precipitation
conditions.
Although the production of grafts containing helical porosities were not taken beyond the
prototype stage, novel techniques for the fabrication of such structures were demonstrated.
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CHAPTER6
Effect of well-defined dodecahedral porosity on inflammation and
neo-vascularization
6.1 Abstract
Porosity is an important factor in the healing of prosthetic devices. To better understand this
phenomenon, porous polyurethane scaffolds were produced by a variation of the phase
inversion/porogen-extraction technique in which a pre-packed column of spherical porogen
particles was infiltrated with a polymer solution prior to polymer precipitation and porogen
. extraction. Scaffolds contained pores of well-defined shape (approaching open-faced,
pentagonal dodecahedra), narrow size distributions (66.1±1.3, 84.2±1.7 and 157.0±2.4flm) and
high interconnectivity (interconnecting windows of 30.1±0.8, 41.9±1.5 and 76.4±2.0flm
respectively). A high degree of accessible macroporosity (greater than 80%) could be achieved
while limiting the inaccessible microporosity to below 2%.
The neo-vascularization and inflammatory responses to the scaffolds were evaluated in the
subcutaneous rat model for 4 weeks. The inflammatory response index (IRI) and foreign-body
giant-cell index (FBGCI) could be reduced by 56% (p<O.05) and 21% (p<O.02) respectively
when the pore size was increased from 66 to 157flm, while the vascularization index (VI) and
arteriolar index (AI) remained unchanged.
Thus a significant decrease in inflammatory response could be achieved without adversely
affecting the degree of neo-vascularization by increasing the size of the pores.
6.2 Introduction
Porous polymeric scaffolds have been widely employed in organ regeneration, structural tissue
repair and prosthetic devices. In order to fulfil the requirements posed by such applications,
scaffolds should exhibit a highly interconnected and uniformly distributed pore structure
throughout the matrix [1]. High porosity values and large interconnected pores have
consequently been identified as essential characteristics for tissue ingrowth, vascularization and
the diffusion of nutrients [2].
In addition to expanded structures created by the stretching of crystalline materials (e.g. ePTFE),
porous scaffolds are conveniently divided into two classes, based on their morphology, i.e.
fibrillar structures and foams. Fibrillar scaffolds may be produced by knitting and weaving [3],
melt or solution spinning [4], electrostatic spinning [5], and other non-woven techniques [2].
Several techniques are also available for the production of the second class, termed foamed
structures. Replamineform [6], thermal inversion [1], blowing/reticulation [7] and gas expansion
[8] are among those reported. Liquid-liquid phase inversion of polymeric solutions is another
versatile technique that has been used extensively in the production of porous scaffolds [9, 10].
This method is typically restricted to the production of pores in the I-Hlum range. Larger pores
(typically 25-200llm) can be introduced by the addition of extractable porogens to the polymer
solution prior to precipitation [11-13]. The porogens are added to polymer solutions and
extracted concurrent with or subsequent to the precipitation of the polymer. A macroporosity of
roughly the dimensions of the porogen is thereby superimposed on the microporosity achieved
by the phase inversion process. The use of salts and other irregularly shaped porogens, together
with the premixing methods used during production, generally result in irregularly shaped pores,
limited pore interconnectivity, and residual porogen remaining in the structure [1].
The effect of pore size on the ingrowth of tissue into porous devices has been studied by various
workers. Structures with pores smaller than 0.51lm allow for the passage of fluids but prevent
91
Stellenbosch University http://scholar.sun.ac.za
Chapter 6 Effect of Porosity
the ingrowth of cells and bacteria, and are preferred for wound dressing applications [14]. An
increase in pore size to 5-lOJlIIl allows only limited cell ingrowth [15]. In addition to cellular
ingrowth, structures with interconnected pores of 10-30!lm have been reported to additionally
support the ingrowth of fibrohistiocytic tissue and capillaries [6, 16]. Organised fibrous tissue
forms in pores of 30-100!lm [17], while fibrocartilaginous tissue has been reported to form in
pores of 18-180!lm [18].
The objectives of the present study were to produce porous structures containing regularly
shaped pores of well-defined size distribution and high interconnectivity, and to evaluate the
effect of pore size on the neo-vascularization and inflammatory response to such scaffolds in the
subcutaneous rat model. The lowest of the three pore sizes used in this study has interconnecting
windows (the limiting dimension for ingrowth) of 30!lm, which corresponds with the lower
porosity range that has been reported to support capillary ingrowth. The largest pore size was
chosen to fall in the> 1OO!lm range, that has been reported to support fibrocartilaginous tissue
formation, while the mid-range pore size was chosen to correspond to the lOO!lm divide
described above.
6.3 Materials and methods
6.3.1 Porous scaffold production
Spherical gelatin beads (Thies Technologies, St Louis, USA) were fractionated into the desired
size ranges by passing them through graded sieves The 63-75!lm, 90-106!lm and 150-180m
fractions were collected. The beads were packed into the lumens of cylindrical glass tubes
(ID=5.4mm, length =180mm) vertically mounted in a custom-made manifold containing upper
and lower reservoirs. The upper reservoirs were filled with a 20% (m/m) solution of segmented
polyurethane (in N-methyl pyrollidone, NMP, Sigma-Aldrich, RSA), after which a pressure of
750kPa and a vacuum of 100kPa were applied to the upper and lower manifolds, respectively.
After complete infiltration of the entire length of the packed bead column, the resultant
polymerlsolventlporogen rods were demoulded and the polymer precipitated by phase inversion
achieved in a non-solvent for both the polymer and the porogen (24hrs, RT, 96% ethanol,
Saarchem Holpro, Krugersdorp, RSA). Extraction of the porogen beads (5x1h, 60°C, water),
extensive washing (5 days, 60°C, water) to remove traces of porogen and solvent, and drying,
resulted in the porous scaffold (Figure 6.1). The rods were skinned by applying a 5% solution of
the polyurethane in chloroform (Sigma-Aldrich, RSA) to the outer surface (in order to limit
tissue ingrowth to the longitudinal direction) and subsequent drying at elevated temperatures
(Fig 6.2b). After slicing disks of uniform thickness (2mm) from the rods, sterilization by
ethylene oxide (ETO) exposure, and removal of residual ETO at low pressure (24hr, RT, -
750mmHg), the morphological and in vivo evaluations were performed.
6.3.2 Porogen, pore and window size measurement
Standard image analysis techniques, using NIH image software (for Macintosh), were used to
determine porogen, pore and interconnecting window sizes from scanning electron micrographs.
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Figure 6.1: Graphic representation of the methods used in the production of porous disks.
6.3.3 Porosity determination
6.3.3.1 Volumetric method
Porosities were determined by a volumetric liquid displacement technique similar to that
described by Zhang and Zhang [19]. A scaffold sample of a given mass (mscaf) was immersed in
a graduated cylinder containing a known volume (V) of ethanol. After a series of evacuation/re-
pressurization cycles, to ensure penetration of the ethanol into all the accessible pores, the
volume (V2) was recorded. The ethanol-impregnated scaffold was subsequently removed and the
residual volume (V3) recorded. The porosity of the open pores (Pvop) was calculated from
equation (6.1):
Pvop = Vvop/Vvscaf = (~ - V3)/(V2 - V3) (6.1)
where VvseaJ is the volume of the scaffold and Vvop the volume of the open pores. In addition, the
porosity of the closed pores (Pvcp) was calculated by (See appendix 3):
PVC? +-P,.,(';,':_ V,)~ ~: =~ ) (6.2)
where mscafis the mass of the scaffold and Ppol the density of the polymer (l.025g/cm3). The total
porosity of the scaffold (PVtp), as determined by the volumetric method, follows from:
(6.3)
6.3.3.2 Gravimetric method
The total porosity of the scaffold was also calculated directly from the mass and volume of the
scaffold according to:
~ VGscaf - VGpol VGpol mscaf mscalPG = = =1- =1- =1---=t....,.-
tp VGscal VGscal VGscal PpolVGScaJ Ppol(1U
2
Z)
where PGtp is the total porosity and VGtp is the total volume of pores (VGOP + VGCp), as determined
by the gravimetric method, r and Iare the radius and length of the porous rod, and other variables
as defined elsewhere, with the exception that they refer to those obtained via the gravimetric
method (subscript G)
(6.4)
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6.3.3.3 Theoretical method
If one assumes that the volume of the skeleton defined by the polymer solution in a packed bed
method remains constant during phase inversion, it is possible to derive the theoretical macro
(PTma), micro (P Tmic) and total porosity (Pnp) from basic principles based on physical
characteristics of the constitutive elements (polymer, solvent, solution, porogen) alone. It can be
shown that (See appendix 4):
e; = 1- [(xPsoln )(1-~)l
Ppol Ppor
(6.5)
P. _ PBper
Tmac -
Ppor
(6.6)
and hence:
(6.7)
where x is the concentration of the polymer solution (mlm) and Psoln, Ppol' and Ppor the densities
(g/cm") of the solution, polymer, and porogen, and PBpor is the bulk density of the porogen.
6.3.4 Rat subcutaneous implants
All animal experiments described in this dissertation were performed after approval by the
Animal Research and Ethics Committee of the University of Cape Town, and in compliance with
the "Principles of Laboratory Care" and the guidelines for the care and use of laboratory animals
(NIH publication no. 86-23).
Disks were prepared from each porogen size fraction (63-75, 90-106 and 150-180 }tm) as
described above and implanted subcutaneously in young male Wistar rats (+ 200 g). Following
induction of general anaesthesia with an intramuscular injection of a ketamine/xylazine mixture,
the dorsal side of the animal was shaved. Using an aseptic technique, three 1 em longitudinal
incisions were made through the skin at either side of the dorsal midline. A subcutaneous pocket
for each disk was prepared byvgentle blunt dissection with a pair of curved artery forceps. Three
disks were implanted on each side (i.e. 6 per animal) and the skin incision was closed with single
3/0 prolene stitches (Fig 6.2a). After 28 days of implantation, the animals were killed by
inhalation of carbon dioxide. Disks were explanted with their surrounding fibrous capsules and
fixed overnight in 10% buffered formalin.
i i
(b)
Figure 6.2: Schematic representation of rat subcutaneous implant model showing possible
ingrowth directions and circumferential sealant
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6.3.5 Evaluation of neovascularisation and inflammatory response.
One half of each disk (Fig. 6.3B) was then transferred to a 70% ethanol solution for storage,
while the other half (A) was embedded in paraffin wax (C,D) after dehydration in ascending
grades of alcohol and clearing with iso-octane. The embedded samples were subsequently
sectioned to a thickness of 5 Jl.m (E), mounted on microscope slides (E), and excess wax
removed by incubation at elevated temperatures (60°C, 1h) and clearing (iso-octane) (F) .
..................
Figure 6.3: Schematic representation of explant sample preparation steps.
Sections were deparaffinised and stained with a biotinylated Griffonia simplicifolia lectin (GSL-
1) (Vector Laboratories, Burlingame, CA, USA) which shows specificity for endothelial cells,
monoclonal anti-rat smooth muscle cell actin antibody (a-SMCA) (Research Diagnostics,
Flanders, Nl, USA) which shows specificity for vascular smooth muscle cells, and monoclonal
antibody ED1 (Serotec Ltd, Oxford, UK) which shows specificity for tissue macrophages.
Multinucleated foreign body giant cells (FBGC) were identified on hematoxylin and eosin
stained sections.
To quantify the inflammatory response (ED1 positive cells), FBGC content, neovascularisation
(GSL-1 positive cells) and arteriolarization (a-SMCA positive cells), the relevant stained
sections were subjected to image analysis. For each section, a blinded observer captured 18
regions (Fig 6.3· F; 300 X 350Jl.m: neovascularisation, arteriolarization; 150 X 175 us»:
inflammatory response, FBGC content) with a Leitz DM RB microscope. The areas of positively
identified elements were quantified with Qwin image analysis software and normalised to the
available ingrowth area, generating a vascularisation index (VI), arteriolarization index (AI),
FBGC index (FBGCI) and an inflammatory response index (IR!)
6.3.6 Statistical analysis
Data are expressed as means ± standard error of means (SEM). The comparisons of porogen,
pore and interconnecting window sizes, as well as VI, AI, FBGCI and IR! between groups, were
made by Student's unpaired t-tests. One-sided p-values were determined in all cases. A
significance level of 0.05 or less was accepted as being statistically significant.
6.4 Results
6.4.1 Structure
Figure 6.4 a-c shows low magnification scanning electron micrographs of hemicircular sections
of disks produced from the three porogen size fractions (63-75J1.m, 9O-106J1.m and 150-180Jlm),
as well as the thin polyurethane skin around the circumference. The increase in pore size with
increased porogen size, and the uniformity of the pores sizes, is clearly seen in the higher
magnification micrographs (Fig 6.4 d-f).
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(d) 63-75pm(Mag=350X) (e) 9O-106pm(Mag=350X) (f) 158-180pm(Mag=350X)
Figure 6.4: Scanning electron micrographs of unmodified porous polyurethane disks containing
pores of uniform and discrete size distributions.
6.4.2 Porogen, pore and window sizes
The actual porogen sizes were within 14% of the lower value of the sieve ranges from which
they were collected (64.5±0.3pm for 63-75pm range, 87.5±O.7pm for 90-106 range and
129.0±O.9pm for the 150-180pm range). The use of these porogens resulted in the formation of
macropores of 66.1±1.3pm, 84.2±1.7pm and 157.0±2.4pm. The respective sizes of the
interconnecting windows were 30.1±O.8pm, 41.9±1.5pm and 76.4±2.0pm (Figure 6.5). The
differences in intra-feature porogen, pore and window sizes were statistically highly significant
(p < 10-8). The window-to-bead size ratio was relatively constant at an average of 51.3±4.0%,
while the pore to bead size ratio was found to be either close to unity (smaller bead sizes), or
above unity (large beads). The window-to-pore size ratio averaged at 48.0±1.3%, and increased
as the porogen size increased.
6.4.3 Porosity
A comparison of the porosities obtained by the three methods employed is depicted in Figure
6.6. It shows that the porosity of the scaffolds is independent of the size of the porogen used in
its production. According to the volumetric method, the average open porosity of 84.2±O.1%
contributes 99.8% of the total porosity (85.2±O.O%). The gravimetric method produces a slightly
lower total porosity of 81.2±O.O%. A theoretical calculation of the porosities, under the
assumption of constant polymer/polymer solution volume and no contraction or expansion
during phase inversion, yields a much lower value for the macroporosity (61.9±0.3%), and
higher values for the micro and total porosities (30.4±0.3% and 92.3±O.1%, respectively).
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Figure 6.5: The sizes of gelatin porogen beads after fractionation into 63-75,90-106 and 150-
180pmfractions and the sizes of macropores and interconnecting windows of porous scaffolds
prepared by the use of these particulate porogens (Mean ± SEM).
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Figure 6.6: The macro, micro and total porosities of porous scaffolds preparedfrom 63-75, 90-106
and 150-180pmfraction poragens as determined by the volumetric, gravimetric and theoretical
methods described in the text (% ± SEM).
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6.4.4 Rat subcutaneous implants
6.4.4.1 Histology
Hematoxylin and eosin stains of the explanted porous disks indicated that there was an inverse
correlation between the number and size of multinucleated FBGC and pore size (Fig 6.7 a-b).
This trend in an inflammatory response was more clearly perceived in sections that were
immunoperoxidase-stained with the EDI antibody (Fig 6.7 c-d). There were substantially fewer
macrophages in the high pore-size (129pm) relative to the low pore-size (66 pm) disks. A
tendency for the EDI antibody to stain only limited portions of FBGCs was observed. The
incomplete staining was variable and appeared to be more frequent in the 157pm explants.
Capillaries invading the disks were visualised with GSL-l lectin staining. GSL-l also reacts
with FBGCs but vessels could be unequivocally identified by the presence of a lumen (Fig 6.7 e-
O. Vessels were present throughout the depth of the disks, with a slightly higher occurrence just
below the interface between the polyurethane and surrounding tissue. There was no intimation of
relation between pore size and vascularisation. Erythrocytes were evident in a substantial
proportion of vessels suggesting the existence of organised capillary beds in at least some areas
of the implants. Mature vessels vested with mural smooth muscle cells were identified through a
positive reaction with the monoclonal a-SMCA antibody (Fig 6.7 g-h). Arterioles were evenly
distributed throughout the disks and appeared to be at similar levels across the three pore-sizes
implanted.
6.4.4.2 Quantification of indexes
The results of the effect of pore size on the vascular (VI), arteriolar (AI), inflammatory response
(IRI) and foreign body giant cell indexes (FBGCI) are shown in Figure 6.8. The FBGCI
decreased by 21% between the 66 pm and 157 pm pore size scaffolds (5.7±0.5 to 4.5±0.1 % for
the two pore sizes, respectively, p< 0.02). There was an even larger decrease of 56% in the IRI,
as evident in the qualitative examination of the EDI antibody stained sections, between these
two groups (4.0±1.1 to 1.8±0.3% for 66m and 157pm pores respectively, p< 0.05). The vascular
and arteriolar indices did not change significantly with pore-size variation. The proportion of
vessels that were arterialised was 43.7±4.4%, on average, across all pore sizes.
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Figure 6.7: Representative histological images depicting (a,b) Hematoxylin & Eosin, (c,d) EDl
antibody, (el) GSL-l lectin, and (g,h) a-SMCA stained sections of the polyurethane disks.
Left column: 66Jlm porosity. Right column: l57Jlm porosity. (F=FBGC, V=Vessel, A=Arteriole
and M=Macrophage)
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Figure 6.8: The Vascularization (VI), Arteriole (AI), Immune response (IRl) andforeign body giant
cell (FBGCI) indexes of tissue growth into porous scaffolds prepared from 63-75, 90-106 and 150-
180pmfraction poragens (% area).
6.5 Discussion
In the past few decades, the field of biomaterials research has expanded to include a wide range
of prosthetic scaffolds such as orthopaedic, cardiovascular and aesthetic implants. In most of
these implants, complete integration or at least silent acceptance by the recipient organism is a
key goal. Integration and quiescent acceptance, however, often imply both the ability of tissue to
'invade' the prosthetic implant and the absence of an inflammatory rejection response. While
porosity is an evident prerequisite for tissue ingrowth, there is evidence that space dimensions
may influence the degree of foreign-body inflammation [20, 21]. As much as porosity itself was
addressed in numerous approaches towards the creation of polymer scaffolds, pore dimensions
were undefined and often random, thus preventing researchers from establishing a correlation
between space dimensions and inflammation. By combining well-defined spherical porogens
with a refined method of ethanol phase inversion, the authors were able to:
• create well defined, interconnecting, dodecahedron-shaped, ingrowth spaces within
distinct narrow size-ranges,
• reduce the 'micro-porosity' associated with phase inversion to less than 2% and thus
create a material less prone to mechanical failure,
• prove a correlation between space dimensions and inflammation by halving the
macrophage response through doubling of space diameters and
• refute the connotation that inflammation is a prerequisite for vascular ingrowth.
The definition of the macropores was achieved through the use of spherical porogen beads of
uniform spherical shape. They resembled pentagonal dodecahedra often used to describe the
structure of foams. The spherical beads could, unlike irregular salt crystals often used in similar
techniques, be fractionated into very narrow size-distributions that allowed for the regular
packing of beads. The close packing ensured high porosities while the uniform bead-size was
replicated in the scaffold's macropores.
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In a ternary polymer/solvent/non-solvent phase separation, the relative rates at which solvent is
exchanged for non-solvent determines the degree of rnicroporosity, and also indirectly influences
the size of the macrovoids produced by the porogen. In the present case, the microporosity was
minimised by the choice of a non-solvent (ethanol) that enters the polymer solution at a rate
lower than that at which the solvent (NMP) leaves. A low degree of rnicroporosity is important
in the maintenance of the mechanical properties of the scaffold, as they (the micropores) weaken
the structure without contributing to the useful porosity available for ingrowth. This is a
particularly important factor in the development of vascular grafts, where structural integrity and
compliance are crucial. In other applications, where the scaffold is intended to be degradable
and mechanical strength is not critical (e.g. in vitro organogenesis), increased microporosity may
be achieved by careful selection of solvent/non-solvent pairs, and thereby beneficially decrease
the mass of synthetic material to be degraded.
The most significant outcome of an increase in pore size within the polyurethane foam was a
reduction in the inflammatory potential of the material. Strikingly, this occurs at what may be
considered two temporal stages in the inflammatory response, namely the more immediate reply
of the invading mononuclear macrophage and the endpoint of FBGC formation. The FBGC has
been shown to directly induce cracking in implanted polyurethane at its site of adhesion [22] and
therefore any reduction in FBGC presence could have a direct impact on the long-term stability
of polyurethane-based prosthetic implants. There is much debate in the literature on what the
consequences of the macrophage presence are for prosthetic implants [23]. They are generally
considered to be pro-angiogenic due to their release of factors such as the potent angiogenic
factor vascular endothelial growth factor (VEGF) when exposed to the hypoxic environment that
must initially exist within an implant. Other stimulatory factors for tissue ingrowth known to be
secreted by hypoxic macrophages are the fibroblast growth factors (acidic and basic; a-FGF and
b-FGF) and platelet-derived growth factor (PDGF). The latter has been shown to recruit smooth
muscle cells. Therefore it is of interest that the vascularisation and arteriolarization of the high-
porosity implants were not impaired by their relatively decreased content of macrophages. This
could be of particular significance for prosthetic vascular grafts where it has been argued that the
healing of a graft requires transmural tissue ingrowth [24]. Certainly, transmural vascularisation
is the most probable candidate for their spontaneous endothelialization. The ability of an
increase in pore size to 12911m diameter to overcome the possible reduction in pro-angiogenic
signals is a promising sign. The introduction of a pro-angiogenic ingrowth matrix within the
pores which releases cytokines may further enhance this favourable trend.
Although the porous structures described in the present study were produced from a bios table
polymer and were primarily intended for the evaluation of healing responses to implantable
devices such as vascular grafts, the methods used in their production are applicable to the
production of biodegradable scaffolds useful in cell transplantation and organogenesis.
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CHAPTER7
Graft copolymerisation of acrylic acid and acrylamide as a spacer
for the subsequent immobilization of biomolecules
7.1 Abstract
Copolymers of acrylic acid (Aac) and acrylamide (Aam) may be readily grafted to the surfaces
of solid and porous polyurethanes by the use of eerie ion initiation. Unwanted gelation of the
grafting solution, especially when porous substrates are used, could be successfully inhibited by
the addition of a cupric salt. Electronic spectroscopy for chemical analysis (ESCA) of
polyurethanes grafted with solution containing three feed compositions (20, 50 and 80 mol%
Aac respectively) showed enrichment in Aac in the copolymer (relative to the feed). This
implied a preference of both Aac and Aam terminated radical chains for the Aac monomer, and
thus rj>l>r2• Reactivity ratios were determined by the intersection and linearization methods.
Average values ofrj=1.04, r2=0.29 and rj=I.40, r2=0.48 were obtained for grafting onto solid and
porous polyurethane structures respectively. Reconstruction of copolymer composition curves
based on the calculated reactivity ratios showed good fits with the copolymer compositions
determined by ESCA analysis. Of the various reactivity ratios available in the literature for this
comonomer pair, those derived from Q-e values (Qj=1.15, Q2=1.18, ej=0.77, e2=1.30) were
closest to the values obtained in this study. Evaluation of composition-conversion curves
revealed that the difference between the average (Fjav)and instantaneous copolymer composition
(Fj) was less than 1%, up to a conversion of 30%. Thus the assumption needed for the
calculation of reactivity ratios, i.e. that F, could be equated to Fjav (as calculated from ESCA
results) at low conversion, was valid.
7.2 Introduction
Surface modification is a versatile technique by which the chemical and physical properties of
biomaterials may be altered to improve compatibility and integration (See 3.5.1.3). Apart from
being useful materials for the attenuation of protein and macrophage adhesion [1], acrylic acid
on its own, or as a copolymer with acrylamide, has been used as an interim step to the covalent
immobilization of bioactive molecules such as collagen [2-5] and heparin [5-7].
The copolymerisation of two monomers is characterized by their reactivity ratios, i.e. the relative
preference each monomer has for propagation with another of the same type (as opposed to
propagating with the other monomer). The reactivity ratios may be used not only to determine
the relative amount of each monomer that will be taken up in the copolymer for any given feed
composition, but also how the feed and copolymer compositions change with conversion of the
monomers. A concise summary of copolymerisation theory, as applicable to the current study, is
given in Appendix 5.
The accurate determination of reactivity ratios is not a trivial process, and has to be performed
for each monomer pair under consideration. The reaction conditions (solvent, temperature,
concentration etc.) may greatly affect the reactivity of the monomers, as may be seen in the
listing of reactivity ratios r, and r2 for the monomer pair acrylic acid (Mj) and acrylamide (M2)
respectively. (Table 7.1)
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Table 7.1: List of historical r1 and rz values for acrylic acid (MJ and acrylamide (MJ
rl i'. li r2, " it ' .'" k Reference . :£0
3.8 0.58 [8]
1.676 0.465 [9]
1.644 0.445 [8]
1.466* 0.515* [10]
1.376 0.598 [9]
0.341 1.346 [8]
0.333 1.358 [9]
0.29 1.06 [8]
0.289 1.085 [9]
* Calculated from Q =1.15, Q =1.18, e =0.77, e2=1.30
The eerie ion was an effective initiator for the graft polymerisation of polyurethane substrates.
Initiation occurs through formation of free radical on the hard segment carbamate via complex
formation with the eerie ion, as shown in Figure 7.1 [11].
cé+ + H:p~ Ce(OH)3+ + IV and + Ce(OH)3+ ~
ï"
[-R-r.~?] ~
Fi Ce
.( O-H
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"""'R-N-C- CHFC-C-OH~
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Figure 7.1: Mechanism for the eerie ion-induced free radical initiation of PU substrates for graft polymerisation
[11].
The aim of this study is to determine a set of reactivity ratios for the graft copolymerisation of
acrylic acid and acrylamide onto solid and porous polyurethane substrates using eerie ion
initiation, and to compare these values to those obtained by previous researchers for bulk and
solution polymerisation processes involving the same monomers. The efficacy of cupric salts to
inhibit the gellation of reaction mixtures during graft polymerisation [12], will also be evaluated.
7.3 Materials and methods
7.3.1 Acrylic acid!Acrylamide grafting
After cleaning in isopropanol (IPA, lOmin, RT) and multiple rinses with deionised water (DI),
solid PU samples (8x8xO.2mm) and porous polyurethane disks (see Chapter 6) were immersed in
the grafting solution containing acrylic acid (either 4.2M, 2.5M or O.8M, Aldrich, USA),
acrylamide (either O.8M, O.5M or 4.2M, Aldrich), CU(N03)2 (O.lM, Saarchem Holpro, RSA) and
cerium ammonium nitrate (CAN) (O.06M, Saarchem, (NH4)2[Ce(N03)6])' Oxygen was removed
from the grafting solution before the addition of the cerium salt by the bubbling of Argon gas at
1 l/min for 10 min. The reaction vessels were sealed and grafting was continued for 35 min at
room temperature, after which the samples were rinsed in DI water, washed in borate buffer
(O.lM, pH=9, 50°C, 1hr), rinsed again in deionised (DI) water, and finally dried in air. All the
steps, apart from the drying, were performed in an ultrasonic bath to ensure solution/solvent
penetration and mixing.
Solid and porous samples were also grafted without the addition of the copper salt (conditions
otherwise identical).
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7.3.2 Surface analysis and reactivity ratio determination
Electron spectroscopy for chemical analysis (Physical Electronics Quantum 2000 Scanning
ESCA Microprobe, 20W, 45°, CSIR, Pretoria) was performed on the solid (n=2) and porous
(n=2) hydrogel-grafted samples to determine the atomic percentages of C, Nand 0 in the surface
layer. These conditions generally result in a depth of analysis of 2-4nm.
From these values (after equating instantaneous and average copolymer compositions: Flav=FI;
F2av=FIdue to low conversions) and the molar fractions of each monomer in the feed solution
(flO, f2°), the reactivity ratios (r., r2) of the monomers were determined by the approximation
method, the Mayo-Lewis intersection method, and the Fineman-Ross linearization method.
Throughout the following section acrylic acid was taken as monomer 1 (MI):
Approximation method (See A5.2.3.1) [13]:
lj = f2/ F2 and r2 = fJF;
Intersection method (See A5.2.3.3) [13]
lj = r2( F;f2: J+(f2 IF; -IJ
Fdl I, F2
Linearization method (See A5.2.3.4) [14]:
h (F2 -F;) _( F2h2}
- ---2 ,+r2f2 F; F;f2
(7.1)
(7.2)
(7.3)
7.3.3 Sequence length and composition-conversion calculation
The instantaneous sequence length distribution (NI;x)and average sequence lengths (Xlav;x2aJfor
each monomer was calculated according to (See Appendix 5.2.1.6):
NI;x = ~rl ~2 and N 2;x = p~-IP21 (7.4a,b)
1
x'av =-
~2
and (7.5a,b)
where
~,= Ijh and ~2= t.
Ijh + f2 Ijh + f2
P22 = rJ2 and P21= h
rJ2 + I, rJ2 + f..
(7.6a,b)
(7.7a,b)
The calculated reactivity ratios were also used to plot the instantaneous copolymer composition
against the feed composition (F, vs. f.). The feed (fl) and copolymer compositions
(instantaneous (FI) and average (Flav)) were subsequently plotted against the conversion (X) in
order to determine the compositional drift (See A5.2.2):
F; = (Ij _~)h2+ h and hO- h(l-X)
(lj+r
2
-2)h +2(1-r
2
)h+r2 F;av= X (7.8a,b)
(7.9)
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7.4.1 Graft copolymerisation
The success of the hydrogel grafting (f10=0.8; ~=5M, with copper salt) is evident in Figure 7.2.
The internal surfaces of the unmodified porous structure has a smooth appearance, while the
poly(acrylic acid-co-acrylamide grafted sample has a cobblestone appearance after dehydration,
gold sputtering and visualization with the scanning electron microscope (SEM). Atomic force
micrographs (AFM) of the solid PU before and after grafting show similar undulated surfaces on
the grafted samples.
(b) SEM: Porous disk (grafted) 1500X
(c) AFM: Solid shim (control) (d) AFM: Solid shim (grafted)
Figure 7.2: Visualization of porous (a,b) and solid (c,d) M48 substrates before and after graft
copolymerisauon with Aac and Aam. ([MIO]::;5M; f1°=O.8;with Cu(N03)J
Graft polymerisation can also be performed without the addition of cupric ions in the reaction
mixture [5]. In the absence of the cupric ions, however, the polymerisation of the monomer(s) in
the solution surrounding the sample competes with the grafting reaction, and gelation of the
reaction mixture occurred (own experience). With solid samples, sufficient grafting could be
obtained (without the use of cupric ions) before gellation, and even when some gellation did
occur, it was readily removed from the planar surfaces. When the reaction mixtures without
cupric salts were used to graft porous samples, however, it was found that gellation invariably
occurred within the porous structure before sufficient grafting could be achieved. Cupric and
ferric ions act as free-radical scavengers by transferring electrons from propagating radical
polymer chains to their incomplete d-shells [12]. This inhibitory effect is, however, greater in
the bulk solution than in the graft, and is thus a valuable tool for the prevention of gel formation
during graft polymerisation. The effectiveness of the copper nitrate used to graft copolymerise
Aac and Aam onto the exposed surfaces (both internal and external) without unwanted blocking
of the pores, is evident from the lack of ungrafted gel in the porous structure shown in Fig. 7.3b.
All further analysis was performed on samples grafted with the addition of CU(C03)2 (to prevent
blocking of the pores).
7.4.2 Determination of reactivity ratios
The oxygen to nitrogen (OIN) ratios of the PAac-co-PAam grafted surfaces (as calculated from
the ESCA data), and the calculated average copolymer compositions, are tabulated against the
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feed composition in Table 7.2. The molar fractions of monomer 1 (Aac) in the copolymer (Flav)
were higher than in the corresponding feeds (f,").
Table 7.2: Copolymer compositions of grafted PU samples as determined from ESCA (Value±SEM)
flO O/Nsolid O/N porous Flav solid FI" porous
0.8 1O.375±1.375 12.807±1.901 0.824±O.022 0.855±O.020
0.5 4.261±O.630 4.228±O.491 0.620±0.046 0.617±O.036
0.2 2.101±O.134 1.928±O.003 0.355±O.028 0.317±O.OOl
Graphs obtained by the employment of the intersection and linearization methods are included in
Figure 7.3. Although the three lines generated by eq. 7.2 did not intersect at a single point (solid
polyurethane), the intersection did occur in a distinct region on the rl'r2 plane (Fig. 7.3a). For the
grafting of the porous polyurethane, the intersections of the respective lines were much closer to
a single point (Fig 7.3c), as attested by the standard error of the means given in Table 7.3. The
R2 values obtained for lines generated by eq. 7.3 (very close to unity) for both the solid and
porous samples indicate a good correlation between the linearization model and the experimental
data obtained (Fig 7.3b and d).
r2
(a) Solid PU; Intersection
4.0 ----
S.O --- ---
t:
Z.O - ------
1.0 _--
r2
.0.5
·1.0
s « 1.00SS4x + 0.27767
~_o.g8U8 __
-f211 "VF1f2"2
(b) Solid PU; Linearization
'-----------------------' -4.0
-rzn AVF1f2A2
(c) Porous PU; Intersection (d) Porous PU; Linearization
Figure 7.3: Graphical determination of reactivity ratios by the intersection and lineariuuion methods
The approximation method, which resulted in r, and r2 values that were appreciably higher than
the other two methods (Table 7.3), did not fit the experimental data well. The former is based on
the assumption that the copolymer composition is almost exclusively dependent on rl when low
concentrations of M2 are used (and on r2 when MI is low). This method was used only to obtain
approximate values and will not be discussed further. The intersection and linearization methods
produced similar reactivity ratios. There was, however, an appreciable difference in the
reactivity ratios (with either of these two methods) between the substrates used (solid vs.
porous). Both the intersection and linearization method produced lower r, and r2 values for the
solid samples than on the porous disk. On both the solid and porous substrates, since rl> l>r2,
both of the active centres have a preference for addition to one of the monomers, in this case MI.
This leads to the formation of a copolymer that is always enriched in Aac relative to the feed, as
seen in Table 7.2.
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TabIe7.3: Reactivity ratios as determined by the approximation, intersection and linearization methods
Copolymerization
Approximation Intersection Linearization
fl solid l.138 l.061±O.061 l.OO5
f2 solid 0.563 0.292±O.037 0.278
rl porous 1.381 1.397±O.008 l.404
r2 porous 0.631 0.482±O.OO5 0.483
The reconstructed copolymer composition curves (Fig. 7.4), based on the reactivity ratios given
in Table 7.3, show how well both the intersection method and linearization method data fit the
experimentally derived copolymer fractions listed in Table 7.2.
u:: 0.5
0.9
- - - Porous Intercept: r1.1.397; r2_0.482
0.8
0.7 -
0.6
0.4 • Fl SOlid
... - - Solid Intercept rl.1,061: r2_0.292
0.3 --Solid linearization: r1_1.005;rl_C.2?8
0.2 -- o Fl porous
0.1
- Porous lineariZation: r1_1.404; r2-0.483
0.0 ~---~----~-_....'::::::::;:::========::;::::========::'.j
0.0 0.2 0.4 0.6 0.8 1.0
fl
Figure 7.4: Copolymer composition (FJ vs. feed composition (fJfor poly acrylic acid-co acrylamide grafted to
solid and porous polyurethanes as reconstructed from reactivity ratios by the intersection and linearization
methods.
Figure 7.5 shows copolymer composition curves reconstructed from selected reactivity ratios
from the literature (See Table 7.1). The best fit to the experimental data (for the porous PU) is
obtained by using the reactivity ratios derived from the Q and e values of Ham et al. (r1=1.466;
r2=0.515) [10].
1.0
0.9
0.8
0.7
0.6
... 0.5LI.
0.4
0.3
0.2
0.1
0.0
0
• Fl solid
o Fl porous
- FromTable 7.1: n _3.8; r2-O.58
- From Table 7.1: rl.1.676; rZ_O.465
- FromT8bte 7.1: rl-l.466; r2-0.515
-From Table7.1: rl-1.376; r2_0.598
-From Table7.1: rl.0.341; rZ-l.346
-From TatHe7.1: rl.0.289; r2_1.OBS
0.2 0.6 0.80.4 fl
Figure 7.5: Copolymer composition (FJ vs.feed composition (f,)for poly acrylic acid-co- acrylamide as
calculated from reactivity ratios obtained from the literature.
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7.4.3 Determination of instantaneous sequence distributions
Whereas the reactivity ratios and copolymer compositions show the overall composition of the
copolymers, valuable insight into a further aspect, namely the distribution of the two monomers
in the polymer chain, may be obtained by analysing the sequence distributions. Figure 7.6 shows
the instantaneous sequence distributions and average sequence lengths of both monomers taken
up in the copolymer at feeds compositions of flo=0.8, 0.5 and 0.2 respectively. It is interesting to
note that, for a feed containing 80% Aac, 90% of the Aam units appear as single units flanked by
Aac, while the average length of Aac units is 6.6.
1.01---------------;=======::::;-]
0.8
• Nl;x (tl-0.8): xl av=G.G
II Nl;x (fl =0.5): xl av-2.4
lSI Nl;x (fl =0.2): xt av=1.4
• N2;x (fl =0.8): xzev-t.i
IIIN2;x (fl =0.5): x2av-l.5
E;J N2;x (fl =0.2): x2av-2.9
0.9
)(
.t::. 0.7
StjO.G
'00.5
c
.20.4
t
I!0.3
II.
0.2
0.1
0.0
2 3 4
Sequence length (x)
5
Figure 7.6: Instantaneous sequence distributions and average sequence lengths of PAac-co-PAam grafted to
M48 (M.=Aac; Mr=Aam; r.=1.404; ri=().483; [Mo]=5M)
74..4 Influence of conversion on composition
The composition-conversion curve below (Fig. 7.7) has been calculated using the reactivity
ratios obtained by using the linearization method (porous substrate). It shows the change in feed
composition (f.), instantaneous copolymer composition (FI) and average copolymer composition
(Flav)as a function of the conversion (X). The difference between the average and instantaneous
copolymer compositions is less than 1% up to a conversion of 0.3. Thus, the assumption of
FI=Flav(for low conversions) used to determine the reactivity ratios is valid.
0.9
- ----~--~\
\'
\
\
-
--Flav
-Fl
--tl
-
0.8
0.7
! 0.6...
!; 0.5
...
i 0.4
0.3
0.2
0.1
o
o 0.1 0.2 0.3 0.4 0.5 0.6 0.7
Conversion [X = l-M/MO))
0.8 0.9
Figure 7.7: Composition-conversion curves for poly acrylic acid-co acrylamide grafted to porous polyuretlulne
scaffolds as calculated from. r1=1.404 and rz=O.483. ([MlO]=5M; (1°=0.8)
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CHAPTER8
Surface pacification of porous scaffolds
8.1 Abstract
Porosity and surface chemistry are known determinants of the healing response towards devices
used in tissue engineering applications. In order to evaluate the effect of these two parameters
on novel porous polyurethane scaffolds, disks containing three distinctly different pore sizes
(66.4±1.3, 84.2±1.7 and 157.0±2J..lm),as well as large porosity disks (l57.0±2.4J..lm) modified
with collagen, heparin or a combination of collagen and heparin by covalent surface attachment,
were produced. Disks (n=6) were implanted in the subcutaneous rat model for 14 days to
evaluate neo-vascularization and inflammatory response.
By increasing the pore size from 84.2±1.7 to 157.0±2J..lm,and additionally pacifying the surface
by collagen attachment, the inflammatory response (based on foreign body giant cell index,
FBGCI) could be decreased by 80% (p<0.002). More importantly, this dramatic decrease could
be achieved without any significant decrease in the vascularization of the implanted devices.
The immobilization of heparin or the combination of collagen and heparin had no significant
effect on FBGCI.
The long-term outcome of porous prosthetic devices depends to a large degree on the ingrowth
of surrounding tissue into the porous structure and successful incorporation of the device in vivo.
This incorporation, in turn, is influenced by the inflammatory response elicited by the foreign
body, and the successful vascularization of the ingrown tissue. The current results provide a
means to minimise the inflammatory response without adversely affecting the neo-
vascularization.
8.2 Introduction
The injury associated with the implantation of prosthetic devices leads to sequential events
whereby acute inflammation and chronic inflammation are normally followed by the formation
of granulation tissue, foreign body reaction and fibrosis. [1]. The inflammatory response is
often exacerbated in porous polymeric scaffolds used in tissue engineering applications due to
the increased surface area presented to the host. Factors that influence the reaction include the
physical properties (shape, size, porosity, mechanical properties) and the chemical nature of the
scaffold.
It was previously shown that the inflammatory response following implantation in the rat model
(28 day implants) could be significantly reduced by an increase in the pore size in polyurethane
scaffolds containing well-defined, interconnected pores. [2] (See also Chapter 6).
Shimizu reported favourable integration of various polymers of in vivo by the use of telopeptide-
poor collagen immobilized by a lamination process [3,4]. A group headed by Ikada at Kyoto
University later developed a technique whereby collagen was covalently attached via its amine
functionality to silicone [5] and polyethylene [6] implants via a grafted poly(acrylic acid) spacer.
They claimed the method to be superior to that of Shimizu, as the covalent attachment proved to
be more stable than the laminated structure that tends to delaminate in aqueous environments.
Lee et al. also grafted collagen to PU via plasma-induced acrylic acid grafting, and reported
improved cell adhesion [7]. An alternative method of linking collagen to PU with epoxides was
demonstrated by Huang et al [8].
The most widely used function of heparin is related to its antithrombogenicity achieved through
its interaction with anti-thrombin III (ATIII), and the subsequent interaction with thrombin that
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interrupts the coagulation cascade [9]. It has been demonstrated that a unique pentasaccharide
sequence in heparin is required for this interaction (Fig. 8.1).
Heparin is an anionic polysaccharide consisting of partially sulphonated, alternating, D-
glucosamine and glycuronic (L-iduronic and D-glucuronic) acid residues. Consequently it may
be immobilized through ionic means (with cationic substances) or covalent means through its
hydroxyl, carboxyl and amino functions. Ionic methods include the deposition of the water-
insoluble complexes of heparin and certain cationic surfactants [10, 11] and the deposition of
heparin after the pre-treatment of surface with cationic surfactants [12, 13]. The most widely
used ionic method involves the pre-treatment with 1-5% tridodecylmethylammonium chloride
(TDMAC) in lipophilic solvents [14].
Covalent attachment onto cyanogen bromide activated poly(vinyl alcohol) [15, 16] and cyanuric
acid activated agarose [17] via hydroxyl and/or amino groups in heparin have been reported.
The carboxyl functions, after activation with a water-soluble carbodiimide, provide an alternative
attachment site [18-20]. Additional reactive functionality, through which heparin may be
covalently immobilized onto aminated surfaces through reductive amination, may be introduced
through partial oxidation of glycol functions to the corresponding aldehydes [21].
Yet another method involves the attachment of heparin via polyethylene oxide spacers after
functionalisation with isocyanates [22]. The use of PEO spacers is reported to decrease platelet
adsorption by increasing the hydrophilicity, and to increase the bioactivity of the heparin. In
addition, the bioactivity has been shown to increase with spacer length.
As the use of the abovementioned covalent immobilization methods have the risk of interfering
with the pentasaccharide ATIII-binding sequence, a new method, termed end-point attachment
was developed [23, 24]. It involves the partial degradation of heparin with nitrous acid to form
fragments with reactive aldehyde groups at the reducing terminal residues. These fractions were
then coupled to the aminated surface through reductive arnination.
(a) R~,,~~0 ~C(j<Qcoo- ~~ coo- ~ coo-~ OCH, H OH H NHSO'~O H NHSO, H 050, 0-
(b)
(c)
H
(d)
Figure 8.1: Chemical structure of heparin showing (a) the pentasaccharide AT/Il binding sequence; (b) nitrous
acid degradation; and (c) periodate oxidation. Note the possibility of oxidizing the glycol functionality in the
pentasaccharide (d).
Although these methods were developed mainly to impart antithrombotic properties to
substrates, immobilized heparin may also be used for the incorporation and protection of
heparin-binding growth factors [25].
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The overall objectives of the present study was to determine the effect of three surface
modification treatments on the inflammatory response towards and neo-vascularization potential
of porous polyurethane scaffolds containing large (150-180llm) pores. The first treatment,
namely collagen immobilization, has previously been shown to facilitate the incorporation of
polymeric devices in vivo, and was used in this study to determine whether the inflammatory
response toward porous polyurethane scaffolds (with relatively high surface areas) could be
mitigated by using this biomolecule. The effect of heparin immobilization, with the eventual
goal of using it as a substrate for growth factor binding, was evaluated either with or without
collagen pre-treatment. The secondary objective was to re-evaluate the inflammatory response
toward porous polyurethane scaffolds containing various pore sizes (after a shorter implantation
period than previously used).
8.3 Materials andmethods
8.3.1 Porous scaffold Production
Porous polyurethane scaffolds were produced by a phase inversion/porogen extraction method as
described earlier [2]. Briefly, a cylindrical column of sized gelatin beads (63-75Ilm, 90-1061lm
and 150-180llm respectively) was infiltrated with a 20% (rnlm) solution of segmented
polyurethane, and the resultant polymer/solventlporogen rods were demoulded and precipitated
by immersion in ethanol. Subsequent porogen extraction, followed by extensive washing and
drying resulted in the porous scaffold. A thin impenetrable skin (±50llm) of polyurethane was
applied to the outer surface of the cylindrical porous rods. After slicing disks of uniform
thickness (2mm) from the rods, surface modification (where applicable), and sterilization by
ethylene oxide (ETO) exposure, the in vitro and in vivo evaluations were performed.
8.3.2 Surface modification
8.3.2.1 Acrylic acid/Acrylamide grafting
After cleaning in isopropanol (IPA, lOmin, RT) and multiple rinses with deionised water (DI),
porous polyurethane disks prepared from a 150-180llm porogen size fraction were immersed in
the grafting solution containing acrylic acid (4.2M, Aldrich, USA), acrylamide (0.8M, Aldrich),
Cu(N03)2 (O.IM, Saarchem Holpro, RSA) and cerium ammonium nitrate (CAN) (0.06M,
Saarchem, (NH4MCe(N03)6])' Oxygen was removed from the grafting solution before the
addition of the cerium salt by the bubbling of Argon gas at 1 I/min for 10min. The reaction
vessels were stoppered and grafting was continued for 35 min at room temperature, after which
the samples were rinsed in DI water, washed in borate buffer (O.IM, pH=9, 50°C, l hr), rinsed
again in DI water, and finally dried in air. All the preceding and subsequent coupling steps, apart
from the drying, were performed in an ultrasonic bath to ensure solution/solvent penetration and
mixing.
8.3.2.2 Collagen immobilization
I
Collagen was covalently coupled to the poly(acrylic acid-co-acrylamide) (PAac-co-PAam)
samples after activation of the carboxyl groups with a water-soluble carbodiimide. Activation
was achieved by exposure of grafted samples to a O.OIM 1-(3- dimethylaminopropyl)-3-ethyl
carbodiimide (EDC) and O.OIM N-Hydroxysuccinimide (NHS) in an 0.02M morpholino-
ethanesulfonic acid (MES) buffer (pH=4.5, RT, 5min). (See Appendix 7). After removal of
samples from the activation solution, and further removal of excess solution from the substrates
by blotting on lint-free towelling, collagen coupling was achieved through exposure to a solution
containing 0.5mg/ml collagen (Type I, calf skin, Fluka) in an 0.02M MES buffer for 24h at room
temperature. The samples were consecutively rinsed in DI, 0.025M phosphate buffered saline
(PBS, pH=7.4) and DI, and subsequently dried in air at room temperature.
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8.3.2.3 Heparin immobilization
PAac-co-PAam grafted samples were exposed to an O.SMEDA solution in an O.SM MES buffer
containing O.OSMEDC (pH=S.O, 2h, RT), and subsequently rinsed in DI prior to heparinization.
Collagen-coated samples were heparinized without further pre-treatment.
Sodium heparin (Smg/ml, Diosynth, Netherlands) was oxidised in a phosphate buffer (O.OSM,
pH=6.8) containing sodium periodate (0.16Smg/ml, 16h, RT, dark, Saarchem). After oxidation,
the solution containing the oxidized heparin was diluted to 2mg/rnl by addition of acetate buffer
(O.4M, pH=4.6). The diluted heparin solution was pre-heated to 50°C, O.OIM sodium
cyanoborohydrate (NaCNBH3, Saarchem) was added, and after lOmin aminated or collagen-
coated samples were exposed to the resultant solution for 2h at 50°C (Fig 8.2). The samples were
consecutively rinsed in DI, 1M saline and DI, and dried by exposure to an ethanol gradient (lO
min each in 25%, 50% and 96%) and subsequent air-drying.
~ ~,__~ ~
Ï" Ce(Iv) r H:zC=fH ï-fCHr-i+nfCH'-iH-}y
co - fO COOH - co COOH CONH,
I H:zC=fH I
~ (a) ~ (b) CONH, ~ (c)
Figure 8.2: Reaction scheme for the immobilization of collagen, heparin, and a combination of collagen and
heparin onto polyurethanes via acrylic acid/acrylamide grafting.
8.3.2.4 Staining Techniques
Staining techniques were employed to establish the success of each of the surface modification
steps outlined above. All samples were incubated in Toluidine Blue (TB, Saarchem, 0.02% in
O.OSMTris buffer, pH=7.9), Ponceau S (PS, 0.02% in DI water) and Coomassie Blue R2S0 (CB,
0.25% in 40%MeOH, 7% HOAc, rest DI) for Smin at room temperature. Collagen treated
samples were further stained with Azan trichrome (40°C, 2hr.), using PAac-co-PAam grafted
samples as controls. All samples were then well rinsed in DI and dried before visual
comparison.
8.3.3 Rat subcutaneous implants/explants
Six (n=6) disks prepared from each porogen-size fraction (63-75, 90-106 and 150-180 11m), as
well as those that additionally received collagen, heparin, or collagen and heparin modification,
were implanted subcutaneously in young male Wistar rats (± 200 g). Following induction of
general anaesthesia with an intramuscular injection of a ketamine/xylazine mixture, the dorsal
side of the animal was shaved. Using aseptic technique, three 1-cm longitudinal incisions were
made through the skin at either side of the dorsal midline. A subcutaneous pocket for each disk
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was prepared by gentle blunt dissection. The disks were implanted and the skin incisions were
closed with single 3/0 Prolene sutures. After 14 days of implantation, the animals were
sacrificed by inhalation of carbon dioxide. Disks were explanted with their surrounding fibrous
capsules and fixed in 10% buffered formalin.
8.3.4 Evaluation of neovascularisation and inflammation
After 24h fixation in 10% formalin, the disks were bisected perpendicular to their ingrowth
faces, paraffin embedded and 5 11m sections obtained. Sections were deparaffinised and stained
with a biotinylated Griffonia simplicifolia lectin (GSL-l) (Vector Laboratories, Burlingame, CA,
USA) that shows specificity for endothelial cells. Multinucleated foreign body giant cells
(FBGC) were identified on hematoxylin and eosin stained sections. To quantify the
inflammatory response (FBGC content) and neovascularisation (GSL-l positive cells), the
relevant stained sections were subjected to image analysis. For each section, a blinded observer
captured 18 regions (300 X 350l1m: neovascularisation; 150 X 175 11m: FBGC content) with a
Leitz DM RB microscope. The areas of positively identified elements were quantified with Qwin
image analysis software and normalised to the available ingrowth area, generating a
vascularisation index (VI) and a FBGC index (FBGCI). Indexes were defined as the percentage
area (relative to the available ingrowth area) occupied by the relevant features.
8.3.5 Statistical analysis
Data are expressed as means ± standard error of means (SEM). The comparisons of VI and
FBGCI between groups were by Student's unpaired t-tests. One-sided p-values were determined
in all cases. A significance level of 0.05 or less was accepted as being statistically significant.
8.4 Results
8.4.1 Porous scaffolds
8.4.1.1 Scaffold Structure
Figure 8.3 shows a semicircular section of a porous disk containing well-defined macropores
with a high degree of inter-pore interconnectivity. The average diameter of the disks was
5.3±0.lmm, and the thickness of the outer skin an average of 53±2I1m. The dodecahedral
structure of the macropores, the abundance of interconnecting windows, and the low degree of
microporosity are evident from the higher magnification micrograph depicted in the insert. The
micropores were all below 1OI1min size, and have limited connectivity with the macropores.
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Figure 8.3: Scanning electron micrograph of a peripheral section of a porous disk prepared from a 150-180}lm
porogen size fraction (Orig. Mag = 333x), showing the porous structure and external skin. A pentagonal
dodecahedron and a close-up view of an actual pore are shown as inserts.
8.4.2 Surface modification
None of the control samples adsorbed the Toluidine Blue (TB), Ponceau S (PS) or Coomassie
Blue (CB) stains (Figure 8.4). The uniform uptake of the cationic TB after poly(acrylic acid-co-
acrylamide) grafting (A2) shows that the grafting was successful throughout the structure. The
positive staining achieved with anionic stain PS at B3 (together with the negative TB stain at A3)
shows that the majority of the free carboxyl groups present on the hydrogel were capped by
amines after the ethylene diamine coupling step. The increased uptake of Azan stain in D5
(compared to D2: other half of the same disk) shows successful collagen coupling, while the
bathochromatic shift from A2 to A4 is indicative of successful heparin coupling.
1
Control
2 3 4 5 6
B
Aac/ Aam Aac/ Aam Aac/ Aam Aac/ Aam
+ EDA +EDA +Hep + Coli
A
Toluidine Blue
Ponceau S
C
Coomassie Blue
D
Azan
Figure 8.4: Toluidine Blue, Ponceau S, Coomassie Blue, and Azan stains of surface-modified disks
at various stages of modification
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8.4.3 Rat subcutaneous implants
8.4.3.1 HistologicalAnalysis
Representative histological sections stained with GSL-l lectin (GSL-l) and haematoxylin and
eosin (H&E) are shown in Figure 8.5. The areas occupied by the polyurethane (P), as well as the
microporosity (M) resulting from the phase-inversion process used during fabrication, are clearly
seen in the various sections. The increase in pore size with increasing size of porogen used, as
well as the presence of the collagen (C), heparin (H) and collagen/heparin (CH) surface
modification layers were visually discemable.
GSL-l stained sections show the presence of capillary vessels (V) throughout the porous
structures. Although some cross-reactivity of the GSL-l stain was evident for foreign body giant
cells, the vessels were unequivocally identified at higher magnification by the presence of
lumens. There was no visual evidence of the effect of either pore size or surface modification on
the number of vessels present in the structures.
Foreign body giant cells (FBGC), as identified on hematoxylin and eosin (H&E) stained samples
(F), are also shown in Figure 8.5. There is some indication of a decrease in FBGC formation
with an increase in pore size, and a marked decrease in foreign body giant cells (F) when the
large porosity scaffolds (Fig 8.5f) were pacified by collagen immobilization (Fig. 8.5h).
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Figure 8.5: Histological micrographs of small, medium and large porosity disks, as well as large
porosity disks after collagen, heparin and collagen plus heparin immobilization.
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8.4.3.2 Quantification of indexes
Figure 8.6 summarizes the effects of pore size and surface modification on the Vascular Index
(VI) and foreign body giant cell index (FBGCI), respectively. The VI was not significantly
influenced by either the pore size or any of the surface modification treatments. After l4d of
implantation, the FBGCI showed no significant change when the pore size was increased from
63 to 9Ojlm, whereas a decrease from 5.43±1.06 to 3.l4±0.95% was observed when the pore size
was increased from 90 to l50jlm (p=O.069). A further decrease in foreign body giant cell
content to 1.55±O.45% was observed when the large porosity disks were pacified by collagen
immobilization. In total, an 80% decrease was achieved by the combined increase in pore size
(90 to l50jlm) and the covalent immobilization of collagen.
Heparin immobilization on the large porosity scaffolds had no significant effect on FBGCI, and
although the foreign body giant cell content of the collagen/heparin group (2.00± 1.11%) was not
statistically lower than that of the unmodified group (3.l4±0.95%), it was also not significantly
higher than that of the group that received collagen alone.
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Figure 8.6: Vascularization and foreign body giant cell indexes of explanted polyurethane disks showing the
influence of pore size and surface modification on the healing response.
8.5 Discussion
Porosity and surface chemistry have been shown to be important parameters that determine the
healing response toward porous devices intended for tissue engineering applications. Not only is
porosity per se essential for the successful incorporation of a device into living tissue, the nature
of the porosity is also of great importance. The present study (together with previous findings)
shows that large (±l50jlm), interconnecting pores of well-defined shape are conducive to the
ingrowth of capillary vessels that are in tum essential to the viability of other ingrowing tissue
types. Although the decrease in FBGCI with increased pore size (90-106 to l50-l80jlm) was not
significant at the 95% confidence level, a previous study has shown this decrease to be
statistically significant after longer implantation periods (28d). (See Chapter 6)
In addition to angio-permissive porosity, the long-term integration of devices requires the
minimization of acute and chronic inflammatory responses toward the implanted device. If this
reaction is not controlled, implanted devices elicit the formation of granulation tissue that in tum
leads to a fibrotic response that may impede the performance of the device. As the relative area
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of the implant exposed to surrounding tissue is orders of magnitude larger in porous scaffolds
than would be the case with solid implants, the need for surface pacification is proportionally
increased.
Apart from the stated requirements, porous structures used as tissue engineering scaffolds are
required to fulfil their primary objective that may depend on other parameters. The development
of a tissue engineered vascular prosthesis, which constitutes the overall project of which the
current study forms a part, is a case in point. In order for them (vascular prostheses) to perform
their primary function of re-establishing blood flow to the distant vasculature, a number of other
requirements (mechanical strength, compliance, chemical stability) need to be met. Material
choice is often influenced by these requirements. Hence, a method that allows for the alteration
of the polymer/tissue interaction without undue influence on the parameters influencing the
primary function of the device is invaluable. Surface modification provides such a tool.
Thus surface modification provides a means of "hiding" the inflammatory material without
unduly changing its bulk properties. Depending on the choice of modifying material, the action
of the modified surface may be passive or active. Grafted hydrogels have been shown to
favourably influence polymer/tissue interaction by providing a passive hydrophilic surface layer.
In order to provide active interactions, biologically derived substances such as proteins and
glycosaminoglycans (or surface active drugs) are required.
Collagen is a biologically derived protein that was chosen as a surface modifying agent in order
to mimic the native environment in which cells live, i.e. the extracellular matrix (of which it is a
component). The large decrease in FBGC formation with the immobilization of collagen (via a
hydrogel layer) shows the potential of this biomolecule to decrease foreign body reactions and
thus improve the healing response towards implanted devices. It is notable that this could be
achieved without adversely affecting the neo-vascularization in the scaffolds.
Although heparin is generally used as an anti-thrombotic agent, the use of this polysaccharide in
the current study was to determine its effect on vascularization and inflammatory response for
possible later use as a means of immobilizing and stabilizing heparin-binding growth factors that
have the potential of upregulating the neo-vascularization. The finding that the immobilization
of heparin did not increase the FBGC formation, and more importantly that the combination of
collagen and heparin did not elicit significantly higher FBGCI than the best group (collagen
alone), is significant.
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CHAPTER9
Establishment of an animal model for the differentiation between
trans anastomotic and transmural healing
9.1 Abstract
Historically, animal models used in the evaluation of synthetic vascular grafts did not
sufficiently mimic the healing responses encountered in humans. Their use further often
precluded accurate assessment of and differentiation between trans anastomotic and transmural
healing. An isolated chacma-baboon femoral model that would allow for the differentiation
between these two healing modes is proposed.
Thus, 2cm test segments of the graft material under investigation was interposed between two
3cm segments of low porosity (30flm internodal distance) expanded polytetrafluoroethylene
(ePTFE). The resulting 8cm composite grafts were implanted in the femoral artery of adult
chacma baboons (>20kg) after standard access, excision and end-to-end interposition. The
baboon femoral artery promised limited disruption of blood flow patterns due to good size
matching. The isolating segments allowed no transmural ingrowth and further limited
transanastomotic pannus outgrowth to levels similar to those observed in humans. A full
regimen for the qualitative and quantitative evaluation (involving scanning electron micrography
and specific histological staining techniques) of surface and transmural healing is proposed.
9.2 Introduction
Problems pertaining to the use of dog and other animal models, such as the yellow baboon, used
to evaluate vascular grafts intended for human use have been elucidated in Chapter 3. Briefly,
the use of some models led, particularly in dogs, to the full transanastomotic healing of grafts,
whereas similar grafts showed little or no midgraft healing in humans. Another model, the
yellow baboon, allowed for complete transmural healing of large porosity grafts; a phenomenon
that is also not mirrored in clinical applications. In other cases, it was not possible to distinguish
between the two modes of healing. These discrepancies between commonly used animal
experimental models and the human response have prompted this investigation into an
alternative vascular graft evaluation model. Itwas primarily designed to evaluate the extent and
nature of transmural ingrowth, a mode of healing thought to be critical in the development of the
next generation of vascular grafts, while simultaneously eliminating the obfuscating effects of
trans anastomotic outgrowth.
Features of the proposed model include:
• The use of the chacma baboon, a senescent animal model that has been shown to most
closely resemble the healing responses of humans
• The use of the femoral position. This position provides a close match to the size of the grafts
under investigation (4mm ID), ease of access and minimum risk of complications.
• A composite graft consisting of (See Fig. 9.1):
• Proximal and distal isolation segments of 30flm ePTFE. This material has been shown to
be not only resistant to transmural ingrowth in all animals, but also to transanastomotic
endothelialization in the chacma baboon
• A central section (2cm) consisting of the graft material under investigation. The central
section is attached to the isolating sections by application of an adhesive that
simultaneously seals the anastomoses and thus prevents ingrowth into the anastomotic
juncture.
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Figure 9.1: Schematic representation of the isolated graft model used to evaluate the efficacy of graft sections
toward transmural healing
This chapter gives a full account of materials and methods used in graft production,
implantation, explantation, and post-explant evaluation. The results will, however, be limited to
the testing of the model, and selected results only will be used to illustrate the method and its
effectiveness in preventing excessive transanastomotic outgrowth. Specific results on the
transmural healing patterns achieved with ePTFE and PU test segments will be described in
Chapters 10 and 11, respectively.
9.3 Materials and Methods
9.3.1 Graft Production
Test sections of ePTFE (from the indicated source) or polyurethane vascular grafts (as described
in Chapter 5), nominal size: 4mmID, 2cm length, were interposed between two sections of 30]lm
ePTFE grafts (Atrium, 4mm, 30]lmIND, 3cm length) in order to isolate the test section from the
native artery. The anastomoses between the two synthetic materials were affected by repeated
application of a polyurethane solution (5% M48 in CHCI3) to the anastomotic area after
immobilization of the three sections on a stainless steel mandrel. All grafts were sterilized by
standard ethylene oxide exposure (Groote Schuur Hospital).
9.3.2 Implantation
9.3.2.1 Assignment
Isolated test grafts were implanted in chacma baboons (>20kg, male/female) by the method
described below. Assignment of grafts to recipients and implant positions was done according to
a rotational scheme. The group sizes were deemed to be too small for random assignment, and
logical combinations of treatments were assigned on the basis that no animal received two grafts
from the same group.
9.3.2.2 Pre-Implant/Explant Procedure
Animals were starved for 24h prior to the implant/explant date and subsequently injected with
Temgesic prior to transport to the operating theatre. An i.v line was installed, an ECG transducer
attached, Ketamine was administered and the animals were incubated (3-41/min, 15mbar, 1-
2%Ethrane, O2 flow 4-511min). Following the injection of heparin, access was gained to the
superficial femoral arteries via standard access.
9.3.2.3 Implant Procedure
Two vascular-clamps (proximal: l cm after femoral bifurcation and distal 9cm from proximal)
were placed on the superficial femoral artery, a 7cm section of the artery was excised, and the
graft interposed end-to-end with one 7/0 Prolene running suture (proximal end first) after
rehydrating (PBS) and trimming to correspond to the length of the excised vessel. After de-
aeration by removal of the distal clamp, the blood was allowed to clot in the graft wall.
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Subsequent removal of the proximal clamp restored the blood flow to the distal vasculature.
Following the enclosure of the graft in the quadriceps, the skin was closed (in layers) with a 3/0
Maxon running suture. Early occlusion was prevented by administration of ASA (300 mg) orally
through an NG tube at the time of completion of operation. The animals were weaned off the
ventilator as soon as their own respiration was sufficient. Daily oral administration of ASA was
continued for the duration of the implant. Regular visual monitoring of the animals' well-being
and dietary habits was performed.
9.3.2.4 Explant Procedure
After the desired implantation time, the animals were again anaesthetised and access was gained
to the implant sites. The femoral arteries were cannulated proximal and distal to the implant
position, and the veins ligated to prevent back-flow during subsequent rinsing and fixation steps.
After sacrificing the animal by injection of potassium chloride, and confirmation of death by
ECG, the grafts were rinsed with lOOml PBS to remove excess blood, and subsequently flushed
with lOOmlof a 10% formalin solution to effect the in situ fixation of cellular and extracellular
materials present on the lumenal surface. The grafts were then excised with the surrounding
tissue and with 3cm of natural vessel on each end. Grafts were assessed for patency by ligation
of side branches and injection of PBS from the proximal end. The explanted grafts were marked
with a Liga-clip to identify the proximal end and placed in 10% formalin for 24h fixation.
Following fixation and removal of excess surrounding tissue, a macrophotograph of the intact
graft was captured (Fig 9.2A). A 3-5mm longitudinal strip was dissected from the graft to
determine the exact position of the test section and patency assessment. A second
macrophotograph was taken at this point (B). After removal of a 3-5mm transverse section from
the test section (L3), the rest of the graft was dissected into the sections shown in Figure 9.2D.
Sections destined for light microscopy (Ll...L5) were transferred to separate vials containing
10% formalin for further preparation. Samples for scanning electron microscopy (SEM) and
transmission electron microscopy (TEM) were further fixed in a 2.5% solution of glutaraldehyde
(GA).
A
B
c
D
Figure 9.2: Schematic representation of the preparation of samples from explanted grafts for light
microscopy (L), scanning electron microscopy (S), transmission electron microscopy (TEM), and storage.
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9.3.2.5 Evaluation of Neovascularisation and Inflammatory Response
(A) Surface Healing
Sections denoted S in Figure 9.2 (SI, Sla ... S5, S5a ... ) were prepared for SEM analysis by
critical-point drying Balzars Union CPD020) and sputter coating with gold (Polaron SC500).
Their surfaces were evaluated using a Jeol scanning electron microscope coupled to an Orion
image capturing system and NIH image analysis software. The percentage of the sample
covered by endothelium and thrombus were noted and quantified (were applicable).
(B) Transmural Healing
The sections denoted L were prepared for light microscopy by conventional imbedding and
staining methods. The orientations of sections prepared from the samples are shown in Fig 9.3.
LI
L2
Figure 9.3: Schematic representation of the mounting orientations of explanted graft sections and areas used for
image analysis.
The range of staining techniques employed throughout the study, the cellular and extracellular
material targeted by these stains, are listed together with the quantification parameter in Table
9.1.
Table 9.1: Listing of stains and antibodies used in detecting distinguishing features during histological
processing mul image analysis.
Stain! Antibody Target features Cross-reactivity Quantification
cC
Fibronectin Fibrin - -
CD-31 EC - VI
Actin SMC - AI
H&E general Various FBGCI
HAM-56 FBGC/Mac - FBGCI
Factor VIII Fibrin/EC - -
Azan trichrome Collagen (Blue) Nuclei/RBC' s/Fi brin (Red) -
SMC (Orange/Red)
GSL-I: Griffonia simplicifalia lectin (Vector Laboratories, CA, US) EC: Endothelial cells
CD-31: Peeam-I (Platelet endthelialo cell adhesion molecule) SMC: Smooth muscle cells
Actin: Smooth muscle cell actin (a-SMCA) (Research Diagnostics, Nl, USA) FBGC: Foreign body giant cells
H&E Hematoxylin and Eosin VI: Vascularization Index
Azan.c Trichrome Masson: Azocarmine / Orange-G / Aniline Blue (Sigma, USA) Al: Arteriolariuuion Index
FBGCI: FBGCIndex
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For each section, a blinded observer captured the depicted regions (Fig. 9.3) (300 X 3SOpm:
neovascularization, arteriolarization; ISO X 175 uuv: inflammatory response, FBGC content)
with a Leitz DM RB microscope. The areas of positively identified elements were quantified
with Qwin image analysis software and normalised to the available ingrowth area, generating a
vascularization index (VI) and a FBGC index (FBGCI). Indexes were defined as the percentage
area (relative to the available ingrowth area) occupied by the relevant features.
9.3.6 Statistical Analysis
Data are expressed as means ± standard error of means (SEM). The comparisons of VI, AI and
FBGCI between groups were by Student's unpaired t-tests. One-sided p-values were determined
in all cases. A significance level of 0.05 or less was accepted as being statistically significant.
9.4 Results
9.4.1 Composite graft production
Figure 9.4 shows composite grafts prepared by the interposition of test segments between
isolating low-porosity ePfFE segments. The polyurethane sealant provided for both a
structurally sound connection and an impenetrable layer. The high porosities of the test
segments (as opposed to the flanking segments), and the extent of the applied sealant, are clearly
visible in the high magnification macrographs.
(c) original mag = 16x (f) original mag = 16x
Figure 9.4: Macrophotographs of composite grafts with (a-c) high porosity ePTFE and (d-f) PU test
segments interposed between low porosity ePTFE segments
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9.4.2 Baboon femoral implants
Although the size of the exposed implant site, and the length of the femoral artery that was
excised prior to implantation, did not always accommodate the full length (8cm) of the
composite synthetic graft, slight trimming of the graft ends was sufficient to establish a good fit
(Fig 9.5) Even though the high porosity and permeability of the test segments resulted in the
initial free-flow of blood through the central section after removal of the distal clamp,
haemostasis in the wall was generally achieved within 5-10 minutes. The subsequent removal of
the proximal clamp occasionally resulted in some further bleeding due to the increased pressure.
Bleeding at the anastomoses was stopped by the application of additional sutures, while renewed
loss of blood through the mid-section of the graft wall was stopped by the topical application of
aprotinin-impregnated pledges. Blood was not immediately able to penetrate the isolating, low-
porosity ePTFE, as was evident from the continued white colour of these sections in Fig 9.5.
The good size-matching between the grafts and femoral artery can be seen in Fig 9.5 band c.
(a) (b) (c)
Figure 9.5: Macrophotographs of isomted grafts implanted in the bilateralfemoral position in the
chacma baboon.
9.4.3 Surface analysis
An explanted graft containing an adherent outer capsule is shown in Figure 9.6. Careful
longitudinal dissection allowed for the visual evaluation of the lumenal surface and for the
assessment of graft patency. The graft shown below contained no thrombotic deposits apart
from a thin white layer directly on the surface, and was patent throughout.
(a) (b) (c)
Figure 9.6: Macrophotographs of an explanted composite graft containing a high-porosity ePTFE
test section.
Further detailed analysis of the graft surface was possible by scanning electron microscopy.
Although the nature of the surfaces depicted in the micrographs (Figure 9.7) is not visible at the
low magnification shown, it was possible to distinguish between different surface features (e.g.
endothelial cells, exposed graft, and fibrin deposits) at higher magnification.
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Section S4 Section S5a Section S5
Figure 9.7: Scanning electron micrographs of the fuli length of a composite graft
The efficacy of the low-porosity flanking sections in preventing excessive transanastomotic
endothelialization is shown in Figure 9.8. After 14 days of implantation, both the proximal and
distal endothelialization was limited to below Smm. Extension of the implant duration to 21
days resulted in an increase in the proximal transanastomotic endothelialization to approximately
lOmm. This distance is, however, much lower than the length of the isolating segments. The
insert depicts a micrograph of pannus tissue growing across the anastomosis between the natural
artery and the graft.
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Figure 9.8: Extent of transanastomotic endothelialiuuion on low-porosity (30pm) isolating ePTFE sections of a
composite vascular graft.
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CHAPTER10
High porosity ePTFE
Are increased ingrowth-spaces alone sufficient for transmural healing?
10.1 Introduction
The lack of transmural healing in standard ePfFE grafts has been shown to result from the
restricted ingrowth spaces available for tissue ingrowth (see Chapters 2 and 3). Although higher
porosities (60Jlm) allow full transmural capillary ingrowth in the yellow baboon, the ingrowth is
restricted to the outer two-thirds of the wall in the chacma baboon. Davids et al. explained these
phenomena after a detailed analysis of the available ingrowth dimensions in low (30Jlm) and
high (60pm) ePfFE prostheses [1]. In Figure 10.1 (a), the dimensions of the minimum continual
ingrowth channels in 30pm ePfFE are close to the mean diameter of capillary vessels, and far
below the spaces needed for arteriolar ingrowth. Large porosity ePfFE, on the other hand, were
shown to contain spaces large enough for the ingrowth of both capillaries and arterioles (Gigure
10.1 b).
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Figure 10.1: Ingrowth dimensions of (a) standard and (b) large porosity ePTFE [1]
The current study was designed to reinvestigate the transmural healing response in the isolated
chacma baboon model (see Chapter 9), and to determine whether an increase in pore size alone
would lead to improved healing. The hypothesis that the lumenal sealing of the graft surface (in
order to prevent the build-up of impenetrable fibrin deposits) would further improve full
transmural ingrowth was also to be tested.
10.2 Materials and methods
The methods used in graft production, implantation and analysis have been described in detail in
Chapter 9. Thus only the specific parameters pertaining to this study, and additional procedures
not described earlier, will be given.
Both standard (30Jlm nominal IND) and a new, very large porosity (nominal IND=l50Jlm),
ePfFE grafts were obtained by special request from a leading ePfFE graft manufacturer. The
large porosity grafts were interposed between two segments of low porosity material by methods
described in Chapter 9. Five grafts of this type were implanted in the femoral baboon model for
durations for 4h, 7days, 14 days, 21 days and 28 days, respectively. In addition, the central
section of another graft was sealed with a thin layer of polyurethane and implanted for 14 days.
Although the implants were limited to one graft per time period, these pilot implants allowed for
the determination of basic trends while limiting the number of primate experiments. Skinning of
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the 150J.lm grafts was achieved by the repeated application of a 5% solution of polyurethane
(M48) to the lumenal surface and drying at elevated temperatures between application steps.
Analysis of graft porosities (internodal distances) was achieved by standard image analysis
techniques of scanning electron micrographs. Internodal distances are expressed as
means±standard error of the means.
The average internodal distances (IND) of the 30J.lm nominal IND grafts were 22.3J.lm±0.9J.lm
and 25.1 ± 1.1urn, while those of the 150J.lm grafts were very close to the claimed IND (l48±3. 9
and 146±3.1 on the lumenal and ablumenal surfaces respectively) (See Figure 10.2 a,b,e,f). Thus
the large-porosity grafts contained ingrowth spaces that were more that 6 times that of the low
porosity material (as defined by the IND). Apart from this difference in dimensions, there was
also a distinct difference in the transmural structure of the grafts. While the low-porosity
material contained nodes that were fairly randomly distributed through the graft wall, the nodes
in the high-porosity grafts were more parallel to one another, and if one disregards the
impediment created by the fibrils, they defined distinct channels that connected the lumenal
surface to the ablumenal surface (Fig 10.2 c and f).
150}lm Lumen (e)150}lm Ab/urnen
IND=148±3.9}lm IND=146±3.1}lm
Figure 10.2: Scanning electron micrographs of 30pm and 150pm nominal1ND ePTFE vascular grafts
(c) 30}lm Cross-section
10.3 Results and discussion
The healing patterns of the three graft types, namely 30J.lm, 150J.lm, and 150J.lm porosity ePTFE
with a lumenal sealant, are described with reference to the respective figures below (Figures
10.3, 10.5 and 10.7). The responses are further summarized in the attached schematics (Figures
10.4, 10.6 and 10.8) and text that follows each of these figures.
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10.3.1 Low porosity JOpmePTFE
(e) 30 14m ePfFE graft after 3 weeks of implantation (Actin
stain). Beautifully developed, densely-packed, small arteries
(A) on the outside of the graft which cannot penetrate into the
graft wall because of the narrowness of the spaces.
ePTFE Porosity
_'_."*<O-'" ,."...<_~",.....n·
:..r...::-.._-__" _ ,.
- • j ",_r ~__ ~ ~.
(b) 30 14m ePfFE graft after 7 days of implantation.
Immuno-histochemical staining for macrophages (M) shows
that the spaces are even too narrow to allow the penetration
of white blood cells. Only a few erythrocytes and
lymphocytes can be seen in the depth.
implant (30 14m; Actin stain). Well developed
small arteries (A) are positioned parallel to the outside of the
graft. Artery penetration into the graft wall is restricted by
limited ingrowth spaces.
Figure 10.3: Histological analysis of 30}lm porosity ePTFE vascular grafts
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VERY DENSE 1OI'm FN +++ LAYER PLATELETS CD 31++ DENSE FIBRIN
FN ++ FVIII+++
NO VESSELS ENTER
WALL
Figure 10.4: Schematic representation of lack of healing events in 30pm porosity ePTFE grafts.
There are fibrin depositions on both surfaces particularly on the blood surface. This thin thrombus layer
consists primarily offibrin and red blood cells with a few areas of platelets. No blood vessels enter the graft woO
further than a few micrometers. The spaces between the ePTFE nodes and fibres are not only too narrow for
arterioles and capillaries, but also for single white blood cells such as macrophages.
In our non-human primate model it became very obvious that the low porosity 30 ]lm ePTFE
grafts feature all the negative aspects of graft healing without allowing the healing process itself
to occur even at the lowest of all levels.
• Fibrin deposition: The infiltration of fibrin from the blood into the graft wall occurs to
the same degree as in high-porosity grafts. Given the inhibitory effect of compacted
fibrin on tissue ingrowth, it is obvious that the low porosity and the hydrophobicity of the
ePTFE material were not capable of counteracting this detrimental aspect of graft
healing.
Ingrowth spaces: The well healed surrounding tissue with an abundance of capillaries
and arterioles clearly demonstrates that a healing process is well underway. Since not
only capillaries were incapable of growing into the interstitial spaces of the graft but also,
to a large extent, inflammatory cells, low-porosity 30 ]lm ePTFE grafts can be described
as non-healing conduits.
Compliance: The negative influence of the complete lack of compliance of expanded
polytetrafluoroethylene grafts did not have to any visible influence on the healing
because porosity already completely inhibited any cellular ingrowth.
•
•
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10.3.2 High-porosity lS0]lm ePTFE: unsealed blood surface
1~
;6 ~
~:~ iJ
(a) 150 firn ePTFE graft after 4 hours of implantation. The Azan stain
marks primarily fibrin (F). In spite of the huge interstitial spaces in the
graft wall, the fibrin accumulation is primarily at the blood surface.
F
(b) ePTFE (150 firn) implanted for 7 days. A dense surface layer
of fibrin (F) seals the graft off towards the blood side. The interstitial
spaces of the graft wall are only filled by a very loose material.
(d) High porosity PTFE : staining of macrophages (M). Dense
infiltration of macrophages from the outside surface of the graft,
indicating that the lack of an inflammatory reaction in 30 firn ePTFE
was not due to the ePTFE material but to the narrow spaces.
Figure 10.5: Histological analysis of lSOJlm porosity ePTFE vascular grafts
Figure 10.6: Schematic representation of healing events in 150 JImporosity ePTFE.
The wide ingrowth spaces of the interstices of the graft waU allow the penetration by capillaries. The blood
surface is nevertheless equaUy sealed with a dense layer of fibrin, something already seen in 30 micrometer
ePTFE. In spite of a moderate density of penetrating capillaries, hardly any arterioles are seen growing into the
graft wall;
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The porosity of the 150Jtm ePfFE grafts created ingrowth spaces almost 3 times larger than
those in any previously-used, so-called high porosity ePfFE grafts (60Jtm). Our implantation
results clearly confirmed that the spaces available are sufficient for the penetration with micro-
capillaries and arterioles. Overall, the healing was only modestly occurring, with a massive
build-up of compacted fibrin at the blood surface.
10.3.3
Fibrin deposition: Similar to all other high-porosity grafts, an almost acellular, highly
compacted fibrin layer was building up in the inner third of the graft wall, completely
preventing cellular ingrowth in this area.
Ingrowth spaces: Both arterioles and capillaries were occasionally seen throughout the
graft wall except in the area of the compacted fibrin. This indicates that the spaces are
theoretically available for ingrowth. Nevertheless, no circularly aligned parcels of
smooth muscle cells as seen in the polyurethane grafts could be detected. The reason for
this lack of muscularisation of the graft wall may - apart from the lack of compliance -
lie in the combined physical obstruction of circular ingrowth paths by solid transmural
nodes and by a still relatively dense fibrillar meshwork.
Compliance: The modestly developed ingrowth of blood vessels in spite of ingrowth
permissive interstitial spaces stands in stark contrast to the ingrowth events observed in
the compliant polyurethane grafts. In view of the proven stimulatory effect of pulsatile
stress and strain on the proliferation of vascular wall cells, this retarded development of
the new artery wall is most likely the result of the complete lack of compliance in ePfFE
grafts.
•
•
•
High-porosity150pm ePTFE: sealed blood surface,
\
\
\
Sunace skinned 150 pm ePfFE grafts. One can see the thin layer of heparin grafted to the blood surface,
Underneath the protecting sunace sealant capillaries have infiltrated the graft wall all the way to the blood sunace
Figure 10.7: Histological analysis of 150pm porosity ePTFE vascular grafts containing a lumenal skin
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++
Figure 10.8: Schematic representation of healing events in skinned, high-porosity PTFE grafts.
The surface sealing which prevents the build-up of hostile fibrin results in a much better capillary penetration of
the entire graft wall. However, vessel density is stili very modest and smooth muscle cells are very scarce.
In contrast to the unsealed grafts, the inner third of the graft wall is not blocked by compacted
fibrin. Cellular ingrowth goes all the way from the outside adventitial area to the sealant layer at
the blood surface. Overall, the healing of the graft wall is still only moderately expressed and
most importantly, no smooth muscle cell proliferation or orientation characterises this healing.
Therefore, in spite of surface protection and availability of ingrowth permissive interstitial
spaces, no new artery wall is being formed.
• Fibrin deposition: Through surface sealing the infiltration of compacted fibrin matrices
is completely inhibited. As a result, the overall healing of the graft wall is clearly
superior to that of the non-sealed control grafts.
Ingrowth spaces: similar to the unsealed, high-porosity ePTFE grafts interstitial spaces
clearly allow the penetration of both capillaries and arterioles throughout the graft wall.
It must ge considered as a possibility that the complete lack of arteriolarization by the
infiltration of the spaces with the smooth muscle cells is partly caused by the
impenetrable transmural nodular barriers and the dense fibrils that are only maximally
stretchable in the middle ground between two nodes.
Compliance: In spite of the facilitating effect of the surface shield with regards to the
prevention of fibrin insudation, graft healing is disappointing in view of the fact that
spaces are at least theoretically ingrowth-permissive and of the strong biological response
of vascular wall cells to pulsatile stretching. It must be assumed that the lack of
arteriolarization of the graft wall is primarily due to the non-compliant nature of ePTFE
grafts.
•
•
10.4 Reference
1. Davids, L., Dower, T., and Zilla, P., The lack of healing ill conventional vascular grafts, in Tissue
engineering of vascular grafts, P. Zilla and Greisler, H., Editors. 1999, RG Landes: Austin. p. 3-44.
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CHAPTER II
High-porosity PU grafts
Combination of increased spaces, dodecahedral structure and compliance.
11.1 Introduction
Porous polyurethane grafts have been used for the past 30 years as experimental substitutes for
commercially available Dacron and ePTFE prostheses (See Chapter 5). The in vivo evaluation
of these grafts was predominantly performed in the canine model (carotid, aortic, femoralliliac
and vena cava positions), although the rat aortic, ovine carotid and porcine aortic models have
also been employed.
The most commonly reported healing response involved the formation of what is described as a
glistening neo-intima (or pseudo intima) on the lumenal surface of grafts implanted in animal
models [1-12]. The full endothelialization of the grafts were either obtained in many cases [2,
13-16], or assumed without further confirmation [17]. Although the origin of these surface-
healing layers was not identified, the lack of sufficient interconnected porosity, combined with
the use of animals models that allow extensive transanastomotic outgrowth, indicate that the
surface tissue originated from the native artery rather than from the perigraft tissue.
The high patency rates achieved with various PU graft types may also be attributed to the
successful trans anastomotic surface healing in these models. One hundred percent (100%)
patency was achieved in short (x l Zrnonths) [2, 15, 18-20], medium (12 months) [4, 21], and
long-term (lOyears) [14] implants in various animal models. A number of the reviewed grafts
did, however, exhibit much lower patency rates. Apart from one study in which all (of 4) grafts
were occluded [22], the patency rates were, however, generally close to or above 50% [1, 3, 23-
25].
In order to decrease thrombogenicity, a number of workers have pre-seeded PU grafts with
endothelial cells. Hess et al. [26] and Stansby et al. [27] successfully seeded Vascugraft and
Pulse- Tee grafts with ECs, but did not perform in vivo studies. When in vivo studies were
performed on EC seeded PU grafts, the results were encouraging but not striking. While one
study showed the absence of thrombus formation in a 24hr canine AV shunt model [28], and
another could slightly improve patencies (non-seeded controls) [29], the seeded, multicellular
lining on the lumen became detached after 5 weeks in the canine carotid artery model used by
Williams et al. [10].
The current study was designed to evaluate a novel polyurethane vascular prosthesis in the
isolated chacma baboon model. The model was designed to more accurately mimic the healing
responses observed in humans by eliminating the effect of trans anastomotic outgrowth (See
Chapter 9). The main aim of the study was to determine whether full transmural healing
(ingrowth of capillaries, arterioles and smooth muscle cells) could be achieved (as opposed to
trans anastomotic outgrowth) by providing large, well-defined, interconnected pores in the graft
wall. Secondary objectives were to determine (i) the effect of a lumenal sealant, (ii) whether the
three-dimensional porous structure, that provides equal opportunity for growth in all directions,
would allow for the spontaneous helical orientation of smooth muscle cells in the graft wall, and
(iii) whether the pulsatile stress/strain resulting from compliance achieves the biological effects
promised by in vitro experiments [30].
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11.2 Materials and methods
Polyurethane vascular grafts (M48, 150~m pores, 4mm ID, 2cm length) were produced by the
method described in section 5.4.4.3 B(ii) and reinforced by the helical winding of a polyurethane
fibre (200~, 2.5mm pitch) (See 5.4.4.6). The lumenal surfaces of four of the grafts were sealed
by the repeated application of a polyurethane solution (5% M48 in CRCI3) (Fig 11.1), and
heparin was immobilized on the inner surfaces of the sealant layer as described previously (See
8.3.2.1 and 8.3.2.4), with the exception that the grafting was performed for 60min, and that
grafting and heparinization occurred in a flow reactor that limited the modification to the inner
surface.
PU Graft Implants
All grafts were subsequently interposed between 3cm sections of low porosity ePTFE, sterilized
by standard ETO exposure, degassed and implanted into the femoral position of adult chacma
baboons (>20kg) by end-to-end anastomoses (See Chapter 9). The unskinned grafts were
implanted for a duration of 4 hours (n=l ), 7 days (n= l ), 14 days (n=2), 21 days (n=l) and 28
days (n=2) while grafts containing a heparinized lumenal sealants were implanted for 4 hours
(n= l ), 7 days (n= l ), 21 days (n=l) and 28 days (n= l ) respectively. Graft explant and evaluation
was performed as described in Chapter 9.
Figure 11.1: Scanning electron micrographs of a PU graft containing a PU surface sealant.
11.3 Results and discussion
The healing patterns of the two graft types, namely 150~m PU and 150~m porosity PU with a
lumenal sealant, are described with reference to the respective figures below (Figures 11.2 and
11.4). The responses are further summarized in the attached schematics (Figures 11.3 and 11.5)
and text that follows each of these figures.
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11.3.1 150pm Polyurethane: unsealed blood surface
PU Graft Implants
(a) Scanning electron micrograph of a longitudinal cross section
through the anastomosis between the lSOflm PU and the 30flm ePTFB
isolating segment. The healing throughout the graft wall is evident.
(b) 1SOflm PU graft after 4 hours of implantation (Man stain). Build-
up of a moderate surface layer of fibrin and red blood cells (REC)
whereby blood platelets and erythrocytes are contained in parcels
(d) PU graft after 1 week of implantation (Actin stain). Mature
arterioles (A) have already penetrated the outer 30-40% of the graft
wall.
(c) 150fl m PU graft after 4 hours of implantation (Fibrin
Typical appearance of the inside of the graft wall. Most of the spaces
are empty with thin membranes of fibrin (F) surrounding RBes.
(e) 3-week
stain). The immunohistochemical stain strongly marks the dense
surface layer consisting of compacted fibrin (F). Underneath a dense
convolute of blood vessels (V) can be seen reaching all the way
through the wall to the compacted surface fibrin.
Figure 11.2: Histological analysis of 150pm polyurethane grafts
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THIN SURFACE
COVERAGE
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MPLATELET PARCELS"
CD31+
DENSE LAYER
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Figure 11.3: Schematic representation of the healing events ill 150pm PU grafts.
A distinct number of capillaries pelletrate the entire graft waU,but only a minority of them represent arterioles
with smooth muscle cells. An impenetrable layer is built up on the blood surface, preventing any further
ingrowth and influencing the healing pattern of the graft. Only few SMCs align along the compacted fibrin
layer.
In contrast to ePTFE grafts where the fibrils are only maximally stretchable in the middle ground
between 2 nodes but converge towards their anchorage points at both nodes, ingrowth spaces in
the polyurethane grafts evenly provide widely open interstitial spaces. The distinctly higher
density of blood vessels in the interstices of the grafts is most likely the result of the combined
freely communicating ingrowth spaces and the biological effect of stretching in a compliant
graft.
• Fibrin deposition: As in all other high-porosity, non-sealed grafts, high-density compacted
fibrin matrices build up in the inner third of the graft wall. These mostly acellular matrices
appear to be completely impenetrable for cells.
Ingrowth spaces: In contrast to ePTFE grafts, convolutes of capillaries and arterioles are
criss-crossing the graft wall in all directions and up to much larger diameters. Furthermore,
small bundles of smooth muscle cells are already visible in these non-sealed grafts in the
inner third of the prosthesis. The orientation of those smooth muscle cells seems to be
circular rather than longitudinal.
Compliance: It is quite obvious that the few bundles of freely aligned, smooth-muscle cells
are aligning themselves along the vectors of stress and strain. This indicates that compliance
exerts a distinct biological effect on the graft wall. Moreover, vessel density is distinctly
higher than in ePTFE grafts, even in those areas where ingrowth dimensions would be
comparable. This again points towards the important role compliance plays with regards to
the arteriolarization of a prosthetic graft wall.
•
•
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11.3.2 150pm Polyurethane: sealed blood surface
(a) PU graft: 7 days of implantation (CD 31 stain of blood vessels).
This picture is a typical representative of the skinned PU implants
showing that blood vessels rapidly penetrate through the entire graft
wall to reach the outer surface of the skin.
(b) Skinned 150J-lm graft: Blood vessel staining (21 days, Factor
VIII). The entire graft wall is packed with blood vessels (V) which
reach evenly from outside to inside. Furthermore one can already
recognize the tissue bands underneath the lumenal skin (S).
(e) 4 weeks of implantation the muscle layer has grown
to a significant proportion of the inner graft wall. In contrast to intimal
hyperplasia, the SMCs are already densely packed as they are in a
nati ve artery
(d) Skinned 150J-lm PU graft after 14 days of implantation
stain). The surface protection by the skin facilitates the rapid
development of a circumferentially aligned, densely packed layer of
SMCs close to the blood surface.
inside the wall (Actin
stain; 4 weeks). This typical cross-sectional appearance of a
longitudinally cut graft underlines once more that the SMC bundles are
circumferentiallyaligned.
Figure 11.4: Histological analysis oflumenaUy skinned lS0pm PU grafts
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Sealant
Figure 11.5: Schematic representation of healing events in 150 JIm polyurethane grafts.
The surfaces were sealed and thus protected against fibrin insudation. Capillaries penetrate through the entire
graft wall from outside to the surface sealant within less than 2 weeks. The density of blood vessels is distinctly
higher than in the non-sealed controls. Smooth muscle cells are present at a much higher number both as
accompanying layer arterioles and as free cells in the interstices of the graft. Most strikingly, a densely packed
layer of smooth muscle cells starts building up at the illterface with the blood surface sealant as early as after 2
weeks of implantation. At 4 weeks these dense muscle bundles are occupying approximately one third of the
graft wall and are circularly aligned. Their position coincides with the site of highest stress and strain.
Overall, surface protected polyurethane grafts with interconnected dodecahedral structures
resulted in a partial transformation of the scaffold into a new artery within a very short period of
4 weeks. Since these results were obtained in the non-human primate, their relevance for human
implants is obvious. In view of the fact that human graft implants are supposed to replace or
bypass an artery for up to decades, such a rapid healing event promises to turn such a
polyurethane scaffold into a hybrid artery during the very early phase of implantation. Two
main aspects of our concept have been proven in these non-human primate implants, namely the
importance of multi-directional ingrowth spaces and of compliance.
• Fibrin deposition: The surface sealant completely prevented the build-up of compacted
fibrin, which was non-permissive for tissue ingrowth in the non-sealed grafts. As a
consequence, those areas that show the highest stress and strain and are therefore the site of
origin for the development of a muscular wall were not obstructed by the hostile fibrin
matrix.
Ingrowth spaces: The smooth muscle cell bundles and parcels which developed in the inner
half of the graft surface were clearly circularly lined confirming in a powerful way how
important it is to provide ingrowing muscle cells with ingrowth spaces which allow an
orientation according to stress and strain principles rather than scaffold barriers.
Compliance: In vitro experiments performed in our laboratory have previously shown that
cyclic stress and strain has a twofold effect on smooth muscle cells. On the one hand the
smooth muscle cells rapidly align themselves along the vectors of the stress and the strain.
On the other hand, growth factors that are the driving force for the population of the graft
wall with vascular cells are produced at threefold levels by the ingrowing vascular cells if
they are exposed to cyclic stress and strain. Our calculations from the stress and strain
models clearly predicted that the site of smooth muscle cell proliferation will be the
innermost layer of the graft wall. The fact that this was exactly the site where the build up of
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an arterial vascular wall commenced was further proof for the importance of compliance.
Compared with the non-existence of any muscle build up in the wall of high porosity ePTFE
grafts, the distinct presence of the smooth muscle cell rich arterial wall at an early stage
underlines the role compliance plays in our polyurethane grafts once again.
The increased vascularization of the graft wall after lumenal sealing was confirmed by
quantitative analysis. For all the implant durations shown (>14 days), the vascularization
indexes of the skinned samples were greater than that obtained with the PU alone (Fig. 11.6).
The increases were especially noticeable in the shorter implant groups. This indicates the
increased speed at which the grafts are vascularized when a lumenal skin was present. A similar
trend is observed for the arteriolar indexes. Although the 28-day implant showed lower
arteriolarization than the control, the improved ability of the skinned graft to be invaded by
arterioles is evident in the 14 and 21 day implants (Fig.11.7).
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Calculation of the stress distributions in the artery wall demonstrate that the maximum tensile
stress is exactly in those regions of the graft wall where the thick smooth muscle cell bundles are
found in the skinned PU grafts (Fig. 11.8 a) [31]. Furthermore the direction of the principle
stress in a circumferential direction equally coincides with the alignment of the SMC bundles.
This orientation of SMCs also coincides with the orientation found in a non-scaffolded ingrowth
gel that was exposed to similar strains. These experiments by Kanda et al. [32] predicted the
orientation of SMCs in a scaffold with unrestricted ingrowth spaces and sufficient compliance to
freely exert tensile strain (Fig 11.8 b).
--or
\,
(a) (b)
Figure 11.8: Orientation of smooth muscle cells resulting from applied stresses
Another explanation of the rapid development of oriented SMC bundles in the grafts was
provided by Smith et al. [30], who showed not only the alignment of these cells in the direction
of the applied stress (in vitro), but also an upregulation in vascular endothelial growth factor
production with the application of cyclic stretch (Fig 11.9).
.mRN • Protei
Cyclic Stretch Static bFG Cyclic Stretch
Figure 11.9: Orientation of smooth muscle cells and the upregulation of growth factor production resulting from
applied stresses
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11.4 Comparison of graft types
The healing responses towards the five graft types described in Chapters 10 and 11 are
summarized in Table 11.1 for comparison. Apart from a thin lumenal fibrin layer deposited on
the low porosity (30llm) ePTFE, the ingrowth spaces are insufficient for significant ingrowth of
cellular material. Some capillary and SMC ingrowth could be achieved by increasing the IND
from 30 to 150llm, and the application of the lumenal sealant on the high porosity ePTFE
material led to further increases in capillary ingrowth and overall healing response. The lack of
compliance and restrictive nodular structure did not, however, allow for the orientation of
smooth muscle cells. The more open structure of the high porosity PU grafts, combined with
compliance, led to an even further improvement in arteriolization and SMC penetration, with the
result that these grafts showed overall improved healing over the high porosity ePTFE grafts.
The high porosity PU grafts allowed for some SMC orientation, but full transmural healing was
prevented by the presence of the fibrin layer. When the deposition of the fibrin layer was
prevented by the application of the sealant on the PU grafts, full vascularization of the graft wall
and helical SMC orientation was achieved. It may therefore be concluded that a combination of
large, interconnected porosity, compliance, and the prevention of lumenal fibrin deposition are
required to achieve full transmural neo-vascularization and circumferential SMC orientation.
PU Graft Implants
Table 11.1: Comparison of in vivo healing responses obtained with ePTF E and PU vascular grafts in the isolated
baboon femoral model.
Macrophage Penetration + +
+
++ +
+ +
++ +++
++ +++
++ +++
+ ++
4 5
Lumenal Fibrin Deposition + ++
:"z •.... Feat1iIe't Ys . '''30i4n enJ:<h ". :,160jmhPTFE' ,1500fJ1}1VeP1!fE" : 150prri'PU '~ \' ~~'50~ptit'
: .• .'[i,. •. .;'. ,c·' oe ..... '" ,. + Sl<in.;::>·: "/. ~., 'cc. .;. ",F'$jn .. 'fF
Compliance
Capillary Penetration + ++
Arteriole Penetration + +
SMC Penetration + +
SMC Orientation
Overall Response 2 3
-: minimal presence or absent +; ++; +++: Increased levels of presence 1,2,3,4,5: Increased levels of healing
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CHAPTER12
Conclusions
This study has resulted in an overall appreciation of the shortcomings of commercially available
synthetic vascular prostheses in providing successful long-term outcomes in small-diameter
applications. The conclusions that may be drawn from this study relating to the effect of the
many variables that determine the healing responses toward, and hence outcomes associated
with, vascular grafts are listed below.
~ Conventional Dacron and ePTFE prostheses fail in small-diameter applications due to
insufficient ingrowth spaces and compliance mismatching, resulting in the incomplete
healing of the graft wall. Even though various researchers produced experimental
polyurethane with sufficient compliance, transmural healing was not achieved due to a lack
of ingrowth space and/or pore interconnectivity.
~ A vascular graft should ideally contain unit pores that resemble open-faced pentagonal
dodecahedra. These structures allow for the uninhibited ingrowth of tissue in all dimensions,
and should theoretically allow for the helical re-orientation of radially ingrowing smooth
muscle cells to resemble the structure of a natural artery. Helical re-orientation has been
identified as a sine qua non for the mimicking of the structure and properties of natural blood
vessels.
~ Novel porous grafts, containing well-defined, interconnected pores could be produced by a
variation of the phase inversion/porogen extraction technique. The compliance of the
structure was achieved by using a thermoplastic elastomer (polyurethane).
~ The pore size not only determines the extent of tissue ingrowth, but also the inflammatory
response towards porous implants. A significant decrease in inflammatory response was
achieved by merely increasing the pore size from 60 to 150llm. It is important to note that
this decrease in inflammation was achieved without adversely affecting the neo-
vascularization.
~ The inflammatory response was further decreased by surface pacification. The combination
of large pores and covalent collagen surface immobilization resulted in an 80% decrease in
foreign-body giant cell formation.
~ Conventional animal models (dogs and yellow baboons) used historically for the evaluation
of vascular grafts failed to differentiate between trans anastomotic and transmural healing.
As the transmural outgrowth in the human stops within 1-2cm from the anastomosis, this
healing mode should not be relied upon to improve graft outcomes. The senescent, isolated
chacma baboon femoral model described in Chapter 9 has been shown to eliminate the
interference of transanastomotic tissue on the healing response.
~ Low-porosity (30llm) ePTFE does not allow much tissue ingrowth due to very limited
ingrowth spaces. Although the 6-fold increase in the internodular distance did result in an
improvement in wall healing, the fibrillar structure was not conducive to complete healing or
cellular orientation. The build-up of impenetrable fibrin on the lumenal surface was
identified as an inhibiting factor for full transmural healing. Although the elimination of this
fibrin layer by the application of a lumenal sealant improved tissue ingrowth into high
porosity ePTFE, the lack of compliance, combined with the restrictive structure, did not
allow for the orientation of smooth muscle cells in the graft wall.
~ Although capillaries and arterioles were able to penetrate most of the thickness of a high-
porosity PU graft wall, their progress was inhibited by the formation of an impenetrable layer
deposited and compacted by the blood in the lumen of the graft. Elimination of the hostile
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fibrin layer, again by the lumenal sealing of the graft, resulted in the desired healing
response. Not only were capillary and arteriolar vessels able to penetrate and populate the
entire thickness of the graft wall, but also thick, helically oriented bands of organised smooth
muscle cells were able to form within the porous structure. This response is believed to be a
very important milestone in field of vascular grafting, as holds the key for tissue-engineered
polymer/tissue composites that mimic natural vessels in form and function.
,t
Helically oriented SMCs.
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CHAPTER13
Future Research
1. Material stability
The high surface to volume ratio of the porous grafts places high demands on the stability of the
materials used in their production. Long-term studies are to be performed to confirm the
stability of the polyurethanes in vivo.
2. Graft production
The phase inversion/porogen extraction technique was a valuable tool in the production of grafts
containing the desired porosity for the proof of the concept. Large-scale production of vascular
grafts will require up-scaling of the present process (already initiated by the author) or
reinvestigation of the foam-extrusion process.
The biostable lumenal sealant used in this study allowed for the proof of the hypothesis that
healing may be improved by eliminating the fibrin deposition on the blood-contacting surface of
the grafts. In order to allow for the migration of the ingrowing tissue onto the lumenal surface
and to create a viable endothelium, research into the development of biodegradable sealants is
needed. The degradable sealant should be non-thrombogenic, and should be engineered to
degrade only when the ingrowing perigraft tissue reaches its outer surface.
Accurate in vitro and in vivo compliance measurement and mathematical modelling are
invaluable tools in the development of vascular grafts. Initial investigations into these fields
have been performed by other researchers in our laboratories. A further study, involving the use
of both finite element analysis and compliance measurement to optimise graft compliance by the
application of adventitial reinforcement, already forms the basis of a current study by another
Ph.D student.
3. Ingrowth matrixes
Ingrowth matrixes, capable of facilitating the ingress of the desired cell types into the porous
prostheses, may allow for the further improvement of graft healing patterns. The development of
such matrixes is the subject of an ongoing project by one of the groups in our unit (in
conjunction with international collaborators).
4. Long-term primate studies
Long-term implantation of the prosthetic grafts should be performed to follow the healing
patterns resulting from continued cellular ingrowth and reorganisation
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APPENDIX 1
Relationship between volumetric and diameter compliance of
vascular grafts.
c = ~v
v V I1P
d
_ ~vs-~Vd
Vdl1P
W2_W2_ s d
- D211P
d
_ (Dd +W)2 -m;
- D211P
d
W2+2DW+m2-w2_ d d d
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d
2DdW+W
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2W W2
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(A1.l)
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APPENDIX2
Solubility of polyurethanes
Table A3.1: The solubility of Medtronic M48 (A), Chronoflex AL 55D (B), Chronoflex AL 75D(C) and
Hydrothane (D) in various solvents.
ORGANIC SOLVENT s, e, ~ I'>t EXTENT OF SOLUBILITY
MPall2 MPall2 MPall2 MPall2 A B C D
M48 C55 C75 Hy
d
1. Acetic acid 14.5 8 13.5 21.4 4 1 1 1
2. Acetic anhydride 16 11.7 10.2 22.3 4 4 4 4
3. Acetone 15.5 10.4 7 20 3 4 4 4
4. Acetonitrile 15.3 18 6.1 24.4 4 4 4 4
5. Acrylonitrile 16.4 17.4 6.8 24.8 4 4 4 4
6. n-Amvl alcohol 16 4.5 13.9 21.7 3 4 4 4
7. Aniline 19.4 5.1 10.2 22.5 - I 2 2
8. Benzene 18.4 1 2.1 18.5 2 4 2 4
9. Benzaldehyde 19.4 7.4 5.3 21.4 1 1 2 2
10. Benzyl alcohol 18.4 6.3 13.7 23.8 4 4 1 1
Il. n-Butanol 16 5.7 15.8 23.1 4 4 4 4
12. Butyl acetate 15.8 3.7 6.3 17.4 3 4 4 -
13. sec Butyl alcohol 15.8 5.7 14.5 22.2 4 4 4 4
14. Chlorobenzene 18.6 4.3 4.1 19.5 2 4 4 3
15. Chloroform 17.8 3.1 5.7 18.9 1 I 1 1
16. m-Cresol 18 5.1 12.9 22.7 2 1 I 1
17. Cyclohexane 16.7 0 0 16.7 2 4 - 4
18. Cyclohexanone 17.8 6.3 5.1 19.6 1 2 2 3
19. Dichloroethane 19 7.4 4.1 20.9 - - 3 3
20. Diethyl ether 14.5 2.9 5.1 15.8 3 - 4 4
21. Diethylene glycol 16.2 14.7 20.5 30 4 4 4 4
22. N,N dimethyl acetamide 16.8 11.5 10.2 22.7 1 1 1 1
23. N,N dimethyl formamide 17.4 13.7 11.3 24.8 2 1 1 2
24. Dimethyl sulfoxide 18.4 16.4 10.2 26.7 2 2 1 4
25. 14-Dioxane 19 1.8 7.4 20.4 1 2 2 2
26. Ethanol 15.8 8.8 19.4 26.5 3 4 4 4
27. Ethyl acetate 15.8 5.3 7.2 18.1 4 4 4 4
28. Ethyl acetate 14.3 11.9 16.6 24.9 4 1 2 1
29. Hexane 14.9 0 0 14.9 4 4 4 4
30. Methylene chloride 18.2 6.3 6.1 20.2 2 1 2 1
31. methyl ethyl ketone 16 9 5.1 19 3 - 4 I
32. N-methyl-2-pyrrolidone 18 12.2 7.1 22.9 1 1 1 1
33. Nitrobenzene 20 8.6 4.1 22.2 2 3 1 4
34. Nitromethane 15.8 18.8 5.1 25.1 4 3 4 4
35. u-Propanol 16 6.8 17.4 24.5 4 4 4 4
36. Propylene glycol 16.8 9.4 23.3 30.2 4 4 3 4
37. Pyridine 19 8.8 5.9 21.8 1 1 1 1
38. Tetrahydrofurane 16.8 5.7 8 19.4 1 1 2 2
39. Toluene 18 1.4 2 18.2 3 4 4 2
40. Triethanolamine 17.2 15.6 21.3 31.5 4 4 4 4
41. Trimethvl phosphate 16.8 16 10.2 25.3 4 4 4 4
(1) Good solvent (3) Poor swelling agent
(2) Good swelling agent (4) Non-solvent
150
Stellenbosch University http://scholar.sun.ac.za
Appendixes
APPENDIX3
Derivation of the volumetric closed-porosity equation
(A3.1)
151
Stellenbosch University http://scholar.sun.ac.za
Appendixes
APPENDIX4
Derivation of the theoretical porosity equations
A4.1 Vacuum/pressure-cast scaffolds
Under the assumption of constant volume, the volume of the macropores equal the volume of the
porogen, and the degree of macroporosity can be calculated as follows:
P _ VTmac _ VTpor _ P BporT ---------
mac VTscaf VTscaf P por
(A4.I)
The total porosity can be derived in terms of the solution and bead characteristics by:
_ VTtp _ VTscaf - VTpol _ VTpol
PT ---- -1---
tp VTscaf VTscaf VTscaf
(A4.2)
VpOI will first be derived in terms of the known parameters. By definition, under the stated
assumptions:
_ mpar (A4.3)
_ mpor (A4.4)PBPar-V-- r-:«:
Tscaf Tpar
m _ mpol
P -~ (A4.S) (A4.6)soln - v: PPOI-V-
SOlD pol
mpal (A4.7) VTscaf = Vpar +Vsoln (A4.8)X=--
mSOID
Substitution of (A4.S) and (A4.6) into (A4.7) and solving for Vpol yields:
V XPSOlD V
pol = -- soln
Ppol
(A4.9)
From (A4.8) and (A4.9):
V - XP soln (V V)pol - -- Tscaf - Tpar«:
(A4.lO)
Substitution of (A4.1 0) into the originally derived equation for the total theoretical porosity
(A4.2), and simplification, yields:
«; = J I[XPSOID 11-VTpor Jil
~ P pol VTscaf ~
(A4.Il)
Finally, from (A4.1), it follows that:
(A4.12)
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A4.2 Paste-cast scaffolds
If particles are added to the polymer solution, and the sample cast from this mixture, the porosity
can not be determined by using eq. (A4.12) above, since the scaffold volume (VTscaf) cannot be
calculated from the bulk density of the particles (thus eq. (A4.3) does not apply in this case).
Thus substitution from eqs. (A4.6) and (A4.8) into eq. (A4.2) yields:
P = 1- m pol / P pol
Ttl' V
por + Vso1o
(A4.13)
Similar substitutions made from eqs. (A4.4) and (A4.5) yields:
P =1- m 1'01/ P pol
T~ / /m por P por + m solo P solo
(A4.14)
From eq. (A4.7):
P = 1- m 1'01/ P pol
Ttp / /m por P por + mpol XP solo
(A4.15)
Regrouping to obtain PTtp in terms of the particle/polymer ratio:
1PTtp = 1--------
mpor Ppol + Ppol
mpol r.: XPsaln
(A4.16)
Alternately, the porosity can be calculated from the particle/solution ratio by recognising that:
mpor _ mpor---x--
msoln mpol
(A4.17)
Thus from (A4.15):
P = 1- X/Ppol
Ttl' mIl
___!!!!!_ -- +--
msoln P par Psoln
(A4.18)
The theoretical macroporosity (PTmac) can be calculated from:
_ Vpor
PTmac -v-
lO/
(A4.19)
From (A4.4), (A4.6), (A4.8), and (A4.19):
P = mpor/ Ppor
Tmac m
_!!!!!_ + msoln
r.: Psoln
(A4.20)
Which becomes:
1
PTmac =----P--
1+ mso1n ___!!!!!_
(A4.21)
mpor Psoln
Calculation of porogen content
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For the vacuum casting method, the fraction of porogen in a dried graft (before porogen
extraction) can be calculated from:
mporPar = ---''-''-'--
mpor +mpol
PporVTpor=__ -,---,c..::..:._....:..r..::..:...._ __
(A4.22)
By dividing the numerator and denominator by VTscaf's one obtains:
Por= P~p_or_V~~_or~/_V_n_ca~if _
P por VTpor /VTscaf + XP so In Vso In /VTscaf
(A4.23)
Since the volume of the porogen and volume of the solution makes up the volume of the graft:
V V -V V~ _ Tscaf Tpor = 1- Tpor
VTscaf VTscaf VTscaf
(A4.24)
Substitution of eq A4.1 and A4.24 in A4.23 yields:
Por= PporPBpor/Ppor
P porPBpor / P por + XPsoln (1- (PBPor/ P por))
(A4.25)
= PBpor
PBpor + XPsoln (1- (PBPor/ P por))
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APPENDIXS
Derivation of copolymerisation equations
AS.1 Introduction
Copolymerisation may be defined .as a process whereby more than one distinctly different
monomer is incorporated into the same polymer chain. The generic term copolymer is used to
describe the product of such a process, whereas the terms bipolymer, terpolymer, quadripolymer
etc. are used to describe copolymers containing two, three, four, or more, monomers. Although
this definition may include the formation of many step-growth or condensation polymers, it is
not useful to do so, and this discussion will concern itself only with the chain-growth
copolymerisation of olefinic monomers. The discussion will further be limited to free-radical
copolymerization of binary mixtures, on which most of the work has been based.
Since it is the kinetics, rather than the thermodynamics, of a free-radical copolymerization that
determines the structure of the product, the copolymer composition and sequence distribution
may be determined by obtaining a set of differential equations describing the rates at which the
monomers are incorporated into the polymer. Various models have been developed to predict
the chemical composition of copolymers. They include the terminal model, the penultimate
model, the complex participation model, the complex dissociation model, and the depropagation
model. Only the terminal model will be discussed.
AS.2 Terminal model
A5.2.1 Instantaneous copolymer composition
The terminal model, which has become the standard kinetic treatment for free-radical
copolymerization systems, was independently published in 1944 by Mayo and Lewis [1], by
Wall [2], and by Alfrey and Goldfinger [3]. The model assumes that the reactivity of the
macroradical depends solely on the identity of the last-added monomer. Thus, for binary
systems, the four chain propagation steps in the copolymerization of a mixture of monomers
containing MI and M2 are shown in eq. (A5.1):
M;+MI
kil )M·I
M;+M2
k12 )M;
(A5.1)
M;+MI k21 )M;
M;+M2
k22 )M·I
The rates of disappearance of MI and M2 are then given by
-d[MI ]/ dt = kll[M;HMI ] + k21[M;HMI ]
-d[M2 ]/dt=kI2[M;][M2]+ k22[M;][M2]
(A5.2)
(A5.3)
If it is assumed that the radicals are low-concentration intermediates, that chains are long so that
the major path by which radicals MI· and M2• are formed is by interconversion of one into the
other, the following steady-state expression may be written:
d[Mn/dt=k21[M;HM( ]-kI2[M;HM2]=O (A5.4)
Division of eq. (A5.2) by eq. (A5.3), elimination of the radical concentrations via eq. (A5.4), and
the subsequent introduction of the reactivity ratios r, and r2 yield the following copolymerization
equation:
155
Stellenbosch University http://scholar.sun.ac.za
Appendixes
(A5.5)
where
lj = IsJk12 and r2= k22/k21 (A5.6)
Equation (A5.5), the differential copolymer composition equation, has widely become known as
the Mayo-Lewis equation, and has been used to determine the reactivity ratios of many
comonomer pairs.
Equation (A5.5) may also be rewritten in the following convenient forms (eqs. (A5.7) and
(A5.10»:
F; ljit2 + itf2
F2 r2f22 + itf2
(A5.7a)
by eliminating F2:
F. = Tjit2+ itf2
1 Tjit2 +2fJ2 +rd22
where
(A5.7b)
(A5.8)
and
(A5.9)
Skeist [4] proposed the following form (by eliminating f2):
F; = (lj - ;)it2 + it
(lj + r2 - 2).1; + 2(1- r2).I; + r2
(A5.1O)
where
f2 = 1- it and F2 = 1- F; (A5.lt)
The dependence of the instantaneous copolymer composition on the feed composition for
various rl-r2 pairs is clearly seen in Figure A5.1, which is the graphical representation of eq.
(A5.1O) for the following cases:
A5.2.1.1 r1=r2=O (kll«k12 and k22«k21)
Each of the two growing macroradicals shows a strong preference for cross-propagation. In the
theoretical case where r1=r2=O, this preference is absolute, and each of the radicals will add only
to the monomer that does not constitute its own active centre. This will result in the formation of
a strictly alternating copolymer. The Mayo-Lewis equation simplifies to:
(A5.12)
which shows that the two monomers are consumed at the same rate, regardless of the
composition of the monomers in the feed.
A5.2.1.2 r1=r2=1 (kll=k12; k22=k21)
In this case, neither of the radicals shows any preference for either of the monomers, so that the
relative rate of monomer consumption depends solely on the relative composition of the
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monomers in the feed. Equations (A5.5) and (A5.7) can then be simplified to eq. (A5.13), where
the copolymer composition equals the monomer feed composition.
d[M]] [M]]
d[MJ = [M2]
or F; = J; (A5.13)
This is equivalent to the early Wall [5] treatment with a=1
A5.2.1.3 rl>l; r2<1
Both of the active centres have a preference for addition to one of the monomers, in this case M].
This leads to the formation of a copolymer that is always enriched in M], relative to the feed. A
similar argument can be made for the case (r.c-l ; r2<1).
If r]r2=1, or k]/k]2=k]2/k22' which is clearly a special case of (r.c-I: r2<1), both active centres
show the same preference for addition to the more reactive monomer. The Mayo-Lewis equation
can then be simplified to:
d[M]] [M]]
d[MJ=Ij[M
2
]
or F. - 'it;
]- (lj-l)J;+1
(A5.14)
This is equivalent to the earlier Wall [5] treatment with a=r], and was later termed "ideal
copolymerization" by the same author [2], who also pointed out the analogy between binary
copolymerization and Raoult's law describing the boiling of a mixture of liquids.
Each radical prefers cross-propagation to homopropagation, although this preference is not
absolute. The tendency to alternate will increase as r, and r2 approach zero. The cross-over
point in a graph of F] vs. f], or the point where the copolymer composition curve crosses the
diagonal representing the composition of the feed, can be determined by determining three the
roots of eq. (A5.7) with F]=f].: [2]
J; =0 (A5.15a)
(A5.15b)
(A5.15c)
The two solutions, f]=O and f]=I, are trivial since they represent the two pure monomers. Since
f] is a fraction, the third root only has a significance for O<f]<I, which requires that:
lj < 1 and r2 < I simultaneously, or
lj> I and r2 > 1 simultaneously
Both conditions can be incorporated into one statement, namely:
(lj-l)h-1»0
This composition can also be defined as the point where d[M]]/d[M2]=[M]][M2].
into eq. (A5.5) yields:
[M]] = 1-r2
[M2] I-Ij
Substitution
(A5.16)
Simple substitution of eqs. (A5.8) and (A5.lI) shows that eq. (A5.16) is equivalent to eq.
(A5.15c).
157
Stellenbosch University http://scholar.sun.ac.za
Appendixes
At this point the monomer and copolymer compositions are identical. Wall [2], in analogy to
distillation, has termed the reaction under such conditions an azeotropic copolymerization.
A5.2.1.5 rl>l; r~l
In this case, both types of radical prefer homopropagation to cross-propagation, and there will
either be a tendency toward independent and concurrent homopolymerization, or toward the
formation of copolymers containing long sequences of each monomer ("blocky: copolymers).
There are very few, if any, cases where the rlr2 product is significantly greater than unity [6].
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
fl
1- -- rl-0;r2-0-rl-I; r2-1-rl-0.l; r2-10-rl=10; r2-0.1-rl-0.2; r2-0A -rl.l0; r2.,sl
Figure A5.1: Graphical representation of instantaneous copolymer composition as afunction of monomer
composition for various reactivity ratio pairs.
A5.2.1.6 Instantaneous sequence distribution
Consider the first propagation step in eq. (A5.1) where MlO adds to MI. The probability of this
step occurring (Pil) is given by:
(A5.17)
Similar treatment of the other three propagation steps III eq. (A5.1), and subsequent
simplification leads to the following four probabilities:
lj[MI] rJI (A5.18a)
~I = [ ] [ ]lj MI + M2 rJI + 12
~2=
[M2] 12 (A5.18b)
lj[M;]+[M2] ljJ; + 12
P22 =
r2[ M2] r212 (A5.18c)
'2[M2]+[M;] r212 + J;
P21 =
[Ml] J; (A5.18d)
r2[ M2] + [M2] r212 + ft
with
~1+~2=1 and P22 + P21 = 1 (A5.19)
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Copolymer sequence distributions are usually expressed as the number-fractions of uninterrupted
sequences of a given monomer (MI or M2) that are of a particular length. An uninterrupted
sequence of MI units of length x is formed when an MI'-terminated macroradical adds (x-I) MI
units followed by an M2. The probability of such a sequence occurring can be determined by
calculating the product of the probabilities of the independent steps that lead to the sequence.
The number fraction of all MI sequences of which the length is x (NI;J then equals the
probability that any particular MI sequence is of that length (PI;J. A similar argument holds true
for M2 sequences. Thus:
(A5.20a)
and
(A5.20b)
The statistical approach toward copolymer composition is very useful, not only in the
determination of sequence distributions, but also in the derivation of the instantaneous
copolymer composition equation. In the derivation of the Mayo-Lewis equation (5) it was
necessary to assume the steady-state condition stated in eq. (4). Even more complex steady-state
assumptions are required for the derivation of composition equations for models where the
effects of more remote units are considered (penultimate model, pen-penultimate model, etc.).
Goldfinger and Kane [7] were the first to use the statistical approach to derive the copolymer
composition equation for the terminal model without recourse to steady-state assumption.
The number average sequence length of MI (xlaJ, which equals the "relative weight" of all MI's
(WI)' determined by the summation of the sequence fractions properly weighed according to the
number of MI units in each sequence, is given by
WI = xlav = L xNI;x
x=1
(A5.21a)
and similarly:
oe
W2 = x2av = LxN2;x
x=1
(A5.21b)
which can be shown to correspond to (see Appendix 6):
1
WI=XI =-av p.
12
(A5.22a)
and
(A5.22b)
The molecular composition of the copolymer can now be expressed as the ratio of the respective
weight fractions.
F; = WI = P21 = f. x Ijf.+ /2 (A5.23)
F2 W2 ~2 /2 r2/2 + f.
Simple substitution shows that eq. (A5.23) is equivalent to the Mayo-Lewis equation.
A5.2.2 Composition drift
The copolymer compositions, sequence distributions, and average sequence lengths derived
above are instantaneous values, and are therefore only adequate to describe the polymer
properties at fixed (constant) feed compositions (and fixed reactivity ratios). Fixed feed
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compositions can be maintained by continuously feeding the reactor at a rate that equals the
polymerisation rate with a monomer mixture identical in composition to the copolymer being
formed. If this is not done, there will be a continuous change or drift in feed (and hence
polymer) composition as the reaction progresses, since the compositions of copolymer and feed
generally differ. Exceptions are terminal-model copolymerisation in which azeotropic behaviour
is observed. Fixed feed compositions in batch reactors can also be approximated by stopping
copolymerization reactions at very low conversions (typically 5 to 10%), thereby limiting the
effect of composition drift.
For obvious reasons, it is customary in practice to carry out polymerisations to high conversions,
and the manner in which the copolymer composition varies as the reaction proceeds is of great
importance. This relation can be obtained by integrating the differential composition equation
(5) to yield [1]
In [M2] =__l_ln [M~][MI]
[Mn l-r2 [M?][M2]
(A5.24)
Direct application of the integrated composition equation is difficult, and although computation
may be made easier by simplifications or power-series approximation [8], the use of this
equation is time consuming [6].
There is, however, a more convenient way of deriving a conversion-composition equation. The
analogy between copolymerization and the boiling of a mixture of liquids has already been
mentioned. Skeist [4] took this analogy further by using the Raleigh equation, which relates the
composition and yield in distillation processes, to derive the relation between the composition
and conversion of copolymerization reactions. Consider a mixture of monomers MI and M2' of
mole fractions fl and f2 respectively, such that the polymer originally formed is enriched in MI
relative to the feed (FI>fl). If there is a total of M moles of monomers present, the number of
moles of MI will be f.M.
When dM moles have polymerised, the polymer will contain FldM moles of MI. At this time,
the number of moles of MI in the feed will be reduced to (M-dM)(fl-dfl). A material balance of
MI dictates that:
I.M - (I. - dI.)(M - dM) = F;dM
Ignoring the product of the differentials, Skeist [4] showed that:
In Mo = f J~ dI. Skeist EquationM Jl F;-I.
This conversion-composition equation (26) is model independent and can be used to determine
the conversion, irrespective of which model was used to calculate the instantaneous copolymer
compositions. Thus, if FI is calculated at suitable intervals for Ocf.« l by using the appropriate
model, graphical or numeric integration of the function l/(FI-fl) between the desired values of fl
yields In(MlMo). The conversion, X, can then easily be calculated form:
(A5.25)
(A5.26)
X=I- M
MO
Meyer and Lowrey [9] have obtained an analytical solution to Skeist's equation for the terminal
model by substitution of eq. (A5.10) into eq. (A5.26) and subsequent integration. This yields:
(A5.27)
.!!_ =(.iJ...J(iLJ(I.O - oJ (Meyer-Lowry equation)
MO I.0 /2° I.-o (A5.28)
where
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a = r2/(1- r2)
f3 = r.J(l- 'i)
r= (1- 'ir2)/(1- 'i)(1- r2)
0= (1- r2)/(2- 'i - r2)
The average composition of the total polymer formed at that point, Flav' then follows either by:
• graphical integration of FI vs. MI' or
• by calculating the difference between the composition and amount of residual monomers and
those originally present. Thus:
F = Mlo-MI
lav MO-M
~oMo- ~M_ I I
- MO-M
_ J;0 - J;(M/ MO)
- l-(M/MO)
or, by substituting eq. (27):
F. _ J;0 - J; (1- X)
lav - X (A5.29)
A5.2.3 Determination of reactivity ratios
Reactivity ratios are generally determined by the preparation of copolymers from known feed
compositions (f.; f2), analysis of the copolymer composition (Flav; F2av), and subsequent
calculation of the ratios (r.; r2) by manipulation of the appropriate copolymerisation equations.
Since the use of the integrated forms of the copolymerization equations is impracticable,
constant feed compositions are approximated by limiting the reactions to low conversions.
Under these conditions:
J; ::::;J;0 ::::;const
and thus
(A5.30)
(A5.31)
A5.2.3.1 Approximation method
The approximation method depends on the fact that the composition of the copolymer is almost
exclusively dependent on r, when low concentrations of M2 are used [10]. Under these
circumstances, it can be shown that:
(A5.32)
The advantage of this method is that it allows for quick estimation of the reactivity ratio rl by
performing a single experiment, but sensitive analytical procedures are required to accurately
determine the mole fraction of monomer 2 incorporated into the polymer (F2). The method is
also based on the assumption that the system obeys the usual copolymerisation mechanism
without any means of independently evaluating the validity of the assumption, and may be
seriously biased ifrl<O.l or rl>1O.
Similarly, at low concentrations of MI' r2 may be obtained from:
r2=J;/F; (A5.33)
161
Stellenbosch University http://scholar.sun.ac.za
Appendixes
A5.2.3.2 Curve-fitting method
This method comprises preparing a graph of observed copolymer compositions (FI) versus
monomer composition (fl) and then drawing a curve represented by eq A5.7a for selected r, and
r2 values. This process is repeated for other r., r2 pairs until a good fit to the experimental data is
achieved. The method provides the observer with:
• a visual check on the validity of the model as the data is generally collected over a wide
range of monomer compositions,
• a qualitative measure of the experimental error (assuming the validity of the model), and
• a qualitative measure of how well the reactivity ratios are estimated.
Extensive iterative calculations and subjective weighing of data (in the determination of how
good the fit is) are major disadvantages.
Tidwell and Mortimer proposed a non-linear least-squares method (based the Gauss-Newton
non-linear least-squares procedure) to remove observer subjectivity and to quantitatively
determine the confidence limits for the r l , r2 set [10]. These authors have also given guidelines
to the planning of experimental conditions. Two concentrations of M2 (f21 and f22) that will
lead to precise estimates of the reactivity ratios are calculated. The first method relies on
maximizing the modulus of the determinant of a 2x2 matrix with elements consisting of the
partial derivatives of functions of (f21, f22, r l , and r2) with respect to r l and r2. They have also
provided a table of computations that maximise the modulus for selected r l , r2 values in order to
facilitate future experimental work without the need for further calculation.
A somewhat less exact, but much simpler method, involves the estimation of experimental
conditions such that:
121"" r.J(2+ 'i)
and
(A5.34a)
(A5.34b)
A5.2.3.3 Intersection method
Mayo and Lewis proposed the rearrangement of eq A5.7a to yield [10]:
'i = r2(FJ~ J+(1211<; -IJF2f. f. F2
Thus, if for each experimental data set, r l (ordinate) was plotted against r2 (abscissa), a line with
slope (Flf/1F2f/) and intercept (fifl)[(FIIF2)-1] would ensue. Theoretically (and in the absence
of experimental errors) these lines should intercept at a single point on the rl , r2 plane.
(A5.35)
A5.2.3.4 Linearization method
Yet another re-arrangement of eq 7a, proposed by Fineman and Ross [11] yields:
f. (F2 - F;) _( F2f.2}
- ---2 l+r2
121<; 1<;12
Consequently, a plot of f1(F2-FI)/f2F1 versus -F2fI2IFlf/ would yield a straight line with slope r,
and intercept r2•
(A5.36)
A5.2.3.5 The Q-e scheme
The reactivity of monomers with free radicals involves resonance, polar and steric factors.
Although the Q-e scheme does not accommodate steric factors, it is an attempt to combine the
effects of resonance stabilization and polarity on the reactivity of monomers with free radicals in
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a semiquantitative fashion. Whereas copolymerization theory allows the description of
monomer pair reactivities by relative reactivity ratios for that particular pair, the Q-e scheme is
an attempt to characterize each individual monomer with a set of numerical constants.
The central assumption of the scheme is that the rate constant, ~j for the attack of radical i upon
monomer j is given by:
(A5.37)
Where Pj is characteristic of radical i; Qj is the mean reactivity of monomer j; and ej and ej are
measures of the polarity of the radical and monomer, respectively. When eq 5.37 is applied to
the relative rate constants for a given radical i with monomers j and k, the radical reactivity
factor cancels out:
k.. Q. (( ))i': = QJ exp -ei ej -ek
jk k
(A5.38)
Thus the relative reactivity ratios, r1 and r2, of a binary system may be written as:
(A5.39)
r: = k22= Q2 exp(-e (e - e ))
2 k /) 221
21 ~
(A5.40)
Each monomer is characterised by two numbers, Q and e, from which the reactivity ratios of any
chosen monomer pair can be estimated, even before any experiment with the particular pair is
carried out (as long as each monomer has previously been copolymerised with any other
monomer). Styrene was chosen as the standard and assigned values of Q = 1.00 and e = -0.80.
Values of Q generally increases with increased resonance stabilization, while e values become
less negative as groups attached to the double bond become more electron-attracting [12].
(i) Resonance stabililization
A fundamental premise inherent in the Q-e scheme is that resonance stabilization affects the
reactivity of both monomer and corresponding radicals, but in reverse ways [13]. Thus,
conjugation in a monomer leads to high reactivity of the monomer with radicals in general, and
low reactivity of the corresponding radical to monomers in general. Unconjugated monomers,
on the other hand, possess low reactivity towards radicals, while their corresponding radicals
possess high reactivity towards monomers in general.
The effect of delocalization can be further illustrated by the series of R-groups below (in the
monomer RCH=CH2 and the corresponding radical), arranged in decreasing delocalization
potential. R-groups with high delocalisation potential (egg -CH6) increase the stability of the
radical (and thus decrease the reactivity thereof), while a group such as -OCOCH3 decreases the
stability of the radical (and thus increases the reactivity thereof). Thus:
Increased radical reactivity
-CH6 > -CH=CH2 > -COCH3 > -CN > -COOR> -CH3 > alkyl> -OCOCH3
... Increased monomer reactivity
Suppression of radical reactivity toward a monomer is, however, stronger than the enhancement
of monomer reactivity toward a radical [12]. The styrene radical, for example, is 1000 times less
reactive toward a given monomer than the vinyl acetate radical, whereas the styrene monomer is
only 50 times more reactive than the vinyl acetate monomer toward a given radical.
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(ii) Polar effects
The polarity of the R-group also influences the nature of the copolymer. Strong electron-
withdrawing groups (ester, acid, ketone, nitrile) reduce the electron density of the double bond,
while electron-donating groups (alkyl, ether, acetate) have the opposite effect. Thus acrylonitrile
and methyl vinyl ketone with similar polarities form random copolymers, whereas acrylonitrile
and methyl vinyl ethers with opposite polarities generally form alternating copolymers.
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APPENDIX6
Derivation of average weight equation
cc
W; = LxNI;X
x=1
= LX~~-I ~2
x=1
= 1-PII~ xPx
LJ I I
~ I x=1
Expansion of the series leads to:
w; = 1-~ I (~I + 2~21 + 3~31+ ... +XPI~+"')
~I
= 1- ~ 1+ 2PII - 2P/1 + 3~; - 3~31+ ... +XPI~-1 - x~~+ ...
= 1+ ~ I + ~21+ PI31+",+PI~+'"
And its summation:
Now consider:
n
L~~=~ I+ ~~ + Jfl+"'+~~
k=1
and
n
~pk+1 p,2 r: r: pn+1LJ II = II + II + 11+"'+ II
k=1
so that
n nv r: ~pk+1 P, p,n+1LJ 11- LJ II = 11- II
k=1 k=1
n n
LPI~ - ~IL~~ = PII- Ptl+!
k=1 k=1
n .
LPI~(l- ~I)= ~ 1- ~nt
k=1
n P pn+1~pk _ 11- II
LJ 11-
k=1 1-P; I
_l_~p'k _ 1-~~
LJ 11-
~ I k=1 1-PIl
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APPENDIX7
Reaction mechanisms and side reactions for the EDC/NHS
activation of carboxylic acids
-
- AND
N.N'·Substituted urea
+
°II
R1-N-C-N-R2H H
+
fl
~
f
N
IR2
Carbodiimide
Carboxylic acid
HYdrolY';'!
N,N'-Substituted urea
--- N-Acyl shift
fl-
F~ FO
R-C-N
IR2
N-AcylureaCarboxylic acid O-Acylisourea
°
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